{"meta":{"query_hash":"1e57ce0a9843","filters":{"venue":"European Journal Of Haematology"},"cohort_total":183,"direct_labels_cover":0,"predictions_cover":183,"exported":183,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1e57ce0a9843","api":"https://metacan.xera.ac/api/v1/cohort?venue=European+Journal+Of+Haematology"},"results":[{"id":"W11553269","doi":"10.1034/j.1600-0609.2001.067001056.x","title":"Fisheries management evaluation: a case study of the British Columbia groundfish fisheries","year":2008,"lang":"en","type":"dissertation","venue":"European Journal Of Haematology","topic":"Marine and fisheries research","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Groundfish; Fishery; Fisheries management; Fisheries science; Bycatch; Business; Fish <Actinopterygii>; Fishing; Biology","score_opus":0.027903666116209258,"score_gpt":0.26287988905615145,"score_spread":0.2349762229399422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W11553269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9476924,0.0011692414,0.0018995554,0.0064810677,0.00004113752,0.0007012541,0.00015331159,0.00003238061,0.04182974],"genre_scores_gemma":[0.9758691,0.0018131334,0.00605895,0.0009610387,0.000021542004,0.00027253118,0.00011555622,0.000032969783,0.014855185],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9915577,0.004546297,0.0002992697,0.00026057524,0.0019394945,0.0013966018],"domain_scores_gemma":[0.9895873,0.004929668,0.0006312824,0.0003633892,0.0031448908,0.0013435031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009111725,0.00066385075,0.00043481015,0.0021135793,0.012994749,0.0037984322,0.0013179433,0.002299945,0.0027536913],"category_scores_gemma":[0.019514129,0.00037988543,0.00039388225,0.0040349723,0.0025453025,0.0016773936,0.0032550585,0.0022333143,0.0002474489],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075141975,0.003998898,0.2179086,0.0013216924,0.00022217474,0.081794456,0.21416742,0.0098792445,0.0036304938,0.02130649,0.04418677,0.40083236],"study_design_scores_gemma":[0.00014941528,0.0012319939,0.24021193,0.0018203835,0.00018729565,0.008650443,0.60951614,0.011464098,0.002607528,0.004432698,0.1195208,0.00020722525],"about_ca_topic_score_codex":0.5972956,"about_ca_topic_score_gemma":0.83112,"teacher_disagreement_score":0.40270442,"about_ca_system_score_codex":0.031173585,"about_ca_system_score_gemma":0.025403613,"threshold_uncertainty_score":0.81015205},"labels":[],"label_agreement":null},{"id":"W1494952166","doi":"10.1111/j.1600-0609.2011.01725.x","title":"The cellular and molecular mechanisms for neutropenia in Barth syndrome","year":2011,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Biology; Myeloid; Apoptosis; Progenitor cell; Molecular biology; Cell biology; Myeloid leukemia; Transfection; Cancer research; Mitochondrion; Haematopoiesis; U937 cell; Cell culture; Stem cell; Biochemistry; Genetics","score_opus":0.010293353384232918,"score_gpt":0.20196479087540822,"score_spread":0.1916714374911753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1494952166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92588073,0.054671325,0.011363254,0.0013967619,0.0001469804,0.00010933401,0.00055020076,0.00025366357,0.005627708],"genre_scores_gemma":[0.9833612,0.01284783,0.0018887356,0.00014644128,0.000043756976,0.000060252496,0.00030907747,0.0000064461456,0.0013362489],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998609,0.00003348596,0.000015567934,0.000018698562,0.000044143762,0.000027169845],"domain_scores_gemma":[0.999931,0.000013201421,0.000025336614,0.000008547352,0.000005536636,0.000016432097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019206242,0.00038604793,0.00019315477,0.00035683284,0.00023131316,0.00035507284,0.00029381507,0.0005706634,0.0007423759],"category_scores_gemma":[0.00015246012,0.00017575898,0.00023710389,0.00016094264,0.00058372476,0.0005059986,0.00033419923,0.00056901586,0.00020473829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004033026,0.00007420703,0.0017784357,0.00030382694,0.000022246468,0.0022566544,0.000061399405,0.00057442836,0.97636956,0.007102734,0.0003799739,0.01067319],"study_design_scores_gemma":[0.0002699164,0.0015733435,0.08361988,0.000138486,0.00013908715,0.03031808,0.0003223692,0.0047967,0.847052,0.007849013,0.023869222,0.00005204787],"about_ca_topic_score_codex":0.00037293695,"about_ca_topic_score_gemma":0.00037285712,"teacher_disagreement_score":0.0007423759,"about_ca_system_score_codex":0.00049484655,"about_ca_system_score_gemma":0.00022847771,"threshold_uncertainty_score":0.003590405},"labels":[],"label_agreement":null},{"id":"W1572717899","doi":"10.1111/j.1600-0609.2011.01629.x","title":"Chromosome abnormalities defined by conventional cytogenetics in plasma cell leukemia: what have we learned about its biology?","year":2011,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Karyotype; Cytogenetics; Biology; Chromosome; Multiple myeloma; Genetics; Leukemia; Somatic evolution in cancer; Plasma cell leukemia; Cancer research; Cancer; Pathology; Immunology; Gene; Medicine","score_opus":0.0699727070098944,"score_gpt":0.2965551187885002,"score_spread":0.22658241177860583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572717899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89950526,0.030286366,0.06307768,0.0041224747,0.00010850837,0.000033970526,0.00035860136,0.00013718012,0.0023700013],"genre_scores_gemma":[0.9851694,0.007894951,0.0062042335,0.000106450694,0.00007201757,0.00001744059,0.00013095782,0.000011490383,0.00039317427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967575,0.00013633096,0.000017781747,0.000066472574,0.00007131793,0.000032454216],"domain_scores_gemma":[0.99859506,0.0007790029,0.0003062594,0.00014309259,0.000102965816,0.00007362755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012760424,0.0002844672,0.00035587518,0.0006737624,0.00014641606,0.00087895524,0.00064128835,0.000667242,0.0007226828],"category_scores_gemma":[0.004796296,0.0001570093,0.00037591602,0.00080002943,0.0009897354,0.0015446859,0.0004593773,0.00046434824,0.00014981741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008760196,0.00018736,0.52601,0.00077762984,0.0003406209,0.0011343338,0.00076971855,0.2059305,0.011018503,0.038896266,0.0023066003,0.21175256],"study_design_scores_gemma":[0.00009510007,0.0010752028,0.23893398,0.00020475175,0.00020389253,0.0051077246,0.0010938725,0.58695835,0.0034575807,0.15241799,0.010326107,0.00012546507],"about_ca_topic_score_codex":0.0024599698,"about_ca_topic_score_gemma":0.0017515178,"teacher_disagreement_score":0.0024599698,"about_ca_system_score_codex":0.00072140706,"about_ca_system_score_gemma":0.0004805823,"threshold_uncertainty_score":0.006748438},"labels":[],"label_agreement":null},{"id":"W1572992859","doi":"10.1111/j.1600-0609.2005.00461.x","title":"Transformation in the use of radiation therapy of Hodgkin lymphoma: New concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT)","year":2005,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Comprehensive Cancer Network","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Randomized controlled trial; Lymph node; Oncology; Radiology; Internal medicine","score_opus":0.08705444835431066,"score_gpt":0.333600224076648,"score_spread":0.24654577572233738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572992859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19787735,0.5983366,0.07075979,0.08390279,0.0051547815,0.00028258684,0.0005568996,0.00057816686,0.04255101],"genre_scores_gemma":[0.57697654,0.26650706,0.09501284,0.035469636,0.01107425,0.00037215167,0.00080977764,0.00037599396,0.013401736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840814,0.00064677926,0.00014946227,0.00037379187,0.00035220088,0.0000696158],"domain_scores_gemma":[0.99766904,0.0008126154,0.0005225021,0.0002780478,0.0005060713,0.00021179042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034612387,0.00042118022,0.0003741712,0.00089700427,0.00027971744,0.001397766,0.00080314174,0.001160984,0.0028620767],"category_scores_gemma":[0.0031556273,0.0001821704,0.00056105986,0.0012732211,0.0020387997,0.0017997451,0.0012790017,0.0022405535,0.0008836839],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000605375,0.00021321935,0.016955549,0.0014877807,0.000061646744,0.0001961343,0.00046077167,0.0008150772,0.011083998,0.027789945,0.0065342537,0.93379635],"study_design_scores_gemma":[0.00021983897,0.002405375,0.11286283,0.0012810163,0.0002395473,0.0071679386,0.0006829305,0.0017976912,0.012061483,0.032243837,0.8288931,0.0001445495],"about_ca_topic_score_codex":0.0013318984,"about_ca_topic_score_gemma":0.0014163123,"teacher_disagreement_score":0.0034612387,"about_ca_system_score_codex":0.0021137653,"about_ca_system_score_gemma":0.0014075689,"threshold_uncertainty_score":0.018305004},"labels":[],"label_agreement":null},{"id":"W1576118523","doi":"10.1111/j.1600-0609.2011.01602.x","title":"Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients","year":2011,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; University of Alberta","funders":"","keywords":"Carfilzomib; Multiple myeloma; Oncology; Variation (astronomy); Alkaline phosphatase; Medicine; Internal medicine; Chemistry; Lenalidomide; Biochemistry; Enzyme","score_opus":0.04353107053041077,"score_gpt":0.26935986516702304,"score_spread":0.22582879463661226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1576118523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850756,0.0009476014,0.00007477633,0.000040543327,0.0000026874754,0.000006599998,0.00012110064,0.000007891851,0.00029117346],"genre_scores_gemma":[0.99969363,0.00008484725,0.000030217117,0.000016789416,0.000004757804,0.0000032273667,0.000114225964,0.0000011080972,0.000051295763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955267,0.00011578822,0.000053494634,0.00008999306,0.000109809516,0.000078219244],"domain_scores_gemma":[0.998887,0.00020000583,0.0006358555,0.00004496062,0.00007128823,0.00016090213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045964794,0.00019205932,0.0005241762,0.0004977503,0.0002130242,0.00044265797,0.00019625713,0.0003393005,0.00055687863],"category_scores_gemma":[0.0014453117,0.0001388159,0.00033629843,0.000683137,0.0001695968,0.00021238536,0.00018250437,0.0003911106,0.00011128033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025272977,0.000060509487,0.9800095,0.000030832714,0.00013427112,0.00034441744,0.00007274412,0.00021602695,0.0057414677,0.000020435386,0.00014281725,0.010699696],"study_design_scores_gemma":[0.000036288584,0.0006466505,0.99650455,0.000003918647,0.00007054982,0.0011546713,0.000034636814,0.0002494362,0.0009254533,0.00001937415,0.00034990654,0.000004426212],"about_ca_topic_score_codex":0.00074637495,"about_ca_topic_score_gemma":0.0011897496,"teacher_disagreement_score":0.00074637495,"about_ca_system_score_codex":0.00039805673,"about_ca_system_score_gemma":0.00015858041,"threshold_uncertainty_score":0.0028880835},"labels":[],"label_agreement":null},{"id":"W1582036651","doi":"10.1111/j.1600-0609.2005.00464.x","title":"Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?","year":2005,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; ABVD; Disease; Radiation therapy; Randomized controlled trial; Lymphoma; Chemotherapy; Stage (stratigraphy); Oncology; Intensive care medicine; Internal medicine; Surgery; Vincristine; Cyclophosphamide","score_opus":0.1503753029679155,"score_gpt":0.3515405477591824,"score_spread":0.20116524479126693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1582036651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034218337,0.8636821,0.0006988805,0.08802801,0.004972543,0.00014810341,0.0005912312,0.00003325278,0.007627631],"genre_scores_gemma":[0.33774185,0.51032406,0.004451957,0.118532896,0.024648197,0.0003827178,0.0013353133,0.00007007432,0.0025129556],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9938088,0.0036527417,0.0008861657,0.0005072227,0.0009597035,0.00018527485],"domain_scores_gemma":[0.91736025,0.063845426,0.011523575,0.0018870024,0.003356833,0.0020269416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009963442,0.0004061584,0.0030621458,0.0009790158,0.0005401562,0.0018485659,0.001746776,0.0049206913,0.009116243],"category_scores_gemma":[0.05349334,0.00037288095,0.0030569462,0.0019962604,0.0016599172,0.0031803045,0.00082129,0.003988908,0.0012499373],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037893288,0.0010505391,0.033053182,0.04982127,0.00947833,0.00049483037,0.00023641491,0.000834278,0.0014376938,0.0044777603,0.028105129,0.8331173],"study_design_scores_gemma":[0.05297906,0.0462262,0.19418624,0.097072765,0.046877977,0.0047270954,0.0018484882,0.0015042585,0.002569542,0.024343153,0.52726024,0.00040502133],"about_ca_topic_score_codex":0.0010872532,"about_ca_topic_score_gemma":0.0031875188,"teacher_disagreement_score":0.009963442,"about_ca_system_score_codex":0.0011754519,"about_ca_system_score_gemma":0.0019243895,"threshold_uncertainty_score":0.052692354},"labels":[],"label_agreement":null},{"id":"W1794399453","doi":"10.1111/j.1600-0609.2005.00463.x","title":"How to define intermediate stage in Hodgkin's lymphoma?","year":2005,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stage (stratigraphy); Medicine; Internal medicine; Multivariate analysis; Population; Oncology; Lymphoma; Prospective cohort study; Proportional hazards model; Biology","score_opus":0.019069780225030735,"score_gpt":0.26287488639337947,"score_spread":0.24380510616834875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1794399453","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631825,0.014983519,0.010145601,0.0049353205,0.00051648327,0.00016894448,0.000683237,0.00009743056,0.0052869976],"genre_scores_gemma":[0.99286664,0.0012330048,0.004523099,0.0003493497,0.00022450533,0.000045603934,0.00040986534,0.000016290167,0.00033159714],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9993476,0.0003290296,0.000066063796,0.000065152984,0.00011080149,0.00008132784],"domain_scores_gemma":[0.99803036,0.00077081023,0.000353598,0.0000878801,0.00044235506,0.0003149353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029063094,0.0003587298,0.00041607665,0.0011178124,0.00022024004,0.00083115435,0.0005968178,0.00048045313,0.0011853889],"category_scores_gemma":[0.008751177,0.00008022192,0.0002275505,0.0007600243,0.000731195,0.0009622914,0.00038949098,0.0006838695,0.0004946268],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054335775,0.000033166998,0.93379664,0.00010076046,0.000027475906,0.000115349496,0.0001455105,0.0003417939,0.0005636513,0.00035045564,0.0030187364,0.060963247],"study_design_scores_gemma":[0.00016636356,0.0013016083,0.9670109,0.0005746556,0.00019034262,0.0033330356,0.002053597,0.0062644402,0.0013680408,0.0054337536,0.012232168,0.000071005066],"about_ca_topic_score_codex":0.0027758821,"about_ca_topic_score_gemma":0.004920542,"teacher_disagreement_score":0.0029063094,"about_ca_system_score_codex":0.000418345,"about_ca_system_score_gemma":0.00074144866,"threshold_uncertainty_score":0.01537019},"labels":[],"label_agreement":null},{"id":"W1844789861","doi":"10.1034/j.1600-0609.2003.00049.x","title":"Complex interaction of Hb Hekinan [α27(B8) Glu–Asp] and Hb E [β26(B8) Glu–Lys] with a deletional α‐thalassemia 1 in a Thai family","year":2003,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Associated Medical Services","funders":"Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; National Science and Technology Development Agency","keywords":"Thalassemia; Chemistry; Medicine; Genetics; Molecular biology; Biology","score_opus":0.019009262736221357,"score_gpt":0.2544439669909967,"score_spread":0.23543470425477533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1844789861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994141,0.00007887647,0.00015075396,0.0000265269,0.0000041581643,0.000004736679,0.000018187508,0.0000055042196,0.00029717575],"genre_scores_gemma":[0.99931455,0.000048569476,0.00017590876,0.0000390381,0.000009350425,0.000003115128,0.00007086544,0.000004289617,0.0003342851],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9997327,0.000069818205,0.000026896249,0.00006246937,0.00005829486,0.00004979818],"domain_scores_gemma":[0.99957246,0.00016944246,0.00008167815,0.00001993627,0.000026521262,0.00013000416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001602615,0.00051772996,0.00028077685,0.0004377346,0.0005643363,0.00039112906,0.00033793255,0.00075737375,0.0015883483],"category_scores_gemma":[0.0009519428,0.00038593498,0.0003056804,0.0003368295,0.00030134953,0.00021039843,0.00028717233,0.0005155118,0.00032916557],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025415062,0.0007326536,0.24133675,0.00020288344,0.00030534147,0.3441442,0.007291993,0.00072847184,0.38895604,0.0004743337,0.0011431512,0.012142623],"study_design_scores_gemma":[0.00025768927,0.0023655163,0.38894126,0.000055670094,0.00040367703,0.53843147,0.0027764195,0.010179963,0.05092137,0.00039821074,0.0051785205,0.000090202884],"about_ca_topic_score_codex":0.0039014474,"about_ca_topic_score_gemma":0.0017345003,"teacher_disagreement_score":0.0039014474,"about_ca_system_score_codex":0.00025833846,"about_ca_system_score_gemma":0.00012669474,"threshold_uncertainty_score":0.007757485},"labels":[],"label_agreement":null},{"id":"W1875763950","doi":"10.1111/j.1600-0609.2005.00458.x","title":"Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long‐term survivors of Hodgkin's disease: July 9–16, 2003, Bellagio, Italy","year":2005,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Disease; Medicine; Quality of life (healthcare); Foundation (evidence); Developing country; Gerontology; Intensive care medicine; Pediatrics; Environmental health; Family medicine; Pathology; Economic growth; Political science; Nursing","score_opus":0.042623741761769154,"score_gpt":0.32552792253056484,"score_spread":0.2829041807687957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1875763950","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026556252,0.06446682,0.0040101334,0.66581446,0.1413812,0.0033559003,0.007665523,0.00031455702,0.08643522],"genre_scores_gemma":[0.11438523,0.081316136,0.010671676,0.18959537,0.049674615,0.0059480546,0.016108457,0.0004700643,0.53183043],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983897,0.00048170285,0.000092440525,0.00014137944,0.00043911967,0.00045554482],"domain_scores_gemma":[0.99528295,0.0006007643,0.00022631897,0.00007277645,0.0018440358,0.001973226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076726787,0.0013119427,0.00052655785,0.00069033715,0.0013860633,0.0021405416,0.0015028879,0.004827813,0.018353377],"category_scores_gemma":[0.0037126495,0.000381315,0.00071853324,0.00048564744,0.00031702485,0.0010902886,0.0018186616,0.005046666,0.005113392],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024889832,0.00029897637,0.0016445741,0.00034125912,0.0000188651,0.00026246865,0.00040357135,0.000082545805,0.00040785762,0.0002501295,0.96331877,0.032722145],"study_design_scores_gemma":[0.00017715874,0.00043468416,0.016864384,0.0009814479,0.000053067197,0.0002294129,0.0019502485,0.00011829374,0.00057514943,0.00024531377,0.9783311,0.000039784518],"about_ca_topic_score_codex":0.011185503,"about_ca_topic_score_gemma":0.021995537,"teacher_disagreement_score":0.018353377,"about_ca_system_score_codex":0.0015936625,"about_ca_system_score_gemma":0.0065779397,"threshold_uncertainty_score":0.06139815},"labels":[],"label_agreement":null},{"id":"W1896961192","doi":"10.1111/j.1600-0609.2010.01419.x","title":"Effective ex vivo expansion of hematopoietic stem cells using osteoblast‐differentiated mesenchymal stem cells is CXCL12 dependent","year":2010,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Stem cell; Mesenchymal stem cell; Ex vivo; Cell biology; CD34; CD38; Haematopoiesis; Cord blood; Biology; Cytokine; Chemokine; Bone marrow; Immunology; In vivo; Inflammation","score_opus":0.018893009431150867,"score_gpt":0.2565551116369715,"score_spread":0.23766210220582062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1896961192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97821224,0.0035001936,0.012747254,0.00016442446,0.000078740944,0.00020968588,0.0013257727,0.00022131682,0.0035403618],"genre_scores_gemma":[0.9713775,0.0028902218,0.016233647,0.00014602907,0.000031426032,0.00029512495,0.0023319325,0.00006492638,0.0066292672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997589,0.000031720447,0.00003120387,0.00003564253,0.00009792545,0.000044579814],"domain_scores_gemma":[0.99989843,0.00002045862,0.000026058642,0.000010690968,0.0000145337535,0.000029766234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023247306,0.00043750848,0.00033203937,0.00025488806,0.0000923703,0.00029867401,0.00013906245,0.00022859493,0.0019194694],"category_scores_gemma":[0.00007891009,0.00014621949,0.00026958503,0.00020383665,0.0001845407,0.00017946395,0.00025420656,0.0006699577,0.00053202466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006912382,0.000046117584,0.00017625127,0.00006639716,0.000004005896,0.00003422376,0.000014776237,0.00004195207,0.99736625,0.000042726988,0.00006453571,0.0020736947],"study_design_scores_gemma":[0.000023549246,0.0003519527,0.0039541475,0.000009972644,0.000018912284,0.00016472078,0.00001825359,0.0005934276,0.99174994,0.000018431596,0.0030929365,0.0000037397306],"about_ca_topic_score_codex":0.0003371649,"about_ca_topic_score_gemma":0.00091597636,"teacher_disagreement_score":0.0019194694,"about_ca_system_score_codex":0.0001605602,"about_ca_system_score_gemma":0.00020507963,"threshold_uncertainty_score":0.006421268},"labels":[],"label_agreement":null},{"id":"W1905318784","doi":"10.1111/j.1600-0609.2009.01357.x","title":"BCR‐ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients","year":2009,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Myeloid leukemia; Chromosomal translocation; clone (Java method); Immunology; Population; Biology; Immune system; ABL; Leukemia; Cancer research; Tyrosine kinase; Medicine; Receptor; Gene; Genetics","score_opus":0.008542085462240891,"score_gpt":0.23313671559384858,"score_spread":0.2245946301316077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1905318784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996226,0.00009064902,0.00003550886,0.000009297972,0.0000016427789,0.0000022777926,0.000008859301,0.000002040056,0.00022713264],"genre_scores_gemma":[0.9997255,0.00005330795,0.000032525175,0.000011910605,0.0000064346104,0.000002537477,0.000022180773,9.27924e-7,0.00014466894],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99985385,0.000031942312,0.000016502314,0.000029574,0.000031294392,0.00003682271],"domain_scores_gemma":[0.999539,0.0001457821,0.000149302,0.000028215018,0.00002399035,0.000113773676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022685013,0.00016987938,0.00014521103,0.0007766918,0.0003257329,0.00038204362,0.00011016224,0.00030849242,0.0026945537],"category_scores_gemma":[0.0008668231,0.00020163166,0.00009137185,0.00023181413,0.00037272173,0.00027716628,0.0002013892,0.00027423992,0.00024887064],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012188606,0.00018730992,0.94910496,0.000023923274,0.000020082078,0.0028688242,0.00030987686,0.000074387324,0.0409227,0.0001267168,0.00010510623,0.0050372747],"study_design_scores_gemma":[0.00008038154,0.0012999495,0.9758986,0.000013041358,0.000048981954,0.014092644,0.0003458224,0.00041860598,0.0070290794,0.00012993248,0.00063264335,0.000010261223],"about_ca_topic_score_codex":0.00035078923,"about_ca_topic_score_gemma":0.00035603633,"teacher_disagreement_score":0.0026945537,"about_ca_system_score_codex":0.00014136256,"about_ca_system_score_gemma":0.000100427445,"threshold_uncertainty_score":0.00901413},"labels":[],"label_agreement":null},{"id":"W1965573028","doi":"10.1111/ejh.12338","title":"Early lymphocyte recovery at 28 d post‐transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts","year":2014,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Cumulative incidence; Lymphocyte; Transplantation; Donor lymphocyte infusion; Hematopoietic stem cell transplantation; Gastroenterology; Leukemia; Myeloid; Incidence (geometry); Haematopoiesis; Stem cell; Biology","score_opus":0.004312094474801542,"score_gpt":0.18298448789232943,"score_spread":0.17867239341752789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965573028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99941075,0.00038563463,0.00005524172,0.000021564641,0.0000032440278,0.0000017928211,0.000024532143,0.000003346002,0.000093923096],"genre_scores_gemma":[0.9997062,0.000079741374,0.000044365363,0.00001414983,0.0000074787345,0.0000016920688,0.00008415318,9.972654e-7,0.0000612075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980766,0.00006977119,0.0000157027,0.000030895884,0.000037744987,0.00003821793],"domain_scores_gemma":[0.99907243,0.00025839335,0.00036555735,0.000051724626,0.000055394496,0.00019656555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047920085,0.0002237551,0.00034404208,0.0002517963,0.00016140984,0.00048467855,0.00026627674,0.00030139636,0.00050820253],"category_scores_gemma":[0.0014233135,0.00012024169,0.0002735187,0.00023508046,0.00023828461,0.00026154018,0.0003172298,0.0006119002,0.00019459648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001093164,0.00006625924,0.9919193,0.000009234005,0.000044039614,0.0000859551,0.000032341268,0.00011424554,0.0011220542,0.000009824383,0.00007051733,0.0054330863],"study_design_scores_gemma":[0.000019142999,0.0007571218,0.9975042,0.0000046303444,0.000059081107,0.00038017303,0.000059216258,0.0005837904,0.00041819215,0.00004132345,0.00016899384,0.000004163856],"about_ca_topic_score_codex":0.00061656215,"about_ca_topic_score_gemma":0.0008035103,"teacher_disagreement_score":0.00061656215,"about_ca_system_score_codex":0.00016554161,"about_ca_system_score_gemma":0.00016601029,"threshold_uncertainty_score":0.00253433},"labels":[],"label_agreement":null},{"id":"W1967630686","doi":"10.1034/j.1600-0609.2003.00146.x","title":"Shwachman–Diamond syndrome with late‐onset neutropenia and fatal acute myeloid leukaemia without maturation: a case report","year":2003,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neutropenia; Medicine; Myeloid leukaemia; Bone marrow; Chemotherapy; Myeloid; Congenital Neutropenia; Leukemia; Internal medicine; Gastroenterology","score_opus":0.006528774815631207,"score_gpt":0.22411312398542887,"score_spread":0.21758434916979766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967630686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939069,0.0014235679,0.0013140738,0.00045529695,0.00006321953,0.000039472794,0.00007578231,0.00005781075,0.0026638878],"genre_scores_gemma":[0.99805284,0.0005041905,0.00053829706,0.00013847368,0.00013280637,0.000011369907,0.000045659155,0.0000063965313,0.0005700144],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996648,0.000047325313,0.00003136346,0.0000946885,0.000046632947,0.00011525485],"domain_scores_gemma":[0.9992119,0.00022391132,0.00019740291,0.00006340367,0.000035209825,0.0002681289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023961625,0.0013417867,0.00073110225,0.0010384549,0.0011711478,0.00083125685,0.0005549711,0.0020590425,0.0014668991],"category_scores_gemma":[0.0014111996,0.0006773366,0.00045662766,0.0005328702,0.00084182655,0.0007327369,0.0010157586,0.0010298176,0.00040086877],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005875172,0.00004030548,0.0147548355,0.00002636249,0.000011405062,0.9803631,0.00018587367,0.00005721919,0.001911882,0.00023332886,0.0002025036,0.0021545503],"study_design_scores_gemma":[0.000014003803,0.000054020085,0.003046511,0.000002867337,0.0000074005084,0.99592775,0.00005343663,0.000081053855,0.0003422285,0.00007978514,0.0003851876,0.0000056947997],"about_ca_topic_score_codex":0.0011300736,"about_ca_topic_score_gemma":0.00097130303,"teacher_disagreement_score":0.0020590425,"about_ca_system_score_codex":0.00042529166,"about_ca_system_score_gemma":0.00038579357,"threshold_uncertainty_score":0.0049072504},"labels":[],"label_agreement":null},{"id":"W1967872782","doi":"10.1111/j.1600-0609.2004.00396.x","title":"Hemoglobin oxygen saturation discrepancy using various methods in patients with sickle cell vaso‐occlusive painful crisis","year":2005,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dartmouth General Hospital; Dalhousie University; University of Saskatchewan","funders":"","keywords":"Pulse oximetry; Vaso-occlusive crisis; Oxygen–haemoglobin dissociation curve; Medicine; Limits of agreement; Hemoglobin; Internal medicine; Anesthesia; Oxygen saturation; Hemoglobinopathy; Oxygen; Gastroenterology; Cardiology; Sickle cell anemia; Nuclear medicine; Disease; Chemistry","score_opus":0.008543875382826622,"score_gpt":0.27051220799579273,"score_spread":0.2619683326129661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967872782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993406,0.00016449096,0.00034146992,0.000011698975,0.0000044716353,0.0000054388274,0.00002367639,0.000008975376,0.00009916921],"genre_scores_gemma":[0.999435,0.000037817306,0.00041960043,0.0000128209285,0.0000062376453,0.000008019651,0.00005730832,0.0000019190877,0.000021281852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794775,0.00092208845,0.00029819534,0.00029359662,0.00045235452,0.00008600966],"domain_scores_gemma":[0.9936673,0.003704733,0.001339436,0.0003173503,0.0007615662,0.00020958397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028166706,0.0003482369,0.00044452716,0.0008395107,0.0002210049,0.0004055208,0.0003117833,0.00046084833,0.00030295088],"category_scores_gemma":[0.01226072,0.0001589225,0.00021445382,0.00038159246,0.00034458024,0.00032516912,0.0004113731,0.00037887713,0.00012131228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041234057,0.00004280791,0.99205595,0.000022500732,0.000070245515,0.00018827635,0.00041862496,0.00018062018,0.0012157361,0.000017547869,0.000069423826,0.005305817],"study_design_scores_gemma":[0.000048719623,0.0006903039,0.9912367,0.00001486311,0.000065170876,0.0023087636,0.00042128874,0.0029053458,0.0020866776,0.00004929913,0.00015648702,0.000016474005],"about_ca_topic_score_codex":0.0006625165,"about_ca_topic_score_gemma":0.00065316726,"teacher_disagreement_score":0.0028166706,"about_ca_system_score_codex":0.00023634889,"about_ca_system_score_gemma":0.00011725809,"threshold_uncertainty_score":0.014896214},"labels":[],"label_agreement":null},{"id":"W1972576558","doi":"10.1111/ejh.12041","title":"A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia","year":2012,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Waterloo; McMaster University","funders":"Canadian Institutes of Health Research; Amgen Canada; Mitacs; Canada Research Chairs","keywords":"Medicine; Bone marrow; Immune thrombocytopenia; Confidence interval; Megakaryocyte; Biopsy; Internal medicine; Pathology; Platelet; Gastroenterology","score_opus":0.020301579440618923,"score_gpt":0.25755128357753115,"score_spread":0.23724970413691224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972576558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977398,0.00033209336,0.0008465922,0.000014540683,0.000026802778,0.0004568137,0.00012690747,0.0000116030305,0.0004448745],"genre_scores_gemma":[0.99847275,0.000062861385,0.00088324933,0.000022199485,0.000030917257,0.00023814107,0.00017964916,0.0000035738162,0.000106696636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99088085,0.0048820255,0.0013034145,0.0015276377,0.0011483433,0.00025778936],"domain_scores_gemma":[0.97866565,0.008237713,0.0037882924,0.0038746654,0.00479674,0.00063701713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010655532,0.00055253133,0.0008151508,0.00075119676,0.00068185636,0.00059217773,0.00038765548,0.00062038004,0.0014207845],"category_scores_gemma":[0.02854903,0.00034905737,0.00032976328,0.0003464238,0.00072475633,0.00043185728,0.0010173178,0.0002740251,0.0004907049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014864214,0.000988208,0.94568896,0.0003824572,0.0003319857,0.00096074934,0.0025166892,0.00030744285,0.010920262,0.00008198331,0.0003720591,0.022585],"study_design_scores_gemma":[0.002179699,0.019882645,0.9557269,0.00010354369,0.00041129036,0.005707621,0.001692311,0.002003912,0.009004014,0.00018234737,0.003033711,0.000072003124],"about_ca_topic_score_codex":0.0005148155,"about_ca_topic_score_gemma":0.0004877602,"teacher_disagreement_score":0.010655532,"about_ca_system_score_codex":0.0003744128,"about_ca_system_score_gemma":0.00058690016,"threshold_uncertainty_score":0.056352556},"labels":[],"label_agreement":null},{"id":"W1986010889","doi":"10.1111/ejh.12052","title":"Rash with the multitargeted kinase inhibitors nilotinib and dasatinib: meta‐analysis and clinical characterization","year":2012,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Dermatology Foundation; Dermatology Foundation; American Society of Hematology","keywords":"Nilotinib; Dasatinib; Medicine; Rash; Incidence (geometry); Internal medicine; Tyrosine-kinase inhibitor; Adverse effect; Dermatology; Myeloid leukemia; Imatinib; Cancer","score_opus":0.0988586204046646,"score_gpt":0.3572264443656417,"score_spread":0.2583678239609771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986010889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18492045,0.80402404,0.0040842784,0.00069442886,0.00025490005,0.00023132018,0.004254031,0.0001105688,0.0014260488],"genre_scores_gemma":[0.94100815,0.054337442,0.0015778536,0.00044934932,0.0001882875,0.00021515455,0.0019124995,0.000058967584,0.00025230035],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9892119,0.005041791,0.00225448,0.0020875758,0.0010820756,0.00032221535],"domain_scores_gemma":[0.9828153,0.011239033,0.003329952,0.0015248037,0.00082472054,0.00026618486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012752144,0.0015425435,0.007369714,0.0034619493,0.00042429648,0.0022784686,0.0016114303,0.0013345547,0.0019516216],"category_scores_gemma":[0.01629883,0.0009518412,0.036494337,0.0054410268,0.00041389294,0.0011567589,0.0011562158,0.0014182086,0.00024291257],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005355598,0.000031467316,0.09915088,0.016759451,0.8674746,0.00016664699,0.00003903769,0.001623807,0.0006299198,0.00010731592,0.0005151912,0.008146034],"study_design_scores_gemma":[0.0007747702,0.0005268495,0.07983717,0.001401716,0.91221374,0.00053087325,0.00006801479,0.0018686677,0.00044893485,0.00041849483,0.00186823,0.00004252516],"about_ca_topic_score_codex":0.0020414412,"about_ca_topic_score_gemma":0.0028930192,"teacher_disagreement_score":0.012752144,"about_ca_system_score_codex":0.0008865724,"about_ca_system_score_gemma":0.0006783349,"threshold_uncertainty_score":0.06744057},"labels":[],"label_agreement":null},{"id":"W1990211195","doi":"10.1111/j.1600-0609.2007.00903.x","title":"Analysis of 6q deletion in Waldenstrom macroglobulinemia","year":2007,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Leukemia and Lymphoma Research; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Waldenstrom macroglobulinemia; Macroglobulinemia; Fluorescence in situ hybridization; Interphase; Cytogenetics; Biology; Pathology; Multiple myeloma; Chromosome; Medicine; Immunology; Genetics; Gene; Lymphoma","score_opus":0.01728273097224054,"score_gpt":0.3187438329478327,"score_spread":0.30146110197559217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990211195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99972814,0.00010686533,0.000042549866,0.000009933267,0.0000011091896,0.0000015408489,0.000034361652,0.0000018542511,0.000073592186],"genre_scores_gemma":[0.9997255,0.00006233621,0.000057453377,0.000006816107,0.000005914424,0.000002836408,0.000088002846,0.0000011288652,0.00004976326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977976,0.000057326502,0.000019629872,0.00004846713,0.0000476846,0.00004716008],"domain_scores_gemma":[0.9994099,0.00021310757,0.00018563375,0.000040251154,0.000055591587,0.00009544896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031409133,0.00022766876,0.00024845244,0.0012560938,0.00030347353,0.00033441567,0.00023714773,0.00032140315,0.00083438115],"category_scores_gemma":[0.0017835321,0.00017557808,0.00012156913,0.00061216386,0.0002850273,0.00024862043,0.0002615215,0.00021610761,0.00020468149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024104888,0.00001726283,0.98971575,0.000007080801,0.000017533677,0.00118979,0.000107978434,0.000060922703,0.0062507614,0.000021467718,0.000066831984,0.0023035698],"study_design_scores_gemma":[0.000015956175,0.00022511829,0.99095005,0.0000049025616,0.00002927639,0.0068328446,0.00012881747,0.00030749687,0.0010422355,0.00005328102,0.00040452986,0.000005601999],"about_ca_topic_score_codex":0.00065571285,"about_ca_topic_score_gemma":0.0005572399,"teacher_disagreement_score":0.0012560938,"about_ca_system_score_codex":0.00010255947,"about_ca_system_score_gemma":0.000096315074,"threshold_uncertainty_score":0.0027912855},"labels":[],"label_agreement":null},{"id":"W1990418413","doi":"10.1111/ejh.12455","title":"How we manage <scp>JAK</scp> inhibition in allogeneic transplantation for myelofibrosis","year":2014,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Discontinuation; Janus kinase; Transplantation; Tofacitinib; Hematopoietic stem cell transplantation; Adverse effect; Stem cell; Constitutional symptoms; Internal medicine; Immunology; Oncology; Cytokine; Disease; Bone marrow","score_opus":0.04522550680314516,"score_gpt":0.30919926107075374,"score_spread":0.2639737542676086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990418413","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018083998,0.99823254,0.000085194144,0.00069685193,0.00015677612,0.0000052123128,0.000009979938,0.000004712472,0.00062787946],"genre_scores_gemma":[0.0012223725,0.9975546,0.00025386983,0.00047363117,0.0001472105,0.00000696943,0.000018674746,0.0000011520509,0.00032142972],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998338,0.00004601882,0.000036497328,0.000018153169,0.00005361292,0.0000118272255],"domain_scores_gemma":[0.9997974,0.000092645045,0.00004327778,0.0000044367443,0.000046569217,0.000015662428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000447894,0.00041838986,0.0008407828,0.0013075977,0.00021474621,0.0007871591,0.0006330847,0.0009152213,0.001724084],"category_scores_gemma":[0.00080816826,0.00015690216,0.00040568013,0.0008438347,0.00024330452,0.0011564493,0.00037033542,0.0012465388,0.00096987386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006709459,0.00005611011,0.00023613712,0.022293743,0.00013126663,0.00032875783,0.0000856266,0.00021664202,0.0008709148,0.0015651459,0.02663383,0.94751465],"study_design_scores_gemma":[0.000053411815,0.00012320613,0.002231771,0.017529845,0.0002765315,0.0045728986,0.0002053088,0.00013615764,0.00050255994,0.002752574,0.97159046,0.000025235802],"about_ca_topic_score_codex":0.001140533,"about_ca_topic_score_gemma":0.002621108,"teacher_disagreement_score":0.001724084,"about_ca_system_score_codex":0.00032984692,"about_ca_system_score_gemma":0.00079173554,"threshold_uncertainty_score":0.0057676435},"labels":[],"label_agreement":null},{"id":"W1993056188","doi":"10.1034/j.1600-0609.2002.02802.x","title":"Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22)","year":2002,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Fulminant; Medicine; Lysis; Immunology","score_opus":0.01763568963201568,"score_gpt":0.22722290478281376,"score_spread":0.2095872151507981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993056188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975712,0.0012418234,0.00059623126,0.00007410575,0.000007873187,0.00002075882,0.000055069617,0.000020578856,0.00041237037],"genre_scores_gemma":[0.9993175,0.00024079515,0.00013551446,0.00004211331,0.000018497609,0.000006481739,0.00010826703,0.0000020579396,0.00012877313],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9997483,0.000055861612,0.0000347272,0.000047047553,0.000042177737,0.00007190766],"domain_scores_gemma":[0.9989396,0.00018341058,0.0005854085,0.00004096704,0.00003749797,0.00021318877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003332073,0.0002826505,0.00035421242,0.00029883697,0.0002444525,0.00035586974,0.00018501833,0.00036284872,0.00082698074],"category_scores_gemma":[0.0016936985,0.00012487893,0.00016043318,0.00036739334,0.00057786255,0.0002703781,0.00052899064,0.0003898327,0.00024350086],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013236648,0.000078463854,0.88966346,0.00017002798,0.00007297472,0.0639418,0.00066544587,0.0003458707,0.012380545,0.00038249767,0.0009057217,0.030069573],"study_design_scores_gemma":[0.00020779418,0.002245932,0.697812,0.000041420863,0.000074569994,0.29162362,0.0003343835,0.00085986237,0.002993168,0.00044966448,0.0033333711,0.000024213698],"about_ca_topic_score_codex":0.00043743447,"about_ca_topic_score_gemma":0.0005788821,"teacher_disagreement_score":0.00082698074,"about_ca_system_score_codex":0.00028703135,"about_ca_system_score_gemma":0.0002052103,"threshold_uncertainty_score":0.0027665496},"labels":[],"label_agreement":null},{"id":"W1997971414","doi":"10.1034/j.1600-0609.2001.066005347.x","title":"Cyclosporin A in the treatment of refractory immune thrombocytopenia purpura in children","year":2001,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Adverse effect; Methylprednisolone; Splenectomy; Refractory (planetary science); Autoimmune thrombocytopenia; Platelet; Gastroenterology; Regimen; Internal medicine; Salvage therapy; Immune thrombocytopenia; Surgery; Chemotherapy; Spleen","score_opus":0.017566489034681883,"score_gpt":0.2725336860001401,"score_spread":0.2549671969654582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997971414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9387338,0.053842,0.0012524723,0.001284182,0.00012314381,0.00006433187,0.00008681684,0.000099931865,0.0045133512],"genre_scores_gemma":[0.98727125,0.010763679,0.00084834715,0.00031296242,0.00017602544,0.00003242054,0.00010249911,0.000012206311,0.0004805629],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99980766,0.00008326279,0.000029102215,0.000015339037,0.000029456161,0.000035278084],"domain_scores_gemma":[0.99964356,0.00011781048,0.0000874898,0.000014717232,0.000012513674,0.00012388549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029982752,0.00034205223,0.00050143135,0.0004276353,0.00054142246,0.0002673477,0.00024333979,0.00065239985,0.00064170285],"category_scores_gemma":[0.0008629699,0.000116766256,0.00026179367,0.00039779686,0.0003529958,0.00021180557,0.00021424024,0.00073713943,0.00017628499],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048499866,0.0009395235,0.31020012,0.0023739417,0.00051250175,0.30913144,0.0013974728,0.0022675223,0.035018224,0.0014554436,0.008901901,0.32295188],"study_design_scores_gemma":[0.0016692472,0.008875355,0.2606244,0.00045063658,0.0007230805,0.6646745,0.0010145049,0.001498349,0.01643026,0.0008227491,0.043160368,0.00005654521],"about_ca_topic_score_codex":0.00076881255,"about_ca_topic_score_gemma":0.0016305215,"teacher_disagreement_score":0.00076881255,"about_ca_system_score_codex":0.00026579987,"about_ca_system_score_gemma":0.00040123196,"threshold_uncertainty_score":0.002146721},"labels":[],"label_agreement":null},{"id":"W2001492984","doi":"10.1034/j.1600-0609.2000.90069.x","title":"Flow cytometric analysis of defensins in blood and marrow neutrophils","year":2000,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia Hospital","funders":"Heart and Stroke Foundation of Canada","keywords":"Bone marrow; Flow cytometry; Myeloid; Granulocyte; Biology; Molecular biology; Immunology; Myeloperoxidase; Alkaline phosphatase; Chemistry; Inflammation; Biochemistry; Enzyme","score_opus":0.009413831502153126,"score_gpt":0.20826294157902994,"score_spread":0.1988491100768768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001492984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9582425,0.003596652,0.03339219,0.00012931011,0.000063706444,0.00017914722,0.001233101,0.00017972938,0.0029837803],"genre_scores_gemma":[0.9405254,0.0024504107,0.05133879,0.0001604687,0.000068436995,0.00045643182,0.001591721,0.00002573431,0.0033826327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998388,0.000031315118,0.000010356691,0.000046547924,0.000048657657,0.000024307874],"domain_scores_gemma":[0.99991655,0.000024799137,0.00001519206,0.000005385136,0.000022875709,0.000015233873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023001451,0.00018431262,0.00015505435,0.0005636697,0.0001907897,0.00025492645,0.00014897721,0.0002757806,0.0013404799],"category_scores_gemma":[0.00020345277,0.00005993592,0.00006182015,0.00025447475,0.00013080584,0.00022540668,0.00015310272,0.0003092507,0.00025919013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001223928,0.000029403896,0.00076650974,0.000043799937,0.0000034871182,0.000016101376,0.000038747978,0.000040485378,0.99286735,0.00022205694,0.00005442814,0.005795346],"study_design_scores_gemma":[0.00006599346,0.0006597251,0.028028345,0.000038291317,0.00003785387,0.0004408365,0.00011433791,0.006556454,0.95708555,0.000725552,0.0062278616,0.000019188861],"about_ca_topic_score_codex":0.00024473818,"about_ca_topic_score_gemma":0.00033884437,"teacher_disagreement_score":0.0013404799,"about_ca_system_score_codex":0.00020453402,"about_ca_system_score_gemma":0.00008023454,"threshold_uncertainty_score":0.0044843554},"labels":[],"label_agreement":null},{"id":"W2003806098","doi":"10.1111/j.1600-0609.2007.00913.x","title":"Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome)","year":2007,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bleeding diathesis; Bernard–Soulier syndrome; Platelet disorder; Splenectomy; Surgery; Internal medicine; Platelet","score_opus":0.01492468069202792,"score_gpt":0.2779179364442399,"score_spread":0.262993255752212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003806098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9285032,0.037070703,0.016805684,0.0032351862,0.0006568397,0.00011428715,0.000095589065,0.0003815516,0.013137045],"genre_scores_gemma":[0.9920948,0.00390332,0.002501749,0.00043525296,0.0003537407,0.000029730158,0.00006883018,0.000008341318,0.0006043961],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9999261,0.000014316086,0.000013333043,0.000009533823,0.000016407213,0.000020298923],"domain_scores_gemma":[0.9998826,0.000027031643,0.0000306282,0.0000068851878,0.000009563112,0.000043373653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001337234,0.00039413333,0.000207281,0.00030648054,0.00038296107,0.00024275605,0.00023479284,0.00059531286,0.00071040326],"category_scores_gemma":[0.0007370372,0.00007445264,0.00020298328,0.00009967858,0.0001569165,0.00025244607,0.00024377194,0.0006419047,0.00022983296],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009522876,0.0007706992,0.24709809,0.0008612231,0.00033861696,0.34150445,0.0007276379,0.0012497295,0.05327904,0.00090965367,0.008104947,0.3442036],"study_design_scores_gemma":[0.00014712644,0.0032037937,0.1977487,0.0007233134,0.00037108772,0.74188685,0.0006849827,0.0045201033,0.028957006,0.001495872,0.020199928,0.00006118269],"about_ca_topic_score_codex":0.00014423291,"about_ca_topic_score_gemma":0.0002604324,"teacher_disagreement_score":0.00071040326,"about_ca_system_score_codex":0.00009126795,"about_ca_system_score_gemma":0.00014740913,"threshold_uncertainty_score":0.0023764968},"labels":[],"label_agreement":null},{"id":"W2010787620","doi":"10.1034/j.1600-0609.2001.00503.x","title":"Bronchiolitis obliterans organizing pneumonia in a patient with chronic myelogenous leukemia developing after initiation of interferon and cytosine arabinoside","year":2001,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Saskatoon Medical Imaging; Saskatchewan Cancer Agency","funders":"","keywords":"Bronchiolitis obliterans organizing pneumonia; Medicine; Bronchiolitis obliterans; Chronic myelogenous leukemia; Pneumonia; Discontinuation; Leukemia; Gastroenterology; Lung; Pathology; Internal medicine; Lung transplantation","score_opus":0.0076239092973383014,"score_gpt":0.21233338178641742,"score_spread":0.20470947248907911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010787620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935109,0.0012179761,0.00036947706,0.0006527653,0.000085283275,0.00007478315,0.000047494916,0.000030916817,0.004010318],"genre_scores_gemma":[0.9985045,0.00035842965,0.00015107174,0.00030982515,0.00020458066,0.000011348918,0.00004457087,0.0000049212827,0.000410675],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999602,0.00006888454,0.000037078895,0.00006623721,0.00005245599,0.00017336375],"domain_scores_gemma":[0.99828583,0.00057306385,0.0003907224,0.00010030094,0.00007798471,0.00057212845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005235755,0.00094542763,0.0008298806,0.0009668515,0.0023361093,0.00093048485,0.00037521977,0.0022868935,0.0012358656],"category_scores_gemma":[0.003296133,0.0007174381,0.0006185026,0.00076063944,0.00096329994,0.0009353814,0.00062988105,0.0019903092,0.0003851176],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036844274,0.00022328488,0.092327304,0.000048712656,0.000029259094,0.90084845,0.0006976445,0.00009263965,0.0021061082,0.00018285243,0.00026750244,0.0028077494],"study_design_scores_gemma":[0.00021145247,0.0011448005,0.10488242,0.00004160491,0.000102502665,0.89015794,0.00039244693,0.0005133287,0.00085709663,0.00023000498,0.0014394067,0.000027019802],"about_ca_topic_score_codex":0.0020726328,"about_ca_topic_score_gemma":0.0025618272,"teacher_disagreement_score":0.0023361093,"about_ca_system_score_codex":0.00069413974,"about_ca_system_score_gemma":0.00066251965,"threshold_uncertainty_score":0.005036354},"labels":[],"label_agreement":null},{"id":"W2025533780","doi":"10.1111/ejh.12491","title":"Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation","year":2014,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis Pharmaceuticals Corporation; Celgene","keywords":"Medicine; Refractory (planetary science); Internal medicine; Multiple myeloma; Gastroenterology; Clinical endpoint; Adverse effect; Chromosomal translocation; Dexamethasone; Clinical trial; Surgery; Biology","score_opus":0.029760721526495826,"score_gpt":0.311031236984917,"score_spread":0.2812705154584212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025533780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955428,0.0010099337,0.00030037767,0.00026812957,0.000058371646,0.0013797211,0.0006025274,0.000047449656,0.0007906316],"genre_scores_gemma":[0.9930171,0.0008780681,0.0009713796,0.0005153701,0.00009688137,0.001424309,0.0017090951,0.000018745413,0.0013690798],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999723,0.00011614563,0.000014825241,0.00005361572,0.000027263708,0.00006518026],"domain_scores_gemma":[0.9996213,0.00005199981,0.00008606701,0.000030784668,0.00002938278,0.00018050324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012953134,0.0011920654,0.001605735,0.0002972837,0.00035348797,0.0007243348,0.000626834,0.00095406745,0.0022772364],"category_scores_gemma":[0.0006707838,0.0005036209,0.0007605655,0.00031677226,0.00047179122,0.000614207,0.0003083275,0.001736936,0.00053370144],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65920395,0.09328994,0.025572902,0.0008271332,0.0016871159,0.0006694606,0.0004047941,0.004315219,0.09441191,0.0003909184,0.0058130254,0.11341369],"study_design_scores_gemma":[0.58239126,0.37954468,0.02557104,0.00003250776,0.00039397972,0.00063739164,0.00006469233,0.0020369675,0.005643225,0.00015300183,0.0035029904,0.000028270959],"about_ca_topic_score_codex":0.00077033206,"about_ca_topic_score_gemma":0.0020105776,"teacher_disagreement_score":0.0022772364,"about_ca_system_score_codex":0.0006913699,"about_ca_system_score_gemma":0.0012322969,"threshold_uncertainty_score":0.0076180696},"labels":[],"label_agreement":null},{"id":"W2026357830","doi":"10.1111/j.1600-0609.2004.00348.x","title":"Recommendations on haematological criteria for the diagnosis of epoetin‐induced pure red cell aplasia","year":2004,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"Albert-Ludwigs-Universität Freiburg; University Health Network","keywords":"Pure red cell aplasia; Medicine; Erythropoietin; Anemia; Epoetin alfa; Intensive care medicine; Disease; Rare disease; Internal medicine; Bone marrow; Erythropoiesis; Aplasia; Pediatrics","score_opus":0.1319050324320348,"score_gpt":0.37397484038988393,"score_spread":0.24206980795784913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026357830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017370617,0.8081021,0.011614257,0.08692705,0.03096795,0.0037883068,0.00431512,0.00025134147,0.052296776],"genre_scores_gemma":[0.017064655,0.69690925,0.14092469,0.0709423,0.0077876216,0.0061596753,0.017488452,0.00013645897,0.042586923],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928392,0.0016895777,0.0029210632,0.00030836853,0.001966454,0.00027529275],"domain_scores_gemma":[0.9798941,0.0051022447,0.0026619097,0.00047124343,0.011266771,0.00060370925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073195,0.0014565041,0.0029055385,0.010157372,0.0010893241,0.0016437052,0.00684976,0.005161873,0.008807628],"category_scores_gemma":[0.017936291,0.0009310942,0.002788291,0.0072109518,0.0016451096,0.0020372896,0.0015419092,0.0049797622,0.008644607],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019856868,0.00016547911,0.0016333683,0.0164417,0.00015806986,0.0025784716,0.0003798631,0.0002886563,0.002055582,0.008049974,0.5792175,0.38883287],"study_design_scores_gemma":[0.00014307813,0.000055981225,0.0032232367,0.015731363,0.0002180697,0.0040485174,0.00023938625,0.0001650788,0.0005405911,0.00331727,0.97227615,0.000041424908],"about_ca_topic_score_codex":0.009790128,"about_ca_topic_score_gemma":0.011585419,"teacher_disagreement_score":0.010157372,"about_ca_system_score_codex":0.0025911422,"about_ca_system_score_gemma":0.007760268,"threshold_uncertainty_score":0.03870964},"labels":[],"label_agreement":null},{"id":"W2035074950","doi":"10.1046/j.0902-4441.2004.00168.x","title":"Clinicopathological correlations of TIMP‐1 and TIMP‐2 in Hodgkin's lymphoma","year":2003,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research Society","keywords":"Lymphoma; Nodular sclerosis; Immunostaining; Pathology; Medicine; Immunohistochemistry; Hodgkin lymphoma; Matrix metalloproteinase; Non-Hodgkin's lymphoma; Connective tissue; Internal medicine","score_opus":0.013220676770787386,"score_gpt":0.24358121841907357,"score_spread":0.23036054164828618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035074950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996747,0.002353485,0.00025299174,0.00004095723,0.000008629659,0.0000048798556,0.00009234398,0.000010595859,0.00048904377],"genre_scores_gemma":[0.9992086,0.0003299393,0.00014384622,0.000006875699,0.000028657876,0.00000586003,0.00009074275,0.0000018447105,0.00018373242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997582,0.00007295729,0.000038236052,0.000043279222,0.000053922096,0.000033504562],"domain_scores_gemma":[0.9987041,0.00037067407,0.00059839257,0.000055254957,0.00013231432,0.0001393807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054411445,0.0002117674,0.00017057,0.00091540697,0.0001854249,0.0003904207,0.0001659405,0.00027514686,0.0021223642],"category_scores_gemma":[0.0019224418,0.00016171626,0.00014827865,0.000592329,0.00029751932,0.00032312085,0.00018483796,0.00027409877,0.00035486813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044833176,0.000020872101,0.98626,0.000046475918,0.000049837752,0.0013471057,0.000070769325,0.000112731985,0.0076229046,0.00003184759,0.000105520616,0.0038834736],"study_design_scores_gemma":[0.0000206248,0.00017929643,0.9861602,0.000012662321,0.00006156547,0.010720579,0.00012990029,0.00033694218,0.0015764167,0.00006659348,0.0007284138,0.0000067492397],"about_ca_topic_score_codex":0.00022142546,"about_ca_topic_score_gemma":0.00026175348,"teacher_disagreement_score":0.0021223642,"about_ca_system_score_codex":0.000119023476,"about_ca_system_score_gemma":0.00012621074,"threshold_uncertainty_score":0.0071000457},"labels":[],"label_agreement":null},{"id":"W2035077408","doi":"10.1111/j.1600-0609.2009.01230.x","title":"Rivaroxaban – an oral, direct Factor Xa inhibitor – lessons from a broad clinical study programme","year":2009,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bayer HealthCare; Bayer","keywords":"Rivaroxaban; Medicine; Dosing; Atrial fibrillation; Stroke (engine); Intensive care medicine; Apixaban; Venous thromboembolism; Internal medicine; Warfarin; Thrombosis","score_opus":0.39316658425784345,"score_gpt":0.5020525776786479,"score_spread":0.1088859934208044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035077408","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015857004,0.9932453,0.0002677576,0.003590196,0.0005641662,0.000019492312,0.000011528345,0.00001222889,0.0021306942],"genre_scores_gemma":[0.0011215269,0.99444324,0.0007930626,0.0022263785,0.0005536049,0.000020490084,0.000022206212,0.0000041827343,0.00081532466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905163,0.00022737707,0.00017866053,0.000103830236,0.00040577704,0.000032800224],"domain_scores_gemma":[0.99770904,0.0011500124,0.00019866538,0.00010450376,0.0006681582,0.00016963588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003768264,0.00062406895,0.0014447317,0.0019129871,0.00027835375,0.0014129606,0.00093309104,0.0014630195,0.0027019023],"category_scores_gemma":[0.0038433615,0.00027475602,0.0006357966,0.0022142194,0.0009204605,0.0029193289,0.00096774864,0.0025587548,0.0016691064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077498626,0.000083375584,0.00015156009,0.015429561,0.000078274155,0.00017478298,0.000103376886,0.0001631509,0.0008807343,0.006091116,0.051340867,0.9254256],"study_design_scores_gemma":[0.000084438616,0.0002000915,0.0016128031,0.017380489,0.0001218098,0.0016754663,0.00012710516,0.00011192691,0.00023333622,0.0066189906,0.9718113,0.000022246706],"about_ca_topic_score_codex":0.0007946395,"about_ca_topic_score_gemma":0.0014857117,"teacher_disagreement_score":0.003768264,"about_ca_system_score_codex":0.00086653075,"about_ca_system_score_gemma":0.0026567704,"threshold_uncertainty_score":0.019928753},"labels":[],"label_agreement":null},{"id":"W2040290774","doi":"10.1111/ejh.12475","title":"Economic evaluation of arsenic trioxide compared to all‐trans retinoic acid + conventional chemotherapy for treatment of relapsed acute promyelocytic leukemia in Canada","year":2014,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Université de Montréal","funders":"Lundbeck Canada","keywords":"Acute promyelocytic leukemia; Arsenic trioxide; Medicine; Internal medicine; Refractory (planetary science); Cost effectiveness; Oncology; Retinoic acid; Arsenic","score_opus":0.01786673555841948,"score_gpt":0.2675080334715705,"score_spread":0.249641297913151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040290774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89610404,0.030267624,0.0060419356,0.011544529,0.00034122617,0.0033142252,0.0145185245,0.00013095283,0.03773691],"genre_scores_gemma":[0.9912363,0.0036115556,0.0019742677,0.0003856246,0.00002270069,0.0002165007,0.0012255989,0.000011608828,0.0013157462],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99726546,0.0014982144,0.00008347384,0.00015167432,0.0005034832,0.0004977789],"domain_scores_gemma":[0.9957699,0.00192843,0.00043234302,0.00006082353,0.0010631577,0.0007453587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038293279,0.0010099804,0.0012002862,0.001391282,0.0010936888,0.0022886742,0.0014526781,0.0010841654,0.0045107366],"category_scores_gemma":[0.011385138,0.0004891593,0.0022024591,0.0018452028,0.0007077361,0.00067149696,0.0010972808,0.0012703357,0.00010672228],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030329645,0.0012446237,0.03175167,0.004427733,0.0037760637,0.0005751002,0.00022355044,0.8160384,0.0015596049,0.021347051,0.012251821,0.07647475],"study_design_scores_gemma":[0.0106837405,0.006275091,0.05280625,0.0018137848,0.0051826877,0.00044571934,0.0009975055,0.89834267,0.0014004305,0.0055718957,0.01622898,0.00025122202],"about_ca_topic_score_codex":0.90413177,"about_ca_topic_score_gemma":0.87758785,"teacher_disagreement_score":0.09586823,"about_ca_system_score_codex":0.0927405,"about_ca_system_score_gemma":0.083030954,"threshold_uncertainty_score":0.67288256},"labels":[],"label_agreement":null},{"id":"W2041638907","doi":"10.1034/j.1600-0609.2002.01523.x","title":"The comprehensive care of sickle cell disease","year":2002,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Disease; Multidisciplinary approach; Health care; General partnership; Quality of life (healthcare); Sickle cell anemia; Family medicine; Medical emergency; Intensive care medicine; Nursing; Internal medicine","score_opus":0.030223638538953244,"score_gpt":0.28715183198898747,"score_spread":0.2569281934500342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041638907","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027576512,0.2215875,0.017083174,0.45785266,0.019611781,0.0006110354,0.0015066667,0.0013994684,0.2527711],"genre_scores_gemma":[0.29506552,0.3621667,0.055609025,0.16234066,0.020433512,0.0009639925,0.0030145114,0.00032607449,0.10007996],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982774,0.00063474727,0.00015033412,0.000106262814,0.0005865881,0.00024475422],"domain_scores_gemma":[0.9966536,0.0003731467,0.00026341542,0.00017425779,0.0006351996,0.001900442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016454385,0.00036371886,0.00047567926,0.00057765277,0.0015439476,0.001895201,0.0008096394,0.0016452256,0.014176956],"category_scores_gemma":[0.005008096,0.00015095295,0.0003359285,0.00071515783,0.0009350325,0.0015163003,0.0037693675,0.0032320437,0.0025956773],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004034741,0.0001597868,0.0047451234,0.00093203934,0.00007019307,0.00073251966,0.0014377454,0.00021208373,0.0012427996,0.020266462,0.5984234,0.37173754],"study_design_scores_gemma":[0.00004697255,0.00021675811,0.012900667,0.0028281563,0.00003585739,0.0017958033,0.0009974577,0.00023915061,0.00022357414,0.013686627,0.9669981,0.000030830008],"about_ca_topic_score_codex":0.0058496613,"about_ca_topic_score_gemma":0.012121061,"teacher_disagreement_score":0.014176956,"about_ca_system_score_codex":0.0016963546,"about_ca_system_score_gemma":0.008801024,"threshold_uncertainty_score":0.0474267},"labels":[],"label_agreement":null},{"id":"W2042482546","doi":"10.1111/ejh.12382","title":"Transient myeloproliferative disorder in neonates without Down syndrome: case report and review","year":2014,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Trisomy; Down syndrome; Myeloproliferative Disorders; Medicine; Population; Aneuploidy; Pathology; Trisomy 8; Disease; Pediatrics; Immunology; Chromosome; Cytogenetics; Genetics; Biology","score_opus":0.015522874665339048,"score_gpt":0.2970291577226387,"score_spread":0.2815062830572997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042482546","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048451774,0.93918794,0.0022311197,0.0014415196,0.0015188826,0.00014014117,0.00019291989,0.00010697155,0.00672863],"genre_scores_gemma":[0.13643259,0.8520767,0.0032616134,0.0018243913,0.0040304405,0.00008514185,0.00032422814,0.000023143966,0.0019418237],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99965954,0.00004681374,0.0001147445,0.000071963084,0.000057510046,0.000049377162],"domain_scores_gemma":[0.9995364,0.00017902632,0.00013118723,0.000017059994,0.000053612148,0.00008276913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029262225,0.0011206041,0.0012346879,0.0038715987,0.0006589018,0.0011055176,0.0013132528,0.0017265109,0.001529056],"category_scores_gemma":[0.0009087057,0.0003343538,0.00044813828,0.0027282087,0.0008970974,0.001642295,0.0008381527,0.0011243075,0.0010078897],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095475,0.0001664931,0.01159324,0.0068946877,0.000119737175,0.80360466,0.0008159843,0.00039669452,0.0038122516,0.0012331874,0.016616601,0.15465097],"study_design_scores_gemma":[0.000007785777,0.00006865648,0.004847588,0.0008180356,0.00008589929,0.95957464,0.0004216076,0.00010729591,0.00031794337,0.00037156887,0.033344667,0.000034414203],"about_ca_topic_score_codex":0.00076328317,"about_ca_topic_score_gemma":0.001013742,"teacher_disagreement_score":0.0038715987,"about_ca_system_score_codex":0.00052740827,"about_ca_system_score_gemma":0.000665716,"threshold_uncertainty_score":0.0051152706},"labels":[],"label_agreement":null},{"id":"W2044636425","doi":"10.1111/j.1600-0609.2009.01257.x","title":"Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma","year":2009,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"Celgene","keywords":"Lenalidomide; Salvage therapy; Dexamethasone; Refractory (planetary science); Multiple myeloma; Medicine; Oncology; Internal medicine; Thalidomide; Chemotherapy","score_opus":0.050451942893496096,"score_gpt":0.30919838829429025,"score_spread":0.25874644540079417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044636425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926317,0.0066089975,0.00008266054,0.00009483786,0.000030119367,0.00004952668,0.00006752524,0.00001238004,0.00042236914],"genre_scores_gemma":[0.99728584,0.0016753285,0.0002933333,0.00012430515,0.00007627962,0.000048774695,0.00024070746,0.000005672018,0.00024975586],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9995092,0.00021757062,0.000044789052,0.00008394024,0.000070750866,0.000073658],"domain_scores_gemma":[0.9993144,0.00018471981,0.00021100735,0.000046058958,0.000022183222,0.00022162512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000703121,0.000442162,0.0017203866,0.00043907505,0.0001446454,0.0007234501,0.00060281187,0.00047041976,0.0006621883],"category_scores_gemma":[0.0010260561,0.00017140916,0.000857122,0.00037533176,0.00022667111,0.00033347774,0.00025301884,0.0008976352,0.00018430999],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4636254,0.008693858,0.09575854,0.0008450644,0.003996894,0.0006793441,0.00039820067,0.00498289,0.041196633,0.00027830017,0.0008164515,0.37872845],"study_design_scores_gemma":[0.057257406,0.46342137,0.4305327,0.0004320144,0.0052734683,0.0036679506,0.0003857948,0.007554035,0.021507349,0.000536553,0.009289664,0.00014172308],"about_ca_topic_score_codex":0.000608536,"about_ca_topic_score_gemma":0.0013803153,"teacher_disagreement_score":0.0017203866,"about_ca_system_score_codex":0.00053152663,"about_ca_system_score_gemma":0.0003811538,"threshold_uncertainty_score":0.0038564801},"labels":[],"label_agreement":null},{"id":"W2047446466","doi":"10.1111/j.1600-0609.2007.00985.x","title":"Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study","year":2007,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Toronto General Hospital","funders":"","keywords":"Deferasirox; Medicine; Myelodysplastic syndromes; Internal medicine; Tolerability; Adverse effect; Gastroenterology; Rash; Creatinine; Deferiprone; Prospective cohort study; Anemia; Deferoxamine; Thalassemia","score_opus":0.01761672658062096,"score_gpt":0.28468205114405354,"score_spread":0.26706532456343257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047446466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980679,0.0015125909,0.000072211886,0.000029255316,0.000008209846,0.000045465138,0.0000801084,0.000004872548,0.00017941899],"genre_scores_gemma":[0.99878556,0.00030665542,0.00016903091,0.00012092405,0.000037966525,0.00006565867,0.00036581987,0.0000022977922,0.00014612344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995129,0.00021410394,0.00005389386,0.00009554786,0.00006144333,0.000062151776],"domain_scores_gemma":[0.9980907,0.00050332997,0.00075994874,0.00010025379,0.00011236708,0.00043345854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001667372,0.00048353948,0.0010992289,0.00022987508,0.00026826945,0.0005340997,0.0003024101,0.00076079165,0.0008088039],"category_scores_gemma":[0.0018642676,0.00028456136,0.00066858734,0.00025494685,0.00036731176,0.0003445883,0.00019118833,0.00085439405,0.0002554164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26066923,0.00490833,0.6664163,0.00040342298,0.0019740167,0.00037163805,0.00025947983,0.0007443569,0.015478572,0.000057457753,0.0004783849,0.04823883],"study_design_scores_gemma":[0.029612627,0.20864141,0.75477666,0.00006274431,0.0012863969,0.0013710618,0.00014214565,0.00076110516,0.0018430917,0.000063157706,0.0014050937,0.000034539386],"about_ca_topic_score_codex":0.00034355145,"about_ca_topic_score_gemma":0.00039853685,"teacher_disagreement_score":0.001667372,"about_ca_system_score_codex":0.00022573747,"about_ca_system_score_gemma":0.00033270323,"threshold_uncertainty_score":0.008817971},"labels":[],"label_agreement":null},{"id":"W2055097184","doi":"10.1111/j.1600-0609.2009.01370.x","title":"Kasabach–Merritt phenomenon: a single centre experience","year":2009,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Vincristine; Surgery; Retrospective cohort study; Kasabach–Merritt syndrome; Platelet; Hypofibrinogenemia; Fibrinogen; Hemangioma; Internal medicine; Gastroenterology; Chemotherapy; Cyclophosphamide","score_opus":0.022267041532408393,"score_gpt":0.2623355091877568,"score_spread":0.2400684676553484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055097184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944458,0.0017185668,0.0010318203,0.00031278806,0.00006653116,0.00007358578,0.00007432259,0.00005599692,0.002220659],"genre_scores_gemma":[0.99823195,0.000655859,0.00045424243,0.00017932308,0.00009175634,0.000020465233,0.0000613403,0.000014567181,0.000290434],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9989159,0.00024091886,0.0001364934,0.00023607032,0.00017031048,0.0003003177],"domain_scores_gemma":[0.99797946,0.00033271275,0.0005311089,0.00020551195,0.00015180868,0.0007994192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055281445,0.0010481357,0.00065186556,0.00063167914,0.0012651978,0.0010328975,0.00063080504,0.0013322707,0.0022006377],"category_scores_gemma":[0.004143321,0.00039619053,0.0005719714,0.0010170407,0.0010418812,0.0009515379,0.0008777999,0.0009978313,0.0006841045],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037388658,0.00084452773,0.64228684,0.00022977962,0.00016829284,0.310479,0.0028715911,0.00054441276,0.0026796465,0.0005679212,0.0028499155,0.03610417],"study_design_scores_gemma":[0.00019033562,0.0024019477,0.21975225,0.000148324,0.00008329512,0.7698136,0.0018580373,0.00063364295,0.0012796662,0.0002482532,0.0035144691,0.00007616958],"about_ca_topic_score_codex":0.0029770161,"about_ca_topic_score_gemma":0.0035813383,"teacher_disagreement_score":0.0029770161,"about_ca_system_score_codex":0.0010054029,"about_ca_system_score_gemma":0.0008533888,"threshold_uncertainty_score":0.0073618293},"labels":[],"label_agreement":null},{"id":"W2055964741","doi":"10.1111/j.1600-0609.2006.00780.x","title":"Abnormality of CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells in idiopathic thrombocytopenic purpura","year":2006,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Science Foundation of Tianjin City; National Natural Science Foundation of China; Peking Union Medical College; Academy of Medical Sciences","keywords":"Thrombocytopenic purpura; IL-2 receptor; Flow cytometry; Immunology; Medicine; Peripheral blood mononuclear cell; Immune system; Regulatory T cell; T cell; Biology; In vitro","score_opus":0.013561190154140009,"score_gpt":0.24098794668683668,"score_spread":0.22742675653269667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055964741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987417,0.0006871517,0.00022966311,0.000016383749,0.0000031486056,0.0000046915966,0.000039222512,0.000012043188,0.00026610738],"genre_scores_gemma":[0.99936694,0.00017941778,0.00020429723,0.00002084255,0.000010712946,0.0000068559584,0.00005852248,0.0000020094067,0.00015052487],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998783,0.00003555315,0.000016250648,0.000023883511,0.000024866727,0.000021105867],"domain_scores_gemma":[0.999828,0.00004813279,0.000065949476,0.000011499209,0.000025323592,0.000021132902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018610309,0.00022535186,0.00022698882,0.00055534334,0.00016272989,0.00023035644,0.000109043634,0.00025392292,0.0015576467],"category_scores_gemma":[0.00040797523,0.00008424849,0.00010643465,0.00019733774,0.00019040407,0.0001433305,0.00008699697,0.00020015426,0.00019559878],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037590452,0.00028551498,0.36213815,0.00036595942,0.00013153374,0.007325984,0.00049062684,0.0003799614,0.56643444,0.00020427509,0.00042872035,0.05805578],"study_design_scores_gemma":[0.00020045153,0.002766181,0.889378,0.00005096111,0.00027046548,0.03986839,0.00050602155,0.0013552789,0.06308247,0.000334276,0.0021682733,0.000019216508],"about_ca_topic_score_codex":0.00019268222,"about_ca_topic_score_gemma":0.00014217471,"teacher_disagreement_score":0.0015576467,"about_ca_system_score_codex":0.00007359604,"about_ca_system_score_gemma":0.00006033407,"threshold_uncertainty_score":0.0052108765},"labels":[],"label_agreement":null},{"id":"W2061310836","doi":"10.1111/ejh.12232","title":"Cost‐effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the <scp>TAPS</scp> trial","year":2013,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Medical Research Council; NHS Blood and Transplant","keywords":"Medicine; Quality-adjusted life year; Disease; Blood transfusion; Cost effectiveness; Elective surgery; Quality of life (healthcare); Pediatrics; Surgery; Internal medicine","score_opus":0.022906171678882672,"score_gpt":0.26213035652600736,"score_spread":0.23922418484712468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061310836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86808306,0.10584789,0.009355963,0.004446335,0.000766478,0.0027690653,0.00282331,0.00008203557,0.00582581],"genre_scores_gemma":[0.99054646,0.006607598,0.0014128151,0.00031494055,0.0000570507,0.00046355315,0.00041648667,0.000006317355,0.00017477454],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9847453,0.01359754,0.00059889257,0.00029696853,0.00045681294,0.00030446125],"domain_scores_gemma":[0.9827613,0.014690978,0.0016758506,0.00025144126,0.00030483058,0.00031556812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011652643,0.0015676572,0.0030994199,0.0009066167,0.00023031032,0.0017908317,0.00078910874,0.0014165964,0.003491083],"category_scores_gemma":[0.026693998,0.0004986155,0.00781755,0.0009647098,0.00063659606,0.0011084387,0.00081400585,0.0024436738,0.00015524933],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5429149,0.0019406117,0.01828751,0.03858431,0.0790589,0.0005856215,0.00021709157,0.18000041,0.0013358531,0.007255594,0.0034551458,0.12636405],"study_design_scores_gemma":[0.40605113,0.09626559,0.028283529,0.014746104,0.18142892,0.0012002,0.00071318675,0.23092866,0.002990537,0.02734674,0.009625767,0.00041962086],"about_ca_topic_score_codex":0.0026469724,"about_ca_topic_score_gemma":0.0023577835,"teacher_disagreement_score":0.011652643,"about_ca_system_score_codex":0.0024368172,"about_ca_system_score_gemma":0.0021274164,"threshold_uncertainty_score":0.06162584},"labels":[],"label_agreement":null},{"id":"W2061727471","doi":"10.1111/ejh.12110","title":"Parathyroid hormone ablation alters erythrocyte parameters that are rescued by calcium‐sensing receptor gene deletion","year":2013,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Parathyroid hormone; Internal medicine; Endocrinology; Erythrocyte fragility; Receptor; Parathyroid hormone receptor; Hemoglobin; Chemistry; Hematocrit; Mean corpuscular volume; Population; Biology; Calcium; Hormone receptor; Medicine; Hemolysis","score_opus":0.03445272615461768,"score_gpt":0.2507992859222206,"score_spread":0.21634655976760292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061727471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945808,0.00095397275,0.0028994533,0.00009229033,0.000029748144,0.000020209098,0.00061314815,0.00018446425,0.0006259346],"genre_scores_gemma":[0.99371934,0.0007223424,0.0024400968,0.00006705533,0.000012663902,0.00005343593,0.0006840738,0.000090598485,0.0022104078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958986,0.00005181304,0.0000617277,0.00009805765,0.00013735278,0.00006121732],"domain_scores_gemma":[0.99941826,0.00008729791,0.00025799908,0.00006469778,0.00003797359,0.00013373411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021201976,0.00053498626,0.00045628025,0.0005718079,0.00014460926,0.00043636162,0.0004558744,0.00051269436,0.0015018379],"category_scores_gemma":[0.00032959104,0.00028346496,0.00037472005,0.00021503141,0.0005099475,0.00030523626,0.00045266695,0.0010308032,0.00025816908],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114130846,0.000012764646,0.0002516446,0.000016849848,0.0000069048306,0.000090865826,0.000015447331,0.00002935982,0.9988011,0.000059573595,0.000015706175,0.0005855454],"study_design_scores_gemma":[0.000062262836,0.00031463048,0.017246185,0.00001083336,0.00006261332,0.0010340184,0.00005703955,0.0009657667,0.97826993,0.00015592042,0.0017999631,0.000020810476],"about_ca_topic_score_codex":0.0004204051,"about_ca_topic_score_gemma":0.0005190028,"teacher_disagreement_score":0.0015018379,"about_ca_system_score_codex":0.00019994177,"about_ca_system_score_gemma":0.00021859069,"threshold_uncertainty_score":0.005024135},"labels":[],"label_agreement":null},{"id":"W2062221225","doi":"10.1111/ejh.12059","title":"<scp>I</scp>gG4‐related disease with hypergammaglobulinemic hyperviscosity and retinopathy","year":2012,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Rituximab; Fludarabine; Pathology; Gastroenterology; Hyperviscosity syndrome; Cyclophosphamide; Internal medicine; Lymphoma; Multiple myeloma; Chemotherapy","score_opus":0.009421351465277705,"score_gpt":0.21201494887274835,"score_spread":0.20259359740747065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062221225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97691625,0.0028363653,0.0014594677,0.0007901728,0.00007191603,0.000083352,0.00010117134,0.00018079551,0.017560422],"genre_scores_gemma":[0.99741447,0.00050673285,0.00041188707,0.00032283753,0.00010454078,0.000009522164,0.00006792635,0.0000132653395,0.0011488366],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998541,0.000029437702,0.000014544811,0.000029556923,0.000021419897,0.0000509539],"domain_scores_gemma":[0.9998055,0.000041669504,0.000070242255,0.000024054463,0.00001254005,0.0000460486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017928077,0.00083497766,0.00032510402,0.0004807532,0.00049336697,0.00037240528,0.0003445515,0.00085472263,0.0018424935],"category_scores_gemma":[0.00044458164,0.00019365082,0.00038314238,0.00046377824,0.0005425626,0.0002986863,0.000339589,0.00057798624,0.0005557964],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017711957,0.00007190969,0.04410204,0.000115255105,0.000049553917,0.9294358,0.00018022682,0.00012128867,0.015181464,0.00045474037,0.0010134507,0.009097168],"study_design_scores_gemma":[0.000045946945,0.00022592102,0.048625514,0.000023018025,0.000042633532,0.94326496,0.00007847402,0.00038509633,0.0031992905,0.0003532591,0.0037470297,0.000008876203],"about_ca_topic_score_codex":0.0016921543,"about_ca_topic_score_gemma":0.0013620509,"teacher_disagreement_score":0.0018424935,"about_ca_system_score_codex":0.00042990438,"about_ca_system_score_gemma":0.00029203919,"threshold_uncertainty_score":0.006163776},"labels":[],"label_agreement":null},{"id":"W2063408197","doi":"10.1111/ejh.12148","title":"Autoimmune hemolytic anemia in a teenager: a wolf in sheep's clothing","year":2013,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Autoimmune hemolytic anemia; Immunodeficiency; Immune dysregulation; Medicine; Autoimmunity; Immune system; Immunology; Malignancy; Anemia; Hemolytic anemia; Severe combined immunodeficiency; Pediatrics; Antibody; Internal medicine; Biology","score_opus":0.007066148431662144,"score_gpt":0.20567719187599423,"score_spread":0.19861104344433209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063408197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97802186,0.0059386804,0.0017458049,0.003599549,0.0005459557,0.00006963438,0.00007673067,0.00015864355,0.009843115],"genre_scores_gemma":[0.9904084,0.0035570366,0.0008840943,0.0015662264,0.00043877005,0.000016949478,0.000051932668,0.000033808574,0.0030428472],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995902,0.000078248,0.000038079786,0.0000815497,0.00007915617,0.0001327762],"domain_scores_gemma":[0.999387,0.00014768374,0.00015312922,0.000027503433,0.000042202162,0.00024250767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037835733,0.0013391842,0.0009958474,0.0018214657,0.0022987428,0.001398029,0.0005235738,0.0026416616,0.003026328],"category_scores_gemma":[0.0020589905,0.0006342448,0.0006932496,0.0007659719,0.00086411735,0.0016554128,0.0011782909,0.0019573383,0.00085879385],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015705458,0.00013711557,0.045933463,0.00002425511,0.000011497747,0.9485147,0.0009399308,0.000030634998,0.0005737246,0.00027045878,0.0008937043,0.0026547106],"study_design_scores_gemma":[0.0000031011484,0.00008849794,0.00591402,0.00003102428,0.000009624394,0.9913958,0.00066538044,0.00008215283,0.00010214845,0.00012187989,0.001579859,0.000006501808],"about_ca_topic_score_codex":0.0017323078,"about_ca_topic_score_gemma":0.0022320738,"teacher_disagreement_score":0.003026328,"about_ca_system_score_codex":0.00046751916,"about_ca_system_score_gemma":0.0004950485,"threshold_uncertainty_score":0.010124087},"labels":[],"label_agreement":null},{"id":"W2073782881","doi":"10.1034/j.1600-0609.2001.5790554.x","title":"VIII International Myeloma Workshop, Banff Springs Hotel, Banff, Alberta, Canada, 4–8 May 2001","year":2001,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Library science; Citation","score_opus":0.021366092669647382,"score_gpt":0.2802701939600759,"score_spread":0.2589041012904285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073782881","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021696502,0.099221006,0.0053260834,0.12078042,0.0746992,0.00088368286,0.010560168,0.0011745701,0.66565835],"genre_scores_gemma":[0.011948796,0.011337766,0.0014107091,0.0015457398,0.0020836296,0.00004963695,0.002591695,0.00010069171,0.9689313],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993131,0.0000412388,0.000015595715,0.00007251253,0.00031312852,0.0002443161],"domain_scores_gemma":[0.99911875,0.000029336714,0.000022912216,0.000015586109,0.0003257031,0.00048771064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016174174,0.0010715128,0.0005389035,0.0010144525,0.0028312665,0.00273359,0.0016072401,0.0020481357,0.11592657],"category_scores_gemma":[0.0007684449,0.0004069269,0.00065563666,0.00091400865,0.0006286195,0.00081655366,0.0016965993,0.001784309,0.03352433],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016302368,0.00005730304,0.0006728971,0.00007565351,0.00000767579,0.00015667416,0.000072038536,0.00017187068,0.0005194452,0.00048457575,0.9577402,0.039878607],"study_design_scores_gemma":[0.000025814861,0.000030989948,0.004109193,0.00011697826,0.000012752864,0.00012966231,0.00035123262,0.00009298008,0.00041066544,0.00027528525,0.9944344,0.0000100765765],"about_ca_topic_score_codex":0.28922746,"about_ca_topic_score_gemma":0.73523825,"teacher_disagreement_score":0.28922746,"about_ca_system_score_codex":0.0064429906,"about_ca_system_score_gemma":0.013941734,"threshold_uncertainty_score":0.5750879},"labels":[],"label_agreement":null},{"id":"W2086152189","doi":"10.1034/j.1600-0609.2003.02838.x","title":"Surface antigen expression and correlation with variable heavy‐chain gene mutation status in chronic lymphocytic leukemia","year":2003,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Tays; Fondation pour la Recherche Médicale; Cancer Research Society","keywords":"Chronic lymphocytic leukemia; CD38; CD5; Antigen; Biology; IGHV@; Immunoglobulin D; Molecular biology; Surface Immunoglobulin; Immunophenotyping; CD23; CD20; Immunology; Antibody; Leukemia; B cell; Genetics; Immunoglobulin E","score_opus":0.015145554584080817,"score_gpt":0.2645746928100752,"score_spread":0.24942913822599436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086152189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99950767,0.00020577032,0.00006293729,0.000007133752,0.0000011056208,0.0000019352597,0.00003307008,0.0000042881306,0.00017610272],"genre_scores_gemma":[0.99970716,0.000071169605,0.000055070024,0.0000041176395,0.0000028634367,0.000003457675,0.00008148545,0.0000017009008,0.00007292358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997551,0.000046019763,0.00002538783,0.000044493252,0.000055482218,0.00007349996],"domain_scores_gemma":[0.9990677,0.00028574574,0.0003041588,0.00006032171,0.00013071993,0.00015126975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028869286,0.0002279896,0.00019896541,0.001364271,0.00024301867,0.00041682675,0.00016069115,0.00041244077,0.0011666918],"category_scores_gemma":[0.0011983761,0.00011997986,0.000114256305,0.00070008566,0.0004017701,0.00024763064,0.0002545177,0.00023022952,0.0001913771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004031342,0.000031275984,0.9582856,0.000019384157,0.00002601954,0.0006607026,0.00012080037,0.00013570015,0.034802545,0.00004557035,0.00006785994,0.0054014064],"study_design_scores_gemma":[0.000015688467,0.00020831698,0.9916715,0.000007829948,0.000023018149,0.003757162,0.00013760208,0.00046182377,0.0031652343,0.00007855704,0.00046633897,0.0000069140574],"about_ca_topic_score_codex":0.00091810705,"about_ca_topic_score_gemma":0.0008430845,"teacher_disagreement_score":0.001364271,"about_ca_system_score_codex":0.00020226497,"about_ca_system_score_gemma":0.000113216025,"threshold_uncertainty_score":0.0039030313},"labels":[],"label_agreement":null},{"id":"W2091177739","doi":"10.1034/j.1600-0609.2003.00115.x","title":"Aplastic anemia following administration of a tumor necrosis factor‐<i>α</i> inhibitor","year":2003,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Etanercept; Medicine; Rheumatoid arthritis; Tumor necrosis factor alpha; Aplastic anemia; Immunology; Infliximab; Blockade; Pancytopenia; Sepsis; Arthritis; Pathogenesis; Anemia; Internal medicine; Receptor; Bone marrow","score_opus":0.009230715432819073,"score_gpt":0.23251930186841183,"score_spread":0.22328858643559274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091177739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98289317,0.0040117563,0.0050184703,0.0009746113,0.000109946384,0.00011030294,0.000091823174,0.00040260443,0.0063874437],"genre_scores_gemma":[0.99732673,0.000544174,0.0004262833,0.0005333729,0.0000550703,0.000010391261,0.00005529475,0.0000127478215,0.0010358556],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99979097,0.000064424166,0.000026180982,0.000028419212,0.00004759205,0.00004245663],"domain_scores_gemma":[0.999173,0.00029187396,0.00030134706,0.000051747298,0.000035822573,0.00014618723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026258331,0.0004206893,0.0005231819,0.00028333394,0.0003330215,0.0003071914,0.00026239714,0.0006887869,0.00056400074],"category_scores_gemma":[0.001138044,0.00020620628,0.00032090134,0.00021231266,0.0003855382,0.00024192815,0.00027999413,0.0012286959,0.0001848295],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047070156,0.00069758005,0.031989623,0.00039379817,0.00026426083,0.72435933,0.0006770027,0.00074289594,0.17537798,0.0010399092,0.0021326323,0.057617974],"study_design_scores_gemma":[0.00045849133,0.007816252,0.06890722,0.0000420947,0.00021501399,0.871949,0.00009677881,0.0017571882,0.041606408,0.0005429045,0.006580544,0.000028124728],"about_ca_topic_score_codex":0.00086129166,"about_ca_topic_score_gemma":0.000837315,"teacher_disagreement_score":0.00086129166,"about_ca_system_score_codex":0.0004947433,"about_ca_system_score_gemma":0.00024271233,"threshold_uncertainty_score":0.0035896897},"labels":[],"label_agreement":null},{"id":"W2130467588","doi":"10.1111/j.1600-0609.2010.01569.x","title":"Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®)","year":2010,"lang":"en","type":"letter","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deferiprone; Deferasirox; Medicine; Deferoxamine; Chelation therapy; Pregnancy; Pediatrics; Thalassemia; Intensive care medicine; Internal medicine","score_opus":0.008570325720383989,"score_gpt":0.21033629528513917,"score_spread":0.20176596956475518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130467588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7714588,0.05264436,0.007349375,0.11507946,0.031479582,0.0003587515,0.0005422499,0.00061474676,0.020472685],"genre_scores_gemma":[0.947372,0.008418037,0.0030832093,0.017963443,0.018852081,0.00005537577,0.000121184676,0.000073233685,0.0040613376],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99922764,0.00018394072,0.00012278852,0.0001997385,0.00011278265,0.0001530289],"domain_scores_gemma":[0.99663997,0.0018125813,0.00051240204,0.00011848015,0.00020665217,0.00070989924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070159184,0.0015954769,0.0014465324,0.0016607646,0.001514583,0.0012240654,0.0023818223,0.0066396124,0.0019305071],"category_scores_gemma":[0.008131028,0.00082499767,0.0009644874,0.0009854621,0.001637716,0.0021692344,0.00076910236,0.0048785484,0.00076102297],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006864158,0.000038559265,0.0023925512,0.00006637848,0.000010666305,0.99288505,0.00018112679,0.00006469388,0.00031436043,0.00014584918,0.002247847,0.0015842615],"study_design_scores_gemma":[0.000022109632,0.0001676122,0.0030155068,0.000081031474,0.000028828039,0.99225074,0.00018252891,0.000571795,0.00030315298,0.00021204397,0.0031449266,0.000019608962],"about_ca_topic_score_codex":0.001520517,"about_ca_topic_score_gemma":0.0017458942,"teacher_disagreement_score":0.0066396124,"about_ca_system_score_codex":0.0011247124,"about_ca_system_score_gemma":0.0005088974,"threshold_uncertainty_score":0.008160353},"labels":[],"label_agreement":null},{"id":"W2140631301","doi":"10.1111/ejh.12496","title":"Various regimens for prophylactic treatment of patients with haemophilia","year":2015,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Haemophilia; Bleed; Arthropathy; Regimen; Venous access; Haemophilia A; Quality of life (healthcare); Surgery; Prophylactic treatment; Risk factor; Intensive care medicine; Pediatrics; Internal medicine; Pathology; Osteoarthritis","score_opus":0.09515856949178594,"score_gpt":0.3663581702857024,"score_spread":0.2711996007939165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140631301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029731038,0.9979778,0.00009885581,0.0001307575,0.00008589512,0.00002108213,0.00005557104,0.000011305036,0.0013215188],"genre_scores_gemma":[0.0024017743,0.99563,0.0003757224,0.00023282372,0.00010021514,0.00003088379,0.00015273088,0.0000037802226,0.0010721019],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99975985,0.000050650087,0.00004770239,0.000040408468,0.00008581658,0.00001561534],"domain_scores_gemma":[0.9997645,0.00012064946,0.000058981033,0.000010164456,0.000032442178,0.000013285693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003261959,0.00076432945,0.0013016502,0.00222664,0.0003516955,0.0005255876,0.0007345095,0.00074954145,0.009170996],"category_scores_gemma":[0.0007971427,0.00019023096,0.00095903024,0.0016937443,0.00032021492,0.00065420073,0.00046177598,0.0012600302,0.002595001],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013172737,0.00011919464,0.00019825187,0.027279465,0.00018994138,0.00019781222,0.000053974465,0.00012304234,0.0009459547,0.0009843055,0.017293181,0.95248306],"study_design_scores_gemma":[0.00017447735,0.00031263533,0.0035535432,0.017444776,0.00055827806,0.0047990936,0.000096060205,0.000083824925,0.0010220248,0.0012503075,0.97066945,0.00003555072],"about_ca_topic_score_codex":0.001024424,"about_ca_topic_score_gemma":0.0019704096,"teacher_disagreement_score":0.009170996,"about_ca_system_score_codex":0.00028738787,"about_ca_system_score_gemma":0.00037049645,"threshold_uncertainty_score":0.03068006},"labels":[],"label_agreement":null},{"id":"W2144684129","doi":"10.1111/j.0902-4441.2003.00209.x","title":"Effect of low‐dose warfarin on D‐dimer levels during sickle cell vaso‐occlusive crisis: a brief report","year":2004,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Dartmouth General Hospital; Dalhousie University; Royal University Hospital","funders":"","keywords":"D-dimer; Medicine; Warfarin; Hemoglobin; Fibrinogen; Internal medicine; Gastroenterology; White blood cell; Sickle cell anemia; Surgery; Anesthesia; Atrial fibrillation; Disease","score_opus":0.007920888680788114,"score_gpt":0.25495132378042434,"score_spread":0.24703043509963624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144684129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860904,0.011852046,0.0006798402,0.00033893005,0.000099733814,0.000026065698,0.0000759658,0.000023882325,0.00081313314],"genre_scores_gemma":[0.99625635,0.0027069354,0.00032987242,0.00016973545,0.00028867545,0.0000076747165,0.00008250279,0.000003094266,0.00015505652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996165,0.00015298584,0.00006904674,0.000048752823,0.00007405613,0.00003872041],"domain_scores_gemma":[0.9987821,0.00072392693,0.00026145997,0.000038980186,0.00009820957,0.00009534025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037809953,0.00024419368,0.0003646577,0.00020236104,0.00014917138,0.00033166417,0.00013070174,0.0003882115,0.00049355935],"category_scores_gemma":[0.0018464045,0.00006610766,0.00034530342,0.00014659026,0.00022961528,0.00016746149,0.000096227035,0.00031349747,0.0001326247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010804582,0.0011506174,0.74210393,0.0012125457,0.00075559854,0.021601453,0.00050890475,0.0005753534,0.03987176,0.00014280817,0.0017020921,0.1795703],"study_design_scores_gemma":[0.0002644985,0.016826287,0.92589533,0.00007486538,0.0006970878,0.03811615,0.00028148902,0.00089050113,0.013276883,0.00011837794,0.0035275298,0.00003110495],"about_ca_topic_score_codex":0.00038284372,"about_ca_topic_score_gemma":0.0003073868,"teacher_disagreement_score":0.00049355935,"about_ca_system_score_codex":0.00018646652,"about_ca_system_score_gemma":0.0001239187,"threshold_uncertainty_score":0.0019996166},"labels":[],"label_agreement":null},{"id":"W2147225705","doi":"10.1111/j.1600-0609.2009.01344.x","title":"The prolyl‐hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia","year":2009,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Genesis Pharma","keywords":"Plasma cell; Plasma cell leukemia; Monoclonal gammopathy of undetermined significance; Cancer research; Multiple myeloma; Methylation; Biology; Plasmacytoma; Epigenetics; Molecular biology; Immunology; Monoclonal; Biochemistry; Antibody; Monoclonal antibody","score_opus":0.0057936439824299545,"score_gpt":0.22146520820641952,"score_spread":0.21567156422398956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147225705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997315,0.0014254302,0.000629319,0.000028814244,0.0000043583814,0.000003813372,0.00013361886,0.000020534995,0.0004390425],"genre_scores_gemma":[0.99894136,0.0003836993,0.00018175674,0.000015465846,0.0000024637882,0.0000024200292,0.000099984085,0.00000434978,0.00036841966],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993646,0.000011096679,0.000006492648,0.000018384444,0.0000143803145,0.000013198422],"domain_scores_gemma":[0.99987257,0.000026399146,0.000057778947,0.000012683216,0.000013107769,0.000017377197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000985098,0.00011474634,0.000146882,0.00037035166,0.00013532309,0.00015712807,0.00012136852,0.00024380682,0.001039419],"category_scores_gemma":[0.00024836644,0.00010521023,0.00015505998,0.0003204889,0.00017300718,0.00010415204,0.00016933841,0.0001495783,0.00019098991],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007756295,0.000017259064,0.05215087,0.000085100815,0.000052824023,0.0014386452,0.00017491737,0.00014546535,0.9336689,0.0001310713,0.00010971487,0.011249561],"study_design_scores_gemma":[0.000031751413,0.00031160528,0.73511624,0.000024121404,0.00012237251,0.016900472,0.0002284979,0.00077526714,0.2410695,0.0004983567,0.00490896,0.000012910483],"about_ca_topic_score_codex":0.000988685,"about_ca_topic_score_gemma":0.00096715783,"teacher_disagreement_score":0.001039419,"about_ca_system_score_codex":0.00017523988,"about_ca_system_score_gemma":0.00011463774,"threshold_uncertainty_score":0.0034772158},"labels":[],"label_agreement":null},{"id":"W2147721382","doi":"10.1111/j.1600-0609.2007.00951.x","title":"ITP: A new regulatory issue!","year":2007,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Citation; Library science; Computer science","score_opus":0.07279011603931608,"score_gpt":0.36313292119362506,"score_spread":0.290342805154309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147721382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027099554,0.87925375,0.0014445207,0.087444015,0.019992596,0.000020632688,0.00012455261,0.00012089427,0.011327992],"genre_scores_gemma":[0.0049902694,0.82096,0.0026534721,0.12647657,0.027793499,0.00008796298,0.00040627288,0.000069283684,0.016562654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984945,0.00038387586,0.00019553279,0.00016366148,0.0005348973,0.00022748901],"domain_scores_gemma":[0.99566,0.0021832106,0.0006483836,0.00018246932,0.00088920945,0.00043667588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052299653,0.001135788,0.0023312953,0.0013751789,0.00060161855,0.0043354253,0.0017733072,0.009458838,0.016443094],"category_scores_gemma":[0.0077073188,0.00040357813,0.0012181638,0.0026585637,0.0023631486,0.006776664,0.0021722896,0.011307227,0.0067925435],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012404207,0.00006961826,0.00011000067,0.0028747858,0.00003297928,0.0003845401,0.000049917042,0.000174621,0.00050638494,0.014723816,0.35005,0.63089937],"study_design_scores_gemma":[0.000043950236,0.000061067694,0.0001868228,0.0017805458,0.000037070247,0.00061727443,0.000032541,0.000053354895,0.00013127636,0.00330011,0.99374455,0.000011434704],"about_ca_topic_score_codex":0.0009924178,"about_ca_topic_score_gemma":0.0015746452,"teacher_disagreement_score":0.016443094,"about_ca_system_score_codex":0.0015118611,"about_ca_system_score_gemma":0.005759755,"threshold_uncertainty_score":0.055007637},"labels":[],"label_agreement":null},{"id":"W2163945456","doi":"10.1111/ejh.12528","title":"Antibody binding to megakaryocytes <i>in vivo</i> in patients with immune thrombocytopenia","year":2015,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Canadian Institutes of Health Research; Mitacs; Amgen","keywords":"Megakaryocyte; Platelet; Immune thrombocytopenia; Bone marrow; Antibody; Medicine; In vivo; Immunology; Thrombocytopenic purpura; Immunoglobulin G; Immune system; Biology; Stem cell; Haematopoiesis","score_opus":0.015912926024002873,"score_gpt":0.2677094112327367,"score_spread":0.2517964852087339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163945456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828243,0.0009839715,0.0001194457,0.000031851258,0.0000060297148,0.000007490059,0.000047438734,0.000009144373,0.00051220524],"genre_scores_gemma":[0.9995639,0.00015647762,0.000097370095,0.00002623146,0.000013706963,0.000003855589,0.00006441776,0.000002131467,0.000071805865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994949,0.0001530475,0.0000716022,0.00011091858,0.00009059493,0.00007891949],"domain_scores_gemma":[0.99922645,0.00026892463,0.00026105045,0.000040837615,0.00009754612,0.000105145715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005213485,0.0005179264,0.0003952932,0.0010468524,0.00034404636,0.000501137,0.0002551037,0.0006313722,0.0017946723],"category_scores_gemma":[0.0017757812,0.00025830718,0.0002019187,0.0005559614,0.00035781442,0.00036212252,0.00030752516,0.0004417502,0.00033323906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005731004,0.00003640714,0.9858357,0.00006104333,0.00005299006,0.0016850207,0.0001483447,0.00006079815,0.0054421695,0.00002150565,0.00015123302,0.0059316293],"study_design_scores_gemma":[0.00003674139,0.00044706312,0.9847099,0.000027537793,0.000079179124,0.01178468,0.00016290051,0.00033497647,0.0018450238,0.00003626741,0.0005295126,0.000006140476],"about_ca_topic_score_codex":0.0007390569,"about_ca_topic_score_gemma":0.0006332968,"teacher_disagreement_score":0.0017946723,"about_ca_system_score_codex":0.00020027586,"about_ca_system_score_gemma":0.000111819936,"threshold_uncertainty_score":0.0060037374},"labels":[],"label_agreement":null},{"id":"W2167996748","doi":"10.1034/j.1600-0609.2000.90070.x","title":"Granulocytopoiesis versus cytokine activities in peritoneal diffusion chamber cultures in the mouse","year":2000,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Norges Forskningsråd; Universitetet i Oslo; Cancer Research Society; F. Hoffmann-La Roche","keywords":"Granulocyte; Progenitor cell; Population; Cytokine; Haematopoiesis; Granulocyte macrophage colony-stimulating factor; Tumor necrosis factor alpha; Immunology; Endocrinology; Internal medicine; Colony-stimulating factor; Cyclophosphamide; Medicine; Andrology; Biology; Stem cell; Cell biology; Chemotherapy","score_opus":0.019645682048456913,"score_gpt":0.2876818523997717,"score_spread":0.2680361703513148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167996748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880642,0.002999661,0.0066695088,0.000072070645,0.000048519483,0.00007647847,0.0005447532,0.00022266748,0.0013020176],"genre_scores_gemma":[0.98125297,0.002137397,0.012181779,0.0000727343,0.000046065932,0.0002235359,0.0009181834,0.000086156855,0.0030811366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945,0.00013691549,0.00005771786,0.00014287895,0.00011028592,0.000102227525],"domain_scores_gemma":[0.9992061,0.00017771455,0.00021945195,0.000115418174,0.000058343445,0.00022302156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048334297,0.00082106976,0.00040519756,0.00091793295,0.00019017707,0.0005493132,0.00028985314,0.0005212233,0.00070001464],"category_scores_gemma":[0.0002930743,0.0003329215,0.00039307916,0.0003373369,0.0004297159,0.0004505161,0.00030283682,0.001039521,0.0004298136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023472417,0.00003658924,0.00023556175,0.000028912247,0.0000022633992,0.000025394513,0.000023700557,0.00002967122,0.9986211,0.000044590357,0.000009498952,0.0007079291],"study_design_scores_gemma":[0.000021237973,0.0010191321,0.0028960707,0.000007267918,0.000023016235,0.0001372083,0.000016060783,0.00041269892,0.9947042,0.000039911003,0.0007174875,0.0000056762824],"about_ca_topic_score_codex":0.00028864085,"about_ca_topic_score_gemma":0.00045605717,"teacher_disagreement_score":0.00091793295,"about_ca_system_score_codex":0.00026905377,"about_ca_system_score_gemma":0.00019705307,"threshold_uncertainty_score":0.0025562048},"labels":[],"label_agreement":null},{"id":"W2170126309","doi":"10.1111/ejh.12597","title":"Gender and <i><scp>BCR</scp>‐<scp>ABL</scp></i> transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia","year":2015,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; London Health Sciences Centre; Juravinski Hospital; McMaster University; Hamilton Health Sciences; Western University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Imatinib; Myeloid leukemia; Medicine; Internal medicine; Regimen; Oncology; Gastroenterology","score_opus":0.017623420847440594,"score_gpt":0.23667557265969524,"score_spread":0.21905215181225465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170126309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99915516,0.00036258466,0.000064135915,0.000023625807,0.000007350067,0.000003029423,0.00013406688,0.0000025625145,0.0002474546],"genre_scores_gemma":[0.9995672,0.000087081244,0.000055280198,0.000017946904,0.000013384865,0.0000040195973,0.00014086653,0.0000014830956,0.00011277977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997782,0.000049963422,0.00003033199,0.000045727535,0.00004279569,0.00005302292],"domain_scores_gemma":[0.9991635,0.00021422147,0.0004310645,0.000028881916,0.00004062498,0.000121712845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029100056,0.0001735468,0.00024447814,0.00035647769,0.0001888927,0.0002977077,0.00014094396,0.00030223976,0.001745276],"category_scores_gemma":[0.0010955073,0.00013283937,0.00022093473,0.00039641382,0.00021146517,0.00022378456,0.00014703615,0.00026534335,0.0003302311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024671035,0.000012064288,0.9977456,0.0000055953738,0.000020519778,0.00009302609,0.000018299048,0.000028481714,0.0006110903,0.000007661467,0.000053395226,0.0011574214],"study_design_scores_gemma":[0.000013576967,0.00018339186,0.9979121,0.000004707528,0.000027557266,0.0011718469,0.00005269148,0.000119344586,0.00020029789,0.000021800504,0.0002895929,0.0000030722636],"about_ca_topic_score_codex":0.0005708478,"about_ca_topic_score_gemma":0.0007465709,"teacher_disagreement_score":0.001745276,"about_ca_system_score_codex":0.00014437271,"about_ca_system_score_gemma":0.00016514905,"threshold_uncertainty_score":0.005838573},"labels":[],"label_agreement":null},{"id":"W2293040160","doi":"10.1111/ejh.12715","title":"Haemophilia in a real‐world setting: the value of clinical experience in data collection","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"Novo Nordisk; Bayer; Baxter International; Pfizer","keywords":"Haemophilia; Data collection; Real world data; Value (mathematics); Medicine; Family medicine; Psychology; Medical education; Sociology; Pediatrics; Social science; Data science; Computer science","score_opus":0.19593758418557503,"score_gpt":0.4532271056941757,"score_spread":0.2572895215086006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293040160","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03458349,0.12451413,0.06354939,0.74339074,0.011580798,0.0021818117,0.0009792214,0.00035054807,0.018869795],"genre_scores_gemma":[0.52992094,0.09797285,0.16927157,0.18005551,0.011070216,0.007308254,0.0011342418,0.0008078756,0.002458579],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.1906981,0.745856,0.022988126,0.007437389,0.029697673,0.003322761],"domain_scores_gemma":[0.08710459,0.80732554,0.01784853,0.03385084,0.042511478,0.011359019],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.62613475,0.0011247793,0.0035802224,0.0066810315,0.008036468,0.03497071,0.007578736,0.0072389776,0.0038614043],"category_scores_gemma":[0.7038267,0.0023036408,0.0023025528,0.008637254,0.027924936,0.038594455,0.027498988,0.022120662,0.0011324519],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009975601,0.000449313,0.034246065,0.0132591035,0.0012422937,0.0013818863,0.22040023,0.001268204,0.0005520128,0.04321505,0.10259607,0.5803923],"study_design_scores_gemma":[0.0006096023,0.0023313444,0.032434013,0.0750794,0.00069125666,0.0034771727,0.2109905,0.0038296243,0.0016709995,0.17222643,0.49520287,0.0014568748],"about_ca_topic_score_codex":0.0092393095,"about_ca_topic_score_gemma":0.012313666,"teacher_disagreement_score":0.62613475,"about_ca_system_score_codex":0.015591249,"about_ca_system_score_gemma":0.037060373,"threshold_uncertainty_score":0.46104246},"labels":[],"label_agreement":null},{"id":"W2294841775","doi":"10.1111/ejh.12738","title":"Thrombophilic risk of individuals with rare compound factor V Leiden and prothrombin G20210A polymorphisms: an international case series of 100 individuals","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Centers for Disease Control and Prevention; American Society of Hematology","keywords":"Medicine; Thrombosis; Factor V Leiden; Pulmonary embolism; Thrombophilia; Venous thrombosis; Prothrombin G20210A; Internal medicine; Gastroenterology; Pediatrics; Surgery","score_opus":0.034876827355871616,"score_gpt":0.27941912999946955,"score_spread":0.24454230264359794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294841775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970349,0.0008154489,0.00037683142,0.00008776307,0.000013977304,0.000022811806,0.00008522009,0.000013154214,0.001549884],"genre_scores_gemma":[0.99931836,0.00026134303,0.00010724012,0.000038146987,0.000033260498,0.0000068643917,0.0000701409,0.0000032400362,0.00016146514],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.999395,0.00014041913,0.0000782628,0.00015599975,0.00013082488,0.00009950505],"domain_scores_gemma":[0.9989195,0.00031317805,0.00030347455,0.00013229164,0.000073899835,0.00025767318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040598327,0.0006444523,0.0004202093,0.00180283,0.00090111705,0.00094933197,0.00048314946,0.0012178766,0.0018951044],"category_scores_gemma":[0.0023946452,0.0005639104,0.00042217918,0.0010463962,0.0008141385,0.00055407576,0.0004827029,0.000660297,0.0004013477],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002033445,0.00013163022,0.89110166,0.00003280356,0.00013045872,0.10026002,0.00057598756,0.00010611237,0.0008078033,0.00017299496,0.00071530044,0.0057618367],"study_design_scores_gemma":[0.000059189268,0.00037024764,0.45348662,0.000037775535,0.00016137533,0.5426761,0.000538933,0.0006185421,0.00049899507,0.00018220098,0.0013335793,0.000036424022],"about_ca_topic_score_codex":0.0020636162,"about_ca_topic_score_gemma":0.0011713092,"teacher_disagreement_score":0.0020636162,"about_ca_system_score_codex":0.00029368096,"about_ca_system_score_gemma":0.0002445728,"threshold_uncertainty_score":0.006339729},"labels":[],"label_agreement":null},{"id":"W2296257365","doi":"10.1111/ejh.12734","title":"Measurement of liver iron concentration by superconducting quantum interference device biomagnetic liver susceptometry validates serum ferritin as prognostic parameter for allogeneic stem cell transplantation","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Ferritin; Serum ferritin; Quantum interference; Iron status; Liver transplantation; Medicine; Transplantation; Internal medicine; Gastroenterology; Cardiology; Superconductivity; Physics; Iron deficiency; Condensed matter physics; Anemia","score_opus":0.040351546373114534,"score_gpt":0.26357578812591853,"score_spread":0.223224241752804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296257365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985904,0.00046403718,0.0005742885,0.000023588842,0.0000051157294,0.000007265227,0.00006570071,0.00000806386,0.00026155618],"genre_scores_gemma":[0.9996006,0.000058978898,0.00022163868,0.00001247358,0.000008627418,0.0000035995718,0.00006161062,0.0000011190905,0.000031510113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921584,0.00034245092,0.00009426449,0.00009351415,0.00020517106,0.000048877988],"domain_scores_gemma":[0.9967801,0.0012753957,0.0012903529,0.00019170242,0.00029591436,0.0001665741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021070624,0.0002690022,0.0002784307,0.0005890833,0.00013656479,0.00035665685,0.00019023512,0.0002061835,0.000734337],"category_scores_gemma":[0.0037948955,0.00012120162,0.00019449688,0.0003942194,0.00043321008,0.00019418704,0.00021327457,0.00027322056,0.00018217943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029651087,0.000014469548,0.99470866,0.000009817926,0.000029838036,0.00004644717,0.0000167276,0.00006765316,0.002391566,0.0000093161825,0.0000330599,0.0023758668],"study_design_scores_gemma":[0.00001755599,0.0007077325,0.99340904,0.000012793565,0.000064422275,0.0010603674,0.00003918125,0.00096397405,0.0034298305,0.00004311504,0.0002481762,0.0000037906855],"about_ca_topic_score_codex":0.00040640085,"about_ca_topic_score_gemma":0.00051450863,"teacher_disagreement_score":0.0021070624,"about_ca_system_score_codex":0.00020454514,"about_ca_system_score_gemma":0.00019889903,"threshold_uncertainty_score":0.011143386},"labels":[],"label_agreement":null},{"id":"W2300956547","doi":"10.1111/ejh.12581","title":"Optimising musculoskeletal care for patients with haemophilia","year":2015,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Grifols; Novo Nordisk; Biogen; Amgen; Pfizer; Swedish Orphan Biovitrum; CSL Behring","keywords":"Medicine; Haemophilia; Joint replacement; Haemophilia A; Arthropathy; Intensive care medicine; Population; Disease; Arthroplasty; Surgery; Physical therapy; Internal medicine; Osteoarthritis","score_opus":0.057802680824921696,"score_gpt":0.374179026491592,"score_spread":0.31637634566667033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300956547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016242478,0.9986615,0.000075265176,0.00034638605,0.00008380317,0.0000065362738,0.000012736404,0.0000043880164,0.0006469591],"genre_scores_gemma":[0.0010424351,0.99807763,0.00029152984,0.00021854282,0.00009995996,0.000008120477,0.000025967096,9.424775e-7,0.00023483325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972945,0.00008043605,0.000058417332,0.000026592981,0.00008702563,0.00001808777],"domain_scores_gemma":[0.99965596,0.00018231363,0.00006985081,0.0000062575323,0.00006620352,0.000019327716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048329984,0.0005730546,0.0009087927,0.0016873048,0.00024453548,0.0008348651,0.00052766374,0.0012656034,0.0029332358],"category_scores_gemma":[0.0014220759,0.00017276584,0.0005648806,0.0011884561,0.00024073581,0.00081951066,0.00057465857,0.000913391,0.00090750644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005300391,0.00005761108,0.00035869147,0.046801094,0.00016899766,0.0002958938,0.00014999487,0.00020377274,0.0006840559,0.0014043975,0.020419035,0.9294036],"study_design_scores_gemma":[0.00006884576,0.00016711718,0.00512061,0.054446943,0.0005405965,0.006046733,0.00035312437,0.00012622283,0.00040252565,0.0019835192,0.930709,0.000034674056],"about_ca_topic_score_codex":0.0012972429,"about_ca_topic_score_gemma":0.0026454346,"teacher_disagreement_score":0.0029332358,"about_ca_system_score_codex":0.00038572168,"about_ca_system_score_gemma":0.0010780761,"threshold_uncertainty_score":0.009812653},"labels":[],"label_agreement":null},{"id":"W2362147867","doi":"10.1111/ejh.12757","title":"The fludarabine, cytarabine, and granulocyte colony‐stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline‐based therapy for the treatment of acute myeloid leukemia for patients with pre‐existing cardiac disease","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Flag (linear algebra); Medicine; Cytarabine; Anthracycline; Fludarabine; Myeloid leukemia; Internal medicine; Granulocyte colony-stimulating factor; Regimen; Chemotherapy; Surgery; Gastroenterology; Oncology; Cyclophosphamide; Cancer","score_opus":0.03171977461410722,"score_gpt":0.3272721738273038,"score_spread":0.29555239921319654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2362147867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989505,0.00076360285,0.00007618931,0.000021087993,0.000004263755,0.000012235069,0.000028823264,0.0000021314188,0.00014112722],"genre_scores_gemma":[0.9993382,0.0002758303,0.0001876765,0.000035366396,0.000013595306,0.000008543304,0.00008308207,5.8029514e-7,0.000057053407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997801,0.00010679081,0.000021553611,0.000031081097,0.000030041576,0.000030400683],"domain_scores_gemma":[0.99957496,0.00012423785,0.0001931645,0.000020556967,0.000014043817,0.00007301714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031719686,0.00014830256,0.00023891067,0.00017598101,0.00015910172,0.00019730351,0.00013277832,0.00020244073,0.0004400136],"category_scores_gemma":[0.00082223554,0.00008419058,0.00018440808,0.00018077626,0.00018551473,0.00012197064,0.00011830833,0.00026450577,0.00008204105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019294148,0.0019874643,0.7936707,0.00027071702,0.0002824566,0.0012373229,0.00022236719,0.0010721084,0.033511605,0.0001451417,0.00042787683,0.14787808],"study_design_scores_gemma":[0.0017225549,0.064123705,0.9127206,0.000054587323,0.00026112734,0.008569045,0.0001808985,0.0010086062,0.0069441907,0.0000810262,0.0043098466,0.000023708586],"about_ca_topic_score_codex":0.00026169932,"about_ca_topic_score_gemma":0.0007252777,"teacher_disagreement_score":0.0004400136,"about_ca_system_score_codex":0.00017858809,"about_ca_system_score_gemma":0.0001720947,"threshold_uncertainty_score":0.0016775131},"labels":[],"label_agreement":null},{"id":"W2410461470","doi":"10.1111/j.1600-0609.2010.01461.x","title":"Meeting the Unmet Needs in Anticoagulant Therapy","year":2010,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Hamilton General Hospital","funders":"","keywords":"Medicine; Warfarin; Vitamin k; Oral anticoagulant; Anticoagulant therapy; Intensive care medicine; Stroke (engine); Atrial fibrillation; Surgery; Internal medicine","score_opus":0.06126052380546305,"score_gpt":0.3252583767967769,"score_spread":0.26399785299131384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410461470","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023966413,0.0619168,0.0017523904,0.9179139,0.0072212075,0.000020798563,0.00013173032,0.00010238476,0.008544033],"genre_scores_gemma":[0.08631761,0.29490492,0.02511128,0.47825107,0.09995038,0.00038887333,0.0011847165,0.00023819481,0.013652984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9895867,0.00408608,0.001357024,0.0009091749,0.0026026003,0.0014583962],"domain_scores_gemma":[0.9540865,0.01649597,0.002731606,0.0011918609,0.007994331,0.017499642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017809767,0.0011390825,0.0022294298,0.0017036712,0.002542476,0.0073157456,0.0029020235,0.018161228,0.043156058],"category_scores_gemma":[0.03603933,0.0004953298,0.0013062248,0.001930418,0.004648937,0.010654803,0.00706212,0.0122041255,0.01095271],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004150583,0.0004498166,0.004380066,0.0032769125,0.00011786409,0.001442168,0.0010468079,0.001301862,0.0012819252,0.035372138,0.47039977,0.4805156],"study_design_scores_gemma":[0.00023836285,0.0004158942,0.010158187,0.0049397256,0.00007693673,0.0052128094,0.006298559,0.0016765109,0.00020198594,0.092751704,0.8778646,0.00016466851],"about_ca_topic_score_codex":0.0015336579,"about_ca_topic_score_gemma":0.0034385617,"teacher_disagreement_score":0.043156058,"about_ca_system_score_codex":0.0029659942,"about_ca_system_score_gemma":0.01439045,"threshold_uncertainty_score":0.14437139},"labels":[],"label_agreement":null},{"id":"W2530762184","doi":"10.1111/ejh.12819","title":"Novel G6B gene variant causes familial autosomal recessive thrombocytopenia and anemia","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"Biotechnology and Biological Sciences Research Council; Dasman Diabetes Institute; Kuwait Foundation for the Advancement of Sciences; National Institute for Health and Care Research","keywords":"Biology; Exome sequencing; Genetics; Haploinsufficiency; Gene; Mutation; Phenotype","score_opus":0.022334285162103562,"score_gpt":0.2633814345967427,"score_spread":0.24104714943463912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530762184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957482,0.00047557018,0.0016700205,0.00037881514,0.000048788937,0.00003535197,0.00033434032,0.00009200754,0.0012168704],"genre_scores_gemma":[0.9981352,0.00013301811,0.00069701555,0.00011453522,0.000038427148,0.000008386167,0.00014465525,0.000012659124,0.0007160046],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9997867,0.000029634519,0.000022883276,0.000074491654,0.000049220766,0.000037062193],"domain_scores_gemma":[0.99979717,0.000049274306,0.00005499384,0.000013757313,0.000013406469,0.000071584305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001454842,0.00143149,0.00049264607,0.00084094505,0.0007256873,0.00025695155,0.00040288808,0.0012189831,0.0023794181],"category_scores_gemma":[0.00048348113,0.00032224075,0.00037601974,0.0005849155,0.00062499335,0.0001783082,0.00047115574,0.0006843543,0.000374739],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024168025,0.000099372075,0.025396062,0.00007736331,0.00006449783,0.9113645,0.0003201645,0.00024580475,0.057315417,0.0007089824,0.0008169733,0.0033493347],"study_design_scores_gemma":[0.000093281145,0.00033620838,0.053886432,0.00003368128,0.000117511816,0.9311008,0.00021064538,0.001285726,0.010236902,0.000565501,0.0021084195,0.00002491297],"about_ca_topic_score_codex":0.0014695016,"about_ca_topic_score_gemma":0.0014239278,"teacher_disagreement_score":0.0023794181,"about_ca_system_score_codex":0.0002735307,"about_ca_system_score_gemma":0.0002602621,"threshold_uncertainty_score":0.007959962},"labels":[],"label_agreement":null},{"id":"W2535960806","doi":"10.1111/ejh.12820","title":"Clinical evaluation of a hemochromatosis next‐generation sequencing gene panel","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University","funders":"Marine Biological Laboratory","keywords":"Hemochromatosis; DNA sequencing; Medicine; Gene; Genetics; Computational biology; Biology","score_opus":0.24135586912203447,"score_gpt":0.3652527442620009,"score_spread":0.12389687513996642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535960806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334234,0.0005297969,0.000962084,0.0005182951,0.000021879052,0.000067998044,0.00025826515,0.000034758763,0.004264534],"genre_scores_gemma":[0.9983247,0.00018266424,0.0007545874,0.00023612082,0.000017396887,0.000010419032,0.00017757218,0.0000057478646,0.00029070178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957496,0.00009654675,0.000045928966,0.00007872179,0.00013478023,0.00006912913],"domain_scores_gemma":[0.9990054,0.00034990927,0.00012711473,0.000022806724,0.00025072868,0.00024419988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053098553,0.00033947828,0.00026565953,0.0008393071,0.00043211522,0.0003584546,0.00021826557,0.00048420666,0.0022066957],"category_scores_gemma":[0.0017147998,0.00010956812,0.00015547659,0.0003774342,0.00028865074,0.0002682797,0.0002159282,0.0004052476,0.0002894654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005751906,0.00015379609,0.858606,0.00008869598,0.000043071257,0.09194864,0.0005319217,0.0004130094,0.026616829,0.0002462389,0.0026255741,0.018150944],"study_design_scores_gemma":[0.00007367576,0.000985079,0.7671728,0.00011562339,0.000106813895,0.21149796,0.0008271309,0.003577067,0.01087782,0.00038804134,0.0043487214,0.0000293214],"about_ca_topic_score_codex":0.0019374535,"about_ca_topic_score_gemma":0.001786363,"teacher_disagreement_score":0.0022066957,"about_ca_system_score_codex":0.00038862065,"about_ca_system_score_gemma":0.00038908425,"threshold_uncertainty_score":0.007382095},"labels":[],"label_agreement":null},{"id":"W2565235298","doi":"10.1111/ejh.12842","title":"IgG4‐related disease and lymphocyte‐variant hypereosinophilic syndrome: A comparative case series","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Richmond Hospital; Vancouver General Hospital; Providence Health Care; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Hypereosinophilic syndrome; Eosinophilia; IgG4-related disease; Immunoglobulin E; Internal medicine; Gastroenterology; Rituximab; Immunology; Antibody; Disease; Lymphoma; Pathology","score_opus":0.017843012332464266,"score_gpt":0.24383983434328502,"score_spread":0.22599682201082075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565235298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966537,0.0015506084,0.00023318181,0.000053857024,0.00002357684,0.000041806794,0.00006907832,0.00001441622,0.0013597833],"genre_scores_gemma":[0.99867517,0.00057485426,0.00023246121,0.000061429375,0.000103483726,0.000025494459,0.00014650145,0.0000066667053,0.00017390611],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99907553,0.00016474229,0.00013807134,0.000257567,0.00017050054,0.00019352071],"domain_scores_gemma":[0.9978066,0.0007862357,0.00048746372,0.00028658233,0.00016846777,0.00046473675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066559063,0.0010383357,0.00064041244,0.0020257747,0.0010040556,0.00090734474,0.00079961104,0.0014442888,0.0037405202],"category_scores_gemma":[0.004014886,0.00062012614,0.0006418597,0.0011361446,0.001199473,0.0008627434,0.001187026,0.000703005,0.00094427174],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057082565,0.0004823821,0.554193,0.00021770013,0.00023756985,0.42485917,0.0009997659,0.00020450282,0.0035539889,0.0002590308,0.00095029204,0.013471757],"study_design_scores_gemma":[0.000094039555,0.0004990402,0.1413896,0.000037898142,0.00006427563,0.8556336,0.0005541119,0.00018374706,0.000524835,0.00006491252,0.000930622,0.000023332339],"about_ca_topic_score_codex":0.00124313,"about_ca_topic_score_gemma":0.0012572556,"teacher_disagreement_score":0.0037405202,"about_ca_system_score_codex":0.0006801203,"about_ca_system_score_gemma":0.0004840029,"threshold_uncertainty_score":0.01251328},"labels":[],"label_agreement":null},{"id":"W2572662326","doi":"10.1111/ejh.12828","title":"The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Novo Nordisk Pharma; Novartis Pharma; Grifols; Novo Nordisk; Bayer HealthCare; Swedish Orphan Biovitrum; Baxalta; CSL Behring; Wyeth; Bayer; Biogen; Baxter International; Pfizer; Women's Fund of Hawaii","keywords":"Haemophilia; Multidisciplinary team; Multidisciplinary approach; Medicine; Health care; Haemophilia B; Haemophilia A; Family medicine; Nursing; Pediatrics; Political science","score_opus":0.02305966482525357,"score_gpt":0.3205823300819092,"score_spread":0.2975226652566556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572662326","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06751964,0.066907585,0.008378077,0.18939795,0.27338362,0.0015002388,0.011083409,0.0011058708,0.38072369],"genre_scores_gemma":[0.05829209,0.014976635,0.004347572,0.0060722562,0.015032676,0.0004345477,0.004139042,0.00036014756,0.896345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986951,0.00033618088,0.00008915088,0.00022440462,0.00035072622,0.00030448817],"domain_scores_gemma":[0.99894124,0.00007152459,0.00006300098,0.00002496857,0.00027225938,0.00062707474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021930502,0.0010922103,0.00044634021,0.0006520076,0.00090789265,0.002065021,0.0005429276,0.0020065706,0.103759706],"category_scores_gemma":[0.0019918024,0.00035733802,0.0005802283,0.00031081995,0.00039789814,0.0011252483,0.0018627589,0.00178794,0.03551408],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009326617,0.00022560118,0.0019683396,0.00039848193,0.0000389958,0.0013617558,0.0005434756,0.0003471896,0.004446473,0.0014465068,0.87028134,0.1180091],"study_design_scores_gemma":[0.00010095061,0.00027631162,0.0062727714,0.0005524541,0.000013303723,0.00059153716,0.0003722341,0.00029727852,0.0011814986,0.00051022856,0.9898136,0.000017899009],"about_ca_topic_score_codex":0.0019354987,"about_ca_topic_score_gemma":0.0063328096,"teacher_disagreement_score":0.103759706,"about_ca_system_score_codex":0.0018965969,"about_ca_system_score_gemma":0.0023945647,"threshold_uncertainty_score":0.3471108},"labels":[],"label_agreement":null},{"id":"W2584962199","doi":"10.1111/ejh.12865","title":"Impact of osteoblast maturation on their paracrine growth enhancing activity on cord blood progenitors","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Ottawa","funders":"","keywords":"Progenitor cell; Haematopoiesis; Paracrine signalling; Cell biology; Osteoblast; Cord blood; Myelopoiesis; Stem cell; Myeloid; Biology; Immunology; Chemistry; In vitro; Biochemistry","score_opus":0.028778063821492703,"score_gpt":0.31193000045461866,"score_spread":0.28315193663312593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584962199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540544,0.0023588052,0.00036020068,0.00003985224,0.000011565688,0.000021786636,0.00019874309,0.000010936761,0.0015927517],"genre_scores_gemma":[0.9963212,0.0011425705,0.000712672,0.000035244328,0.000009451568,0.000025474761,0.00033324823,0.0000060353404,0.0014141393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984515,0.000032135624,0.000015460748,0.00001738791,0.00005691156,0.00003293908],"domain_scores_gemma":[0.9998418,0.000058402,0.00002242888,0.000015706684,0.00002866917,0.00003292546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020150021,0.00019027159,0.00020394474,0.00013374776,0.0000838308,0.00034562618,0.00011735261,0.000118927375,0.0017398836],"category_scores_gemma":[0.00023520646,0.000057275676,0.00009918885,0.00013153392,0.00014985469,0.000099520636,0.00018772366,0.0003320796,0.00019731988],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084042206,0.000050797793,0.0011893511,0.000106295694,0.0000044133867,0.00011026714,0.000053022268,0.000037714482,0.99097496,0.00007214605,0.00005797098,0.0065027718],"study_design_scores_gemma":[0.000034948112,0.0009851215,0.020582959,0.000027987247,0.000034857774,0.0003451845,0.00009899298,0.0002826712,0.9732284,0.00003826775,0.0043361,0.0000045266797],"about_ca_topic_score_codex":0.0011751021,"about_ca_topic_score_gemma":0.001972975,"teacher_disagreement_score":0.0017398836,"about_ca_system_score_codex":0.00021398955,"about_ca_system_score_gemma":0.00031206373,"threshold_uncertainty_score":0.005820513},"labels":[],"label_agreement":null},{"id":"W2597273572","doi":"10.1111/ejh.12876","title":"Economic burden of relapsed or refractory multiple myeloma: Results from an international trial","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Absenteeism; Medicine; Indirect costs; Quality of life (healthcare); Multiple myeloma; Multivariate analysis; Clinical trial; Physical therapy; Randomized controlled trial; Family medicine; Internal medicine; Nursing","score_opus":0.06516772725094637,"score_gpt":0.358220158953896,"score_spread":0.2930524317029496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597273572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631948,0.027845323,0.00038825,0.0021144517,0.00018679799,0.0008793336,0.0017078569,0.00003173726,0.003651486],"genre_scores_gemma":[0.99145573,0.0050522657,0.00044012003,0.00065230206,0.00021061157,0.0005721962,0.0010508047,0.0000133036865,0.00055258384],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99642974,0.0027421184,0.00026734054,0.00022957419,0.00016135686,0.0001699516],"domain_scores_gemma":[0.9902436,0.0044559827,0.0035453746,0.0007809143,0.00030394382,0.0006701233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008501916,0.0009553855,0.0016840164,0.00039966358,0.00045004778,0.0014675187,0.000806522,0.001129776,0.0048633493],"category_scores_gemma":[0.010885157,0.00026799794,0.0031860375,0.0009293752,0.0008915692,0.000994387,0.0007375825,0.0016983981,0.00038974336],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.908511,0.005100193,0.024035886,0.0029229335,0.017114367,0.000105070365,0.00016270638,0.001063656,0.0005915467,0.00037854095,0.0016726517,0.038341522],"study_design_scores_gemma":[0.7592278,0.086765856,0.11461507,0.0013056254,0.029250003,0.00037088039,0.0003178936,0.0016088207,0.00059606443,0.0009877235,0.004872821,0.000081514],"about_ca_topic_score_codex":0.001231064,"about_ca_topic_score_gemma":0.0015102935,"teacher_disagreement_score":0.008501916,"about_ca_system_score_codex":0.0009709122,"about_ca_system_score_gemma":0.00093036174,"threshold_uncertainty_score":0.044963002},"labels":[],"label_agreement":null},{"id":"W2604146377","doi":"10.1111/ejh.12891","title":"Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and <scp>JAK</scp> inhibitors era?","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Myelofibrosis; Medicine; International Prognostic Scoring System; Ruxolitinib; Internal medicine; Univariate analysis; Transplantation; Autologous stem-cell transplantation; Oncology; Stem cell; Overall survival; Gastroenterology; Myeloid leukemia; Hematopoietic stem cell transplantation; Myelodysplastic syndromes; Multivariate analysis; Surgery; Bone marrow","score_opus":0.01402502677181484,"score_gpt":0.24811725934685375,"score_spread":0.23409223257503892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604146377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99202347,0.005257243,0.00034482853,0.0007173779,0.00009699177,0.00000417598,0.00010210859,0.0000089676505,0.0014448466],"genre_scores_gemma":[0.9990085,0.00057291676,0.00006409409,0.00012796656,0.00010711111,0.0000010550613,0.00006165921,0.000001013683,0.0000557061],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.999871,0.000038872808,0.000012708609,0.000019165396,0.000022962555,0.000035216653],"domain_scores_gemma":[0.9993907,0.00014711637,0.00024722228,0.000026884663,0.000043038624,0.00014510611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038672332,0.000083667,0.00026657572,0.00018861896,0.00016969076,0.0003026284,0.00012128186,0.00027684015,0.0012276716],"category_scores_gemma":[0.0007125489,0.000040895164,0.00016550468,0.00029186218,0.00030105718,0.00021705196,0.000098228295,0.00020728417,0.0002146328],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022131265,0.000077424666,0.92692786,0.000116391246,0.0001478353,0.0031852447,0.000056203953,0.00029101293,0.0039288043,0.0004532033,0.0010701378,0.061532665],"study_design_scores_gemma":[0.0001312895,0.0018874233,0.9665415,0.00019364215,0.00031228826,0.02010249,0.0005252341,0.0014522275,0.002859521,0.0010406184,0.004936509,0.000017160364],"about_ca_topic_score_codex":0.00022292313,"about_ca_topic_score_gemma":0.00042790323,"teacher_disagreement_score":0.0012276716,"about_ca_system_score_codex":0.00012806179,"about_ca_system_score_gemma":0.0002808545,"threshold_uncertainty_score":0.0041069984},"labels":[],"label_agreement":null},{"id":"W2607976896","doi":"10.1111/ejh.12897","title":"Low <i>CREBBP</i> expression is associated with adverse long‐term outcomes in paediatric acute lymphoblastic leukaemia","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"National Natural Science Foundation of China","keywords":"Medicine; Internal medicine; Oncology","score_opus":0.018810641628732427,"score_gpt":0.28862023617197735,"score_spread":0.26980959454324493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607976896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99888045,0.00038479886,0.00016500571,0.000047683978,0.0000035600024,0.000005997541,0.00017792809,0.0000088003835,0.00032580216],"genre_scores_gemma":[0.9994574,0.00010640262,0.000114355586,0.000016281278,0.000005326721,0.0000074939276,0.00022265066,0.0000037130583,0.00006622017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972516,0.000085705724,0.000022742504,0.00004338813,0.000065449174,0.000057564197],"domain_scores_gemma":[0.99822277,0.00045175978,0.0009854884,0.000050081228,0.000112280926,0.00017748243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004942467,0.00012256899,0.0002585388,0.00037346315,0.00013494554,0.0004289964,0.00018193119,0.00021367312,0.0010117741],"category_scores_gemma":[0.0018837937,0.00008515164,0.00019232027,0.00043555856,0.00031589225,0.00016290734,0.00026107382,0.00041873043,0.00014361096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013955734,0.00004041294,0.9834757,0.00004169161,0.000040828178,0.00015309303,0.00005601601,0.00026098965,0.0066371053,0.000040000403,0.00017775997,0.0076809376],"study_design_scores_gemma":[0.000016013939,0.00034315445,0.9965417,0.000009839039,0.000037412527,0.0005455275,0.00006844239,0.00035425473,0.0016825454,0.000047307938,0.0003498525,0.0000038967087],"about_ca_topic_score_codex":0.0009908009,"about_ca_topic_score_gemma":0.00069935346,"teacher_disagreement_score":0.0010117741,"about_ca_system_score_codex":0.00037725255,"about_ca_system_score_gemma":0.000308244,"threshold_uncertainty_score":0.003384769},"labels":[],"label_agreement":null},{"id":"W2608830349","doi":"10.1111/ejh.12899","title":"Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo‐<scp>HCT</scp>: 12‐year follow‐up data","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Lymphocytosis; Medicine; Internal medicine; Incidence (geometry); Immunology; Gastroenterology","score_opus":0.03552050049559737,"score_gpt":0.29805925365248,"score_spread":0.26253875315688263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608830349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993419,0.00014517018,0.000061999905,0.000014205561,0.00000272539,0.0000047531553,0.00023955728,0.0000033486986,0.00018634424],"genre_scores_gemma":[0.99941754,0.000044784305,0.00003471753,0.0000097223665,0.0000065970285,0.000005213998,0.00042243864,0.0000010767402,0.000057995003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978036,0.000027539012,0.000035598045,0.000052440988,0.000042640648,0.00006137302],"domain_scores_gemma":[0.9989849,0.0001440185,0.0004512787,0.000076654,0.00008814395,0.00025507534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003671145,0.00017007532,0.00035229753,0.00072705786,0.0003416251,0.00051826047,0.00019150287,0.0004008059,0.0010079881],"category_scores_gemma":[0.0009907117,0.00011556209,0.00044398446,0.00073916005,0.00023622815,0.00040575437,0.00040054313,0.00043506324,0.00026452143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020547872,0.000029177532,0.99786276,0.0000044866933,0.000020691745,0.00021662761,0.000028432598,0.000043826945,0.00037283808,0.0000044282556,0.000040686315,0.0011705788],"study_design_scores_gemma":[0.0000066834104,0.0001432927,0.99864584,0.0000029334278,0.00001767812,0.00078127824,0.00005731328,0.00008635571,0.00010982567,0.000011961762,0.00013316602,0.0000037516825],"about_ca_topic_score_codex":0.0010832342,"about_ca_topic_score_gemma":0.00097010913,"teacher_disagreement_score":0.0010832342,"about_ca_system_score_codex":0.00020005503,"about_ca_system_score_gemma":0.00020635281,"threshold_uncertainty_score":0.0033720136},"labels":[],"label_agreement":null},{"id":"W2614781853","doi":"10.1111/ejh.12903","title":"Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low‐dose dexamethasone: A pooled analysis","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"Celgene","keywords":"Pomalidomide; Medicine; Neutropenia; Lenalidomide; Multiple myeloma; Dexamethasone; Internal medicine; Adverse effect; Bortezomib; Febrile neutropenia; Refractory (planetary science); Surgery; Toxicity; Gastroenterology","score_opus":0.019646255981155318,"score_gpt":0.291607620513063,"score_spread":0.27196136453190767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614781853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6005672,0.37746823,0.0042712064,0.00044583308,0.00030732894,0.0011273937,0.013272231,0.00019741929,0.0023431906],"genre_scores_gemma":[0.96101,0.029371368,0.0015954493,0.00039801325,0.00029608412,0.00057724793,0.0063366885,0.000031907748,0.00038318854],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9915872,0.004032472,0.0017917493,0.0012615515,0.0011344347,0.00019248648],"domain_scores_gemma":[0.98973477,0.0043883957,0.004347272,0.00059175474,0.0007232212,0.00021451483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0131456405,0.0014084271,0.0045892457,0.0027381657,0.00020897432,0.0014413429,0.00075964344,0.0007555075,0.0017122184],"category_scores_gemma":[0.014489791,0.00058888487,0.015484198,0.0034433522,0.00023519949,0.00070584274,0.0008611619,0.0006338726,0.0002078494],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06250235,0.00023864742,0.16989394,0.01439514,0.6701177,0.00019790746,0.00009958476,0.002976622,0.0014087156,0.00010851034,0.0019235808,0.07613729],"study_design_scores_gemma":[0.01401347,0.008647397,0.43003052,0.0015905944,0.53568375,0.00066159235,0.00012747498,0.002867438,0.00080117676,0.00033924248,0.0051186443,0.00011868781],"about_ca_topic_score_codex":0.0012996087,"about_ca_topic_score_gemma":0.0020159215,"teacher_disagreement_score":0.0131456405,"about_ca_system_score_codex":0.00067425054,"about_ca_system_score_gemma":0.000730323,"threshold_uncertainty_score":0.069521606},"labels":[],"label_agreement":null},{"id":"W2619649452","doi":"10.1111/ejh.12909","title":"Extramedullary disease at diagnosis of <scp>AML</scp> does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in <scp>CR</scp>1","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Univariate analysis; Multivariate analysis; Gastroenterology; Hematopoietic stem cell transplantation; Transplantation; Chemotherapy; Leukemia; Disease; Single Center; Surgery","score_opus":0.022036240563716364,"score_gpt":0.2794230375608566,"score_spread":0.2573867969971403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619649452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996012,0.000118822434,0.000032331627,0.000027153877,0.0000035818086,0.0000021850142,0.000043025524,0.0000012612819,0.00017047804],"genre_scores_gemma":[0.99982965,0.000022147615,0.000015218697,0.000012047801,0.000008478675,0.0000012360665,0.00007757979,6.5253886e-7,0.00003287035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999622,0.00010090927,0.000045590637,0.00007935127,0.00007881324,0.00007329113],"domain_scores_gemma":[0.9976427,0.0005271794,0.0011380594,0.00009721261,0.00011725274,0.0004776005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058588665,0.00014974328,0.00025350056,0.00028900872,0.00023712082,0.0005186254,0.00020706373,0.00031431418,0.0016440253],"category_scores_gemma":[0.0027434914,0.00009512085,0.00034343763,0.00030507336,0.0002962877,0.0002833504,0.00037477203,0.00044491296,0.00025984162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004897474,0.000026647831,0.99647945,0.000007602755,0.000034448964,0.00014208403,0.000033890115,0.00005353547,0.0004890114,0.000008730771,0.000049590708,0.002185389],"study_design_scores_gemma":[0.000019974177,0.0003884895,0.99786466,0.000008541013,0.000037639424,0.0010356633,0.000066141256,0.00022488681,0.00018425599,0.000022245713,0.00014482734,0.0000027679966],"about_ca_topic_score_codex":0.00073351135,"about_ca_topic_score_gemma":0.0009766193,"teacher_disagreement_score":0.0016440253,"about_ca_system_score_codex":0.00022286086,"about_ca_system_score_gemma":0.00023092159,"threshold_uncertainty_score":0.00549978},"labels":[],"label_agreement":null},{"id":"W2752464581","doi":"10.1111/ejh.12961","title":"Post‐transplant consolidation plus lenalidomide maintenance vs lenalidomide maintenance alone in multiple myeloma: A systematic review","year":2017,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Lenalidomide; Multiple myeloma; Medicine; Internal medicine; Autologous stem-cell transplantation; Adverse effect; Maintenance therapy; Transplantation; Oncology; Surgery; Chemotherapy","score_opus":0.08682034022645548,"score_gpt":0.35746485631628944,"score_spread":0.270644516089834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752464581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022349458,0.996705,0.00012638749,0.00014587441,0.00007002375,0.00021645614,0.00032614623,0.000007680443,0.0001675351],"genre_scores_gemma":[0.053315464,0.9441477,0.00062780525,0.0006487577,0.000109041845,0.00060574064,0.00037540894,0.00000875326,0.00016125533],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99577445,0.0017702695,0.0013385845,0.00041050845,0.0005440537,0.00016212135],"domain_scores_gemma":[0.9864654,0.009617657,0.0027399878,0.00017771349,0.00083346834,0.00016573363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005781096,0.0014445955,0.010824313,0.0048251287,0.0005045701,0.001978339,0.0016691596,0.0016516431,0.003551294],"category_scores_gemma":[0.018882455,0.000914175,0.0139214285,0.0055546644,0.0005932842,0.001549956,0.0010180867,0.0011155795,0.0002266748],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008492034,0.000021585785,0.0011675038,0.92545897,0.055256385,0.00008682462,0.000094571915,0.00015547371,0.00016768876,0.00013223314,0.0006938946,0.015915673],"study_design_scores_gemma":[0.0011793645,0.0005612687,0.006985928,0.4419304,0.539576,0.00033486643,0.0001733166,0.0002006137,0.00023006769,0.00038486414,0.0083961515,0.00004713451],"about_ca_topic_score_codex":0.0066797584,"about_ca_topic_score_gemma":0.01704932,"teacher_disagreement_score":0.010824313,"about_ca_system_score_codex":0.0026204938,"about_ca_system_score_gemma":0.0053429725,"threshold_uncertainty_score":0.030573726},"labels":[],"label_agreement":null},{"id":"W2765773896","doi":"10.1111/ejh.12989","title":"Longitudinal changes in <scp>LIC</scp> and other parameters in patients receiving different chelation regimens: Data from <scp>LICNET</scp>","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Microsemi (Canada)","funders":"","keywords":"Medicine; Serum ferritin; Chelation therapy; Chelation; Iron status; Ferritin; Wilcoxon signed-rank test; Gastroenterology; Hemochromatosis; Nuclear medicine; Internal medicine; Anemia; Iron deficiency; Thalassemia; Chemistry","score_opus":0.049976941634996754,"score_gpt":0.27902235131814074,"score_spread":0.229045409683144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765773896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885166,0.00018244199,0.000094414536,0.000019611762,0.0000027162707,0.00000853208,0.00040967908,0.000005415252,0.00042549192],"genre_scores_gemma":[0.9989347,0.00004955451,0.00007118952,0.000016789121,0.000006776675,0.000009161795,0.00069013366,0.0000020818766,0.00021964521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996643,0.00006813672,0.00004848677,0.00007644484,0.000093769064,0.00004883729],"domain_scores_gemma":[0.9980116,0.00035056187,0.0008917559,0.00020542725,0.00027508245,0.00026562848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006071054,0.00014166304,0.0002882517,0.00043220687,0.00021119394,0.00030875637,0.00012995397,0.00029264844,0.0010847657],"category_scores_gemma":[0.0016700624,0.00007462416,0.00027275414,0.00047281745,0.00016633891,0.00027279524,0.00024030262,0.000346972,0.00023306451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018907606,0.00010822111,0.99006784,0.000018851455,0.00009345004,0.000106745996,0.00013217221,0.00007545655,0.0014144873,0.000014296833,0.0001778485,0.0058998605],"study_design_scores_gemma":[0.000012338602,0.00067247025,0.99821967,0.0000033973345,0.00003065017,0.00033284424,0.000052286025,0.000095170944,0.00029986148,0.000012437593,0.00026581413,0.00000312598],"about_ca_topic_score_codex":0.0011219591,"about_ca_topic_score_gemma":0.0010319208,"teacher_disagreement_score":0.0011219591,"about_ca_system_score_codex":0.00021050719,"about_ca_system_score_gemma":0.00015312695,"threshold_uncertainty_score":0.0036289096},"labels":[],"label_agreement":null},{"id":"W2768941569","doi":"10.1111/ejh.13000","title":"Impact of comorbidities constituting the hematopoietic cell transplant (HCT)‐comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Hematopoietic cell; Medicine; Comorbidity; Internal medicine; Oncology; Hematopoietic stem cell transplantation; Myeloid; Haematopoiesis; Transplantation; Stem cell; Biology","score_opus":0.05127480759335997,"score_gpt":0.33675227348287484,"score_spread":0.2854774658895149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768941569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99937516,0.00022572481,0.000045254452,0.000025095918,0.0000044043345,0.0000035329995,0.00014933891,8.179905e-7,0.00017074583],"genre_scores_gemma":[0.9997242,0.0000515295,0.00002704582,0.000007927515,0.000007718371,0.0000016325298,0.00015778073,3.4251713e-7,0.000021807125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960464,0.000091420225,0.000057865247,0.000063003565,0.000109570334,0.000073362025],"domain_scores_gemma":[0.99841774,0.00020258845,0.0009484211,0.000049393868,0.00010160745,0.00028017553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043053593,0.00018343706,0.000242158,0.00045944427,0.00025647183,0.00039661376,0.0001643413,0.00017805675,0.0009157551],"category_scores_gemma":[0.0018418202,0.00008190691,0.00030854007,0.000618289,0.00018159255,0.0002614023,0.00044629496,0.00043604936,0.000080360805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006386141,0.0000100318775,0.99904877,0.0000035912296,0.000027955177,0.000023615115,0.000007718146,0.000031946984,0.000078389974,0.000005689571,0.000021784786,0.00067665026],"study_design_scores_gemma":[0.0000023971456,0.00004644328,0.9994785,0.000003586879,0.000017936842,0.00015989112,0.000039963976,0.00015504217,0.00004128266,0.000007575579,0.000046124856,0.0000013612752],"about_ca_topic_score_codex":0.002007158,"about_ca_topic_score_gemma":0.0038631891,"teacher_disagreement_score":0.002007158,"about_ca_system_score_codex":0.00027090966,"about_ca_system_score_gemma":0.00038141134,"threshold_uncertainty_score":0.003991008},"labels":[],"label_agreement":null},{"id":"W2774842751","doi":"10.1111/ejh.13015","title":"Outcome following second allogeneic hematopoietic cell transplantation: A single‐center experience","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Single Center; Hematopoietic cell; Univariate analysis; Transplantation; Internal medicine; Retrospective cohort study; Surgery; Hematopoietic stem cell transplantation; Cohort; Multivariate analysis; Gastroenterology; Haematopoiesis; Stem cell","score_opus":0.045884300600459026,"score_gpt":0.30467172513053575,"score_spread":0.25878742453007675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774842751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995146,0.00016070684,0.00010218217,0.00001995147,0.000004641518,0.000009070644,0.000031241703,0.0000031032966,0.00015454952],"genre_scores_gemma":[0.9996604,0.00009230069,0.000064166205,0.000020917258,0.00001172816,0.000003716342,0.00008331272,0.0000022089162,0.000061291496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996941,0.00007037549,0.000033766788,0.00007584279,0.00006056804,0.00006545482],"domain_scores_gemma":[0.99900454,0.00016786256,0.00038754576,0.0001220695,0.000076092634,0.00024197738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058767095,0.00032643517,0.00033679738,0.00039086796,0.0005017328,0.00060716696,0.00026837716,0.0003623791,0.0013157348],"category_scores_gemma":[0.0015102956,0.00015802433,0.00036964426,0.00040835346,0.00034968136,0.0002848059,0.0005249367,0.00047296195,0.0003121679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028829058,0.00024933394,0.9865465,0.00002246579,0.000054407596,0.0040627564,0.00035191176,0.00012102252,0.00096146046,0.000034157198,0.00025557604,0.0070522167],"study_design_scores_gemma":[0.00011163422,0.0028291875,0.94840384,0.000045699213,0.00009772661,0.04430558,0.0009861743,0.0007498624,0.0013196489,0.000086234955,0.0010389554,0.00002538458],"about_ca_topic_score_codex":0.0012140279,"about_ca_topic_score_gemma":0.0015529445,"teacher_disagreement_score":0.0013157348,"about_ca_system_score_codex":0.000422879,"about_ca_system_score_gemma":0.00040282778,"threshold_uncertainty_score":0.004401624},"labels":[],"label_agreement":null},{"id":"W2789356670","doi":"10.1111/ejh.13059","title":"Screening and diagnostic clinical algorithm for paroxysmal nocturnal hemoglobinuria: Expert consensus","year":2018,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Alexion Pharmaceuticals","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Differential diagnosis; Delphi method; Consensus conference; Pediatrics; Case finding; Algorithm; Family medicine; Intensive care medicine; Pathology; Internal medicine; Artificial intelligence; Computer science","score_opus":0.04960305646498333,"score_gpt":0.33262286750579234,"score_spread":0.28301981104080903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789356670","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0603033,0.0031105739,0.7326611,0.046765134,0.0017839167,0.104493156,0.002625333,0.0018784369,0.046379074],"genre_scores_gemma":[0.089005224,0.0009727845,0.88488156,0.0019613865,0.00021950663,0.018490199,0.0016713915,0.00007760245,0.0027203406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9366047,0.042912893,0.008486109,0.0031897256,0.007411179,0.001395341],"domain_scores_gemma":[0.93909806,0.015764562,0.0049483115,0.0019383669,0.035334002,0.0029167626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06257538,0.0012817535,0.0012253363,0.00643138,0.0023216556,0.003028195,0.004550531,0.003042875,0.009289487],"category_scores_gemma":[0.08803962,0.0008329021,0.0023947547,0.0021732377,0.001331781,0.0034820456,0.0070848973,0.00316662,0.0040752185],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012810518,0.0018468992,0.032244597,0.007959904,0.00053156615,0.0027029547,0.018553235,0.01778282,0.0075848834,0.03100585,0.19946721,0.67903894],"study_design_scores_gemma":[0.0041003022,0.003395233,0.060108297,0.020601371,0.0015093083,0.011875406,0.028823312,0.26228067,0.011982088,0.18636876,0.40789592,0.0010592209],"about_ca_topic_score_codex":0.0022687195,"about_ca_topic_score_gemma":0.0037198083,"teacher_disagreement_score":0.06257538,"about_ca_system_score_codex":0.0050442005,"about_ca_system_score_gemma":0.021245958,"threshold_uncertainty_score":0.33093423},"labels":[],"label_agreement":null},{"id":"W2792382323","doi":"10.1111/ejh.13047","title":"Bacterial neuraminidase‐mediated erythrocyte desialylation provokes cell surface aminophospholipid exposure","year":2018,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; University of Toronto; McMaster University; Canadian Blood Services","funders":"Canadian Blood Services","keywords":"Neuraminidase; Sialic acid; Sialidase; Phosphatidylserine; Ganglioside; Biology; Biochemistry; Red blood cell; Flow cytometry; Haptoglobin; Chemistry; Enzyme; Immunology; Phospholipid; Membrane","score_opus":0.018794752371457377,"score_gpt":0.24198941280747394,"score_spread":0.22319466043601655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792382323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610907,0.001058406,0.0019136429,0.000044918015,0.000016368402,0.00002342839,0.00019359804,0.000022012675,0.00061853847],"genre_scores_gemma":[0.9968777,0.0006424039,0.001294879,0.000039658793,0.000007944265,0.00002548398,0.00026040355,0.0000052592777,0.0008462959],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987125,0.000030855037,0.000012492936,0.000019452347,0.000033082077,0.00003279847],"domain_scores_gemma":[0.999912,0.000018218572,0.000026919039,0.000014297057,0.000010915762,0.000017549124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017201743,0.00032423303,0.00015531019,0.000094048184,0.000063542066,0.00014448081,0.000110863344,0.00022495366,0.0009025219],"category_scores_gemma":[0.00012508547,0.00007412062,0.00015973774,0.0000921095,0.00014932008,0.00012264558,0.00019215622,0.00041799937,0.00022004652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017170887,0.000016386393,0.000157457,0.000024125959,0.00000449398,0.000044960187,0.000009744293,0.000017901179,0.99883825,0.000026458953,0.000013121773,0.0006753873],"study_design_scores_gemma":[0.000010048192,0.00040933,0.0076542674,0.0000040912964,0.000009592378,0.00022471687,0.000017207252,0.0002813873,0.99090064,0.0000221085,0.00046443453,0.0000021858211],"about_ca_topic_score_codex":0.00022486057,"about_ca_topic_score_gemma":0.00024573543,"teacher_disagreement_score":0.0009025219,"about_ca_system_score_codex":0.00019691915,"about_ca_system_score_gemma":0.0000951321,"threshold_uncertainty_score":0.0030192733},"labels":[],"label_agreement":null},{"id":"W2807801451","doi":"10.1111/ejh.13109","title":"Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery","year":2018,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"China Scholarship Council; Haematology Society of Australia and New Zealand","keywords":"Mean platelet volume; Platelet; Medicine; Thrombopoiesis; Aspirin; Internal medicine; Cardiology; Antithrombotic; Artery; Surgery; Haematopoiesis; Stem cell; Biology","score_opus":0.022959712417529546,"score_gpt":0.2644292603759885,"score_spread":0.24146954795845899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807801451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966274,0.0020544932,0.0007157911,0.00003341455,0.000009211894,0.000024936433,0.000121759644,0.000014177679,0.00039872466],"genre_scores_gemma":[0.9985274,0.00038845977,0.00075238524,0.000017126797,0.000017397766,0.000022760622,0.00014335237,0.000002345974,0.00012878596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954695,0.00019459515,0.00005945229,0.000052867472,0.000115385876,0.00003073562],"domain_scores_gemma":[0.99880564,0.0003326993,0.00053143955,0.00007969431,0.00012790934,0.00012271195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007901291,0.0003235216,0.0003912874,0.0006979686,0.0001254261,0.00055177615,0.00018945438,0.00023259789,0.0005875833],"category_scores_gemma":[0.0020827546,0.000097478456,0.00014029296,0.0005789381,0.00019420129,0.00023607977,0.0002621668,0.00063364604,0.000101573445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006101958,0.0002103666,0.9006692,0.00021239274,0.00016244265,0.0005828834,0.0002933548,0.00077692006,0.04729725,0.00015327473,0.00024252498,0.043297388],"study_design_scores_gemma":[0.00007565733,0.0036677234,0.9765079,0.000033887947,0.00016028162,0.0014666473,0.00017072372,0.0022058228,0.014924212,0.00019467385,0.00057280425,0.000019532536],"about_ca_topic_score_codex":0.00027739975,"about_ca_topic_score_gemma":0.00026750527,"teacher_disagreement_score":0.0007901291,"about_ca_system_score_codex":0.00016462282,"about_ca_system_score_gemma":0.00015689601,"threshold_uncertainty_score":0.004178703},"labels":[],"label_agreement":null},{"id":"W2810788093","doi":"10.1111/ejh.13128","title":"The burden of disease in pyruvate kinase deficiency: Patients’ perception of the impact on health‐related quality of life","year":2018,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Psychological intervention; Activities of daily living; Gerontology; Pyruvate kinase deficiency; Pediatrics; Pyruvate kinase; Psychiatry; Internal medicine","score_opus":0.030556991999468052,"score_gpt":0.31093282868735567,"score_spread":0.2803758366878876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810788093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697673,0.00060252636,0.00014759968,0.0005917741,0.000016577465,0.000013337299,0.00008185707,0.0000021199553,0.0015674422],"genre_scores_gemma":[0.9995852,0.00014569085,0.00007957767,0.00006150757,0.0000045152233,0.0000054681063,0.000030330068,5.195763e-7,0.00008721013],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.997486,0.0015618086,0.00020636774,0.000104747975,0.00034207592,0.00029885856],"domain_scores_gemma":[0.99579877,0.0015377268,0.0013555322,0.00008493377,0.00040999847,0.0008129452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035541991,0.00020998558,0.00036648262,0.0004810663,0.0006619513,0.0012348061,0.00023594407,0.00043934447,0.0024333317],"category_scores_gemma":[0.0074776327,0.00013020255,0.00046675265,0.00039772384,0.0007241895,0.0010727032,0.0014686986,0.00076809234,0.0001686936],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044482035,0.00028173192,0.8862723,0.00045662315,0.0003368939,0.0009170988,0.0656061,0.0004739552,0.0013405494,0.00053084845,0.0020457678,0.041293316],"study_design_scores_gemma":[0.00006278345,0.0013153226,0.8635032,0.00032465346,0.00014805015,0.0023803166,0.12409258,0.00081881817,0.0004944451,0.0004978454,0.0062749037,0.000087035696],"about_ca_topic_score_codex":0.0013298906,"about_ca_topic_score_gemma":0.001998579,"teacher_disagreement_score":0.0035541991,"about_ca_system_score_codex":0.000723567,"about_ca_system_score_gemma":0.00053612766,"threshold_uncertainty_score":0.018796623},"labels":[],"label_agreement":null},{"id":"W2893654740","doi":"10.1111/ejh.13176","title":"How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry","year":2018,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Jewish General Hospital; Sunnybrook Health Science Centre; BC Cancer Agency; University of Calgary; Memorial University of Newfoundland; Hôpital Maisonneuve-Rosemont; University of Toronto; Western University; Université Laval; University of Alberta; Université de Montréal","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Statement (logic); Medicine; Pediatrics; Family medicine; Political science; Internal medicine; Law","score_opus":0.057367202817645783,"score_gpt":0.29934983634157303,"score_spread":0.24198263352392724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893654740","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001357338,0.9760369,0.00032066004,0.01946576,0.0025432731,0.0000280874,0.00009175577,0.000017093806,0.0013607318],"genre_scores_gemma":[0.0013152035,0.99025935,0.0010077656,0.005214891,0.001231673,0.0000336194,0.00021137197,0.00000799593,0.0007179963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806684,0.0003338273,0.00042088376,0.00019094296,0.0008159142,0.00017155973],"domain_scores_gemma":[0.99412644,0.0010446161,0.0004900995,0.00009094661,0.0037082,0.0005397334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052414266,0.0008544107,0.0016955642,0.004558649,0.0010476256,0.0016982106,0.0028771085,0.002995559,0.0022040557],"category_scores_gemma":[0.008537507,0.00030743427,0.001047624,0.0036388608,0.0010787377,0.0020780712,0.0011883281,0.0035275447,0.0010567785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059151418,0.00004999381,0.0009661612,0.014937414,0.000114920804,0.00042175985,0.00020159806,0.0004434851,0.00039878866,0.0048141917,0.29095387,0.68663865],"study_design_scores_gemma":[0.000021345199,0.000032113756,0.0018477442,0.022392975,0.0001610766,0.0013814874,0.00020937905,0.00013369865,0.00017484534,0.0016954844,0.9719089,0.00004089179],"about_ca_topic_score_codex":0.055750627,"about_ca_topic_score_gemma":0.07733509,"teacher_disagreement_score":0.99458265,"about_ca_system_score_codex":0.0054173414,"about_ca_system_score_gemma":0.020966688,"threshold_uncertainty_score":0.11085224},"labels":[],"label_agreement":null},{"id":"W2912419506","doi":"10.1111/ejh.13216","title":"Influence of <i>FLT3‐ITD</i> and <i>NPM1 </i>status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"NPM1; Medicine; Internal medicine; Proportional hazards model; Cumulative incidence; Transplantation; Hematopoietic stem cell transplantation; Oncology; Biology; Gene; Karyotype; Genetics","score_opus":0.005951508004904088,"score_gpt":0.22412590677303704,"score_spread":0.21817439876813294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912419506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99957806,0.00009241376,0.000028100088,0.000033904453,0.000002370001,0.0000011866489,0.000061837025,0.0000011965079,0.00020090128],"genre_scores_gemma":[0.99980396,0.000024388295,0.000011925066,0.00001228,0.0000051848333,9.943788e-7,0.000093548406,7.532181e-7,0.00004700066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996934,0.00009723154,0.00002651036,0.00006432033,0.000057649937,0.00006092683],"domain_scores_gemma":[0.9984769,0.0003775215,0.00072748977,0.0000733026,0.00007624562,0.0002684409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054639624,0.00012179957,0.0001592435,0.00030240547,0.00019833524,0.0005000746,0.00019387234,0.00018160311,0.00093887607],"category_scores_gemma":[0.0017670358,0.00008864165,0.0003574929,0.00031323306,0.00024021398,0.00034518837,0.00039886596,0.0005080645,0.00012592283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039450254,0.000020510632,0.99672854,0.0000040104724,0.000036868365,0.00006225991,0.000031343596,0.00014486401,0.00027008518,0.000025525333,0.000084622545,0.0021968253],"study_design_scores_gemma":[0.000011122728,0.00017430844,0.998541,0.000004634782,0.000038367612,0.00019298069,0.000079745565,0.00058275013,0.00017911824,0.000051032097,0.00014106897,0.0000038606354],"about_ca_topic_score_codex":0.0024049468,"about_ca_topic_score_gemma":0.0033312235,"teacher_disagreement_score":0.0024049468,"about_ca_system_score_codex":0.00040194346,"about_ca_system_score_gemma":0.00026796115,"threshold_uncertainty_score":0.004781842},"labels":[],"label_agreement":null},{"id":"W2913349186","doi":"10.1111/ejh.13213","title":"Sequential liver and haematopoietic stem cell transplantation in a case of fulminant hepatitis associated liver failure and aplastic anaemia","year":2019,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Stem cell; Context (archaeology); Hematology; Fulminant hepatitis; Haematopoiesis; Immunosuppression; Hepatology; Hematopoietic stem cell transplantation; Internal medicine; Immunology; Hepatitis; Biology","score_opus":0.03132635471322488,"score_gpt":0.2861108854695674,"score_spread":0.25478453075634255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913349186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005144356,0.9985324,0.00009360682,0.00020170443,0.00009896472,0.000004065288,0.000004941356,0.0000035947996,0.0005462019],"genre_scores_gemma":[0.0057305493,0.99317616,0.00023794512,0.00031037536,0.00024214601,0.000005907536,0.000021844704,0.0000018879332,0.0002732418],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99980026,0.000053757387,0.000052986783,0.000026245572,0.00004946887,0.000017263459],"domain_scores_gemma":[0.9996208,0.00023167432,0.000074602765,0.000008545802,0.00003489626,0.00002950587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004038914,0.0004976144,0.001246993,0.0020052867,0.00029394004,0.0008491412,0.00074130343,0.0012819885,0.0013645173],"category_scores_gemma":[0.0012626046,0.00017490686,0.0005894627,0.00139826,0.00040644617,0.00087064446,0.00046349296,0.0011964097,0.00052154576],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013374987,0.00010942174,0.0014669439,0.036980018,0.0003423977,0.019703222,0.00028293225,0.00039114174,0.0010603769,0.0015545478,0.017577428,0.9203978],"study_design_scores_gemma":[0.00011943482,0.00037192754,0.008988745,0.04452908,0.0013645773,0.3038203,0.00067538366,0.0004301464,0.0012621578,0.0038351682,0.6345176,0.00008539734],"about_ca_topic_score_codex":0.00095967366,"about_ca_topic_score_gemma":0.0025572802,"teacher_disagreement_score":0.0020052867,"about_ca_system_score_codex":0.00029664073,"about_ca_system_score_gemma":0.000937207,"threshold_uncertainty_score":0.0045648217},"labels":[],"label_agreement":null},{"id":"W2928859997","doi":"10.1111/ejh.13230","title":"Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Fludarabine; Thymoglobulin; Cumulative incidence; Busulfan; Incidence (geometry); Graft-versus-host disease; Hematopoietic stem cell transplantation; Cyclophosphamide; Cohort; Surgery; Transplantation; Immunology; Chemotherapy; Tacrolimus","score_opus":0.00867137768890668,"score_gpt":0.2268223089696353,"score_spread":0.2181509312807286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928859997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99840885,0.0010837484,0.00023214139,0.000015350863,0.000004121243,0.000010068684,0.000023421424,0.0000045421916,0.00021780583],"genre_scores_gemma":[0.9997203,0.000084880754,0.00009092421,0.000010899698,0.000009479627,0.000003223079,0.000044336593,8.425643e-7,0.000035035657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991398,0.00039368606,0.00010506753,0.00009801921,0.00018907376,0.00007435745],"domain_scores_gemma":[0.99885666,0.00039108118,0.0004129776,0.00008309329,0.000060890525,0.00019532691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013430301,0.00013725225,0.00023860243,0.0002490349,0.00010123848,0.00032799557,0.00017398139,0.00021872869,0.00071716396],"category_scores_gemma":[0.0020173783,0.00009403715,0.0002001079,0.00020682161,0.00022645984,0.00019683488,0.00022873838,0.00021000861,0.00011073275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006325533,0.00035199543,0.93071866,0.00011706648,0.00021561388,0.0005331042,0.00009559116,0.0005835288,0.013589043,0.000079713485,0.00017150494,0.04721868],"study_design_scores_gemma":[0.00053083454,0.018156236,0.9600397,0.000034800014,0.00029492073,0.0060604913,0.00009602216,0.0019193742,0.011082175,0.000103184786,0.0016702057,0.000012076456],"about_ca_topic_score_codex":0.00016547833,"about_ca_topic_score_gemma":0.00026852943,"teacher_disagreement_score":0.0013430301,"about_ca_system_score_codex":0.00022349178,"about_ca_system_score_gemma":0.00024437046,"threshold_uncertainty_score":0.0071026683},"labels":[],"label_agreement":null},{"id":"W2944731734","doi":"10.1111/ejh.13244","title":"Deferiprone exerts a dose‐dependent reduction of liver iron in adults with iron overload","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Deferiprone; Medicine; Gastroenterology; Adverse effect; Internal medicine; Neutropenia; Cohort; Thalassemia; Chemotherapy","score_opus":0.006068156558330796,"score_gpt":0.20767495292111826,"score_spread":0.20160679636278747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944731734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837214,0.0010779693,0.000105981206,0.000030043246,0.000004503374,0.000008513193,0.000058389895,0.0000062487093,0.00033622733],"genre_scores_gemma":[0.99954873,0.00018482271,0.00010618891,0.000027135056,0.000010495703,0.0000024205194,0.000048830105,7.703042e-7,0.00007050713],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996056,0.00014086455,0.000046774574,0.00006139156,0.000112333575,0.00003292321],"domain_scores_gemma":[0.99866855,0.00031324037,0.0007157367,0.00008305222,0.00011283052,0.00010655048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073182164,0.00017440543,0.00031650902,0.00026551238,0.00014365904,0.00021647799,0.0001435117,0.00024123002,0.0004952512],"category_scores_gemma":[0.0019113872,0.00009556252,0.00029487838,0.00018633215,0.00013709307,0.00014023921,0.00016109204,0.00019896445,0.0001079718],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033577764,0.00026581,0.96333396,0.00008073541,0.00018086951,0.00038027242,0.000119066055,0.0001294185,0.013956906,0.000016560229,0.0001304634,0.018048158],"study_design_scores_gemma":[0.00004372063,0.0030672664,0.99429977,0.000008562407,0.000066674074,0.0008200297,0.000033170527,0.000106635336,0.0011904624,0.000008136078,0.00035300403,0.0000025983838],"about_ca_topic_score_codex":0.00042218962,"about_ca_topic_score_gemma":0.00068646384,"teacher_disagreement_score":0.00073182164,"about_ca_system_score_codex":0.00012568914,"about_ca_system_score_gemma":0.00011181578,"threshold_uncertainty_score":0.0038703084},"labels":[],"label_agreement":null},{"id":"W2946234917","doi":"10.1111/ejh.13250","title":"Pregnancy and delivery in women with von Willebrand disease","year":2019,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Pregnancy; Von Willebrand disease; Von Willebrand factor; Desmopressin; Tranexamic acid; Amniocentesis; Miscarriage; Obstetrics; Vaginal delivery; Abortion; Gynecology; Immunology; Internal medicine; Surgery; Fetus; Platelet; Prenatal diagnosis","score_opus":0.028005730707816267,"score_gpt":0.27689654052219,"score_spread":0.24889080981437373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946234917","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89479804,0.06670196,0.0012817754,0.008554289,0.00071922556,0.0001360184,0.00080630946,0.00008329622,0.026919039],"genre_scores_gemma":[0.9755171,0.020841518,0.00055642286,0.0008955322,0.00035484927,0.00004505879,0.0002526252,0.000009452,0.001527427],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958426,0.00013525764,0.00003810637,0.00005712299,0.00008656208,0.00009870439],"domain_scores_gemma":[0.9996171,0.00012087075,0.00013356542,0.000026875805,0.00002264325,0.00007884728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056751736,0.00019918219,0.000341262,0.0006982956,0.00081613474,0.00052881823,0.0002009898,0.00077736826,0.0036561762],"category_scores_gemma":[0.003343309,0.00023330686,0.0003373443,0.0007218107,0.00034776892,0.000412963,0.0005173945,0.0010120209,0.0005367525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080398243,0.00013690967,0.8836883,0.0003186146,0.0001144174,0.038825367,0.0015293207,0.00012780541,0.0008688084,0.0015019954,0.0044692303,0.067615345],"study_design_scores_gemma":[0.00007727814,0.0009096743,0.7159198,0.0012183838,0.00025681307,0.252457,0.004112012,0.00063952454,0.00050975283,0.004000882,0.019809837,0.00008905839],"about_ca_topic_score_codex":0.0017887615,"about_ca_topic_score_gemma":0.0011284045,"teacher_disagreement_score":0.0036561762,"about_ca_system_score_codex":0.00031623486,"about_ca_system_score_gemma":0.00037429555,"threshold_uncertainty_score":0.0122311115},"labels":[],"label_agreement":null},{"id":"W2948813254","doi":"10.1111/ejh.13272","title":"Implementation of an NGS‐based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; London Health Sciences Centre; Queen's University; Canadian Electricity Association; University of Ottawa; Kingston Health Sciences Centre; Western University","funders":"European Hematology Association","keywords":"Fusion gene; DNA sequencing; Hematologic Neoplasms; Medicine; Gene; Oncology; Internal medicine; Computational biology; Genetics; Biology; Cancer","score_opus":0.07699446865798654,"score_gpt":0.3604213250905318,"score_spread":0.2834268564325453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948813254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92239827,0.00090898445,0.061928827,0.0007664234,0.00007372284,0.002076449,0.0021313601,0.0010117488,0.008704346],"genre_scores_gemma":[0.95556164,0.00015754426,0.040722027,0.000428295,0.000016696205,0.0004953413,0.0015405561,0.00003202058,0.0010458825],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768996,0.00083132135,0.00020945258,0.00038019003,0.00073040975,0.00015871433],"domain_scores_gemma":[0.99851364,0.00039920714,0.00022509725,0.0002660743,0.00043708624,0.00015886262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029160262,0.00038157753,0.00027458213,0.0007769494,0.00030636397,0.00057895,0.0004584523,0.00032343896,0.0017385423],"category_scores_gemma":[0.0039435034,0.00017211094,0.00024488522,0.00033159935,0.00029947556,0.00028167988,0.0005463241,0.00038063983,0.00075740984],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020584115,0.00069720607,0.5174839,0.00021872904,0.000107410684,0.0013946536,0.0011164071,0.006342485,0.2922613,0.00081431854,0.0038223004,0.17368293],"study_design_scores_gemma":[0.00023596648,0.0054072198,0.7123333,0.00012855399,0.00015561904,0.0061015147,0.0005997769,0.02388321,0.23005344,0.0009599107,0.020055342,0.00008609464],"about_ca_topic_score_codex":0.002249237,"about_ca_topic_score_gemma":0.0029588987,"teacher_disagreement_score":0.0029160262,"about_ca_system_score_codex":0.0005886172,"about_ca_system_score_gemma":0.0013685673,"threshold_uncertainty_score":0.015421569},"labels":[],"label_agreement":null},{"id":"W2966006629","doi":"10.1111/ejh.13309","title":"Epstein‐Barr virus associated post‐transplant lymphoproliferative disorder mimicking acute graft versus host disease","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Diarrhea; Differential diagnosis; Immune surveillance; Disease; Post-transplant lymphoproliferative disorder; Epstein–Barr virus infection; Lymphoproliferative disease; Epstein–Barr virus; Virus; Graft-versus-host disease; Presentation (obstetrics); Immune system; Immunology; Pathology; Gastroenterology; Surgery","score_opus":0.011031200839543063,"score_gpt":0.2531761141374302,"score_spread":0.24214491329788712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966006629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97664875,0.004490604,0.0036422752,0.001114077,0.00022321408,0.00012924851,0.00019706391,0.00017034207,0.01338438],"genre_scores_gemma":[0.9969292,0.00084422284,0.0007936777,0.0004068896,0.00024738058,0.000016628672,0.000063968866,0.000014782232,0.00068306515],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995982,0.0000591342,0.00005421902,0.00009040698,0.00004276563,0.00015523932],"domain_scores_gemma":[0.9991509,0.0002728986,0.00020968646,0.00008757855,0.000039172253,0.00023981137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025877776,0.0010497081,0.00046940384,0.0011737793,0.0013959145,0.0013062546,0.0005268506,0.0018810021,0.0028343336],"category_scores_gemma":[0.001866942,0.00047487146,0.0004480379,0.00065826444,0.0008308027,0.001343438,0.0011000428,0.0015784634,0.00071168906],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041113344,0.00004769327,0.026461003,0.00005585546,0.00000937537,0.96690726,0.00028448045,0.00016231948,0.0014507038,0.00028595855,0.00036904993,0.0039250967],"study_design_scores_gemma":[0.0000033673227,0.000028336117,0.003339976,0.000008684593,0.000004201802,0.9956182,0.00007406415,0.00007718725,0.00023237486,0.00010229483,0.00050695566,0.0000043090695],"about_ca_topic_score_codex":0.000709985,"about_ca_topic_score_gemma":0.0010741532,"teacher_disagreement_score":0.0028343336,"about_ca_system_score_codex":0.00047750803,"about_ca_system_score_gemma":0.00041556844,"threshold_uncertainty_score":0.009481728},"labels":[],"label_agreement":null},{"id":"W2968198730","doi":"10.1111/ejh.13314","title":"Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cerebrospinal fluid; Internal medicine; Central nervous system; Myeloid leukemia; Cumulative incidence; Incidence (geometry); Pathological; Oncology; Leukemia; Gastroenterology; Transplantation","score_opus":0.01665544431114275,"score_gpt":0.29888103237909525,"score_spread":0.2822255880679525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968198730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990854,0.00054644264,0.00006893592,0.000024892262,0.0000033554306,0.0000020062175,0.00004920285,0.0000019548625,0.00021780796],"genre_scores_gemma":[0.99976987,0.00008959434,0.000029818118,0.000006928991,0.0000071380946,0.0000013060923,0.00006542583,6.6973905e-7,0.000029323624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995758,0.00014900182,0.000050003546,0.00005854928,0.0001064065,0.000060173305],"domain_scores_gemma":[0.99732274,0.0009557415,0.0011685736,0.00008349137,0.0001683246,0.00030110357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008257354,0.00015572734,0.00018205024,0.00033298976,0.0001312639,0.00041804582,0.00014224985,0.00017388868,0.0009824899],"category_scores_gemma":[0.0030722283,0.000048545124,0.00020286777,0.0002569055,0.0003276049,0.0003359589,0.00034324845,0.00029810081,0.00010903178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047856523,0.000032647185,0.99207616,0.0000148781955,0.000036973757,0.00012751755,0.000025068159,0.00009448344,0.0003878042,0.000010615053,0.00004379823,0.006671589],"study_design_scores_gemma":[0.00001057103,0.00046933297,0.9972452,0.000016101641,0.0000641936,0.0011909184,0.00005632527,0.0002945188,0.0004531795,0.000026294898,0.00016987507,0.0000034945667],"about_ca_topic_score_codex":0.00045440774,"about_ca_topic_score_gemma":0.00095533225,"teacher_disagreement_score":0.0009824899,"about_ca_system_score_codex":0.00026483863,"about_ca_system_score_gemma":0.00024077484,"threshold_uncertainty_score":0.0043669343},"labels":[],"label_agreement":null},{"id":"W2970258757","doi":"10.1111/ejh.13321","title":"Reduced intensity allogeneic stem cell transplant with anti‐thymocyte globulin and post‐transplant cyclophosphamide in acute myeloid leukemia","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cumulative incidence; Anti-thymocyte globulin; Cyclophosphamide; Internal medicine; Gastroenterology; Incidence (geometry); Hematopoietic stem cell transplantation; Myeloid leukemia; Graft-versus-host disease; Surgery; Globulin; Immunology; Transplantation; Chemotherapy","score_opus":0.008846231724032474,"score_gpt":0.21579802800732908,"score_spread":0.2069517962832966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970258757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982521,0.0012825892,0.00016569388,0.000031174168,0.000011773005,0.00002156908,0.000015174772,0.0000050364547,0.00021478608],"genre_scores_gemma":[0.9991817,0.00033554228,0.00024445224,0.000037229765,0.00005325061,0.000021548785,0.000056224493,9.834299e-7,0.00006909863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971133,0.00014845717,0.000023932414,0.00002770842,0.00004849104,0.000040049144],"domain_scores_gemma":[0.9997476,0.00009080468,0.00008165927,0.000015383852,0.0000141403525,0.000050385068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006055791,0.00020496859,0.0003086304,0.00018649391,0.00009052841,0.00014525757,0.00018360435,0.00015284745,0.00066310493],"category_scores_gemma":[0.00068058126,0.000056765366,0.00018413855,0.00012012936,0.00017669088,0.000102847705,0.00011294753,0.00021297303,0.00013302405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06801768,0.00734585,0.4362161,0.0010537468,0.0010489891,0.0018281474,0.00022444017,0.0046815216,0.076472394,0.00038140893,0.0011842104,0.40154546],"study_design_scores_gemma":[0.01307506,0.16261561,0.7734582,0.00024306543,0.0011934909,0.0079930965,0.00014492605,0.0047497107,0.028671356,0.00028200625,0.0075432127,0.000030180865],"about_ca_topic_score_codex":0.00013280642,"about_ca_topic_score_gemma":0.000229723,"teacher_disagreement_score":0.00066310493,"about_ca_system_score_codex":0.00014429384,"about_ca_system_score_gemma":0.0002679665,"threshold_uncertainty_score":0.0032026768},"labels":[],"label_agreement":null},{"id":"W2972452355","doi":"10.1111/ejh.13327","title":"Reduced‐intensity conditioning allogeneic transplant with dual T‐cell depletion in myelofibrosis","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myelofibrosis; Internal medicine; Cumulative incidence; Cyclophosphamide; Gastroenterology; Graft-versus-host disease; Incidence (geometry); Surgery; Transplantation; Bone marrow; Chemotherapy","score_opus":0.011424199007215082,"score_gpt":0.22568699275825554,"score_spread":0.21426279375104046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972452355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807405,0.000735996,0.00044106916,0.000071623464,0.000013709289,0.000023183115,0.000022053491,0.000012804533,0.00060565834],"genre_scores_gemma":[0.9988776,0.00027926874,0.00050673273,0.000051961175,0.00004527853,0.000017746313,0.00009392045,0.0000020347247,0.00012549262],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99993896,0.000020108779,0.000007213132,0.000007574177,0.000009781991,0.000016309998],"domain_scores_gemma":[0.9999167,0.000019103989,0.000021641403,0.000008256222,0.0000054480283,0.000028834966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003395477,0.00022561436,0.00018457731,0.00018518319,0.00015906821,0.00010491149,0.000165691,0.000160019,0.00090625655],"category_scores_gemma":[0.00030904674,0.000046898596,0.00012890591,0.00008669354,0.00021221694,0.000077224126,0.000121834535,0.00019298965,0.00017571893],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029762806,0.005317451,0.39488313,0.000636713,0.00030591662,0.024662348,0.00036340588,0.0042158654,0.17641756,0.0011503233,0.005410156,0.35687444],"study_design_scores_gemma":[0.0092517175,0.07866139,0.6742703,0.00033502292,0.0008557689,0.1307503,0.00019897553,0.009250487,0.07645395,0.0014668913,0.01845301,0.00005226829],"about_ca_topic_score_codex":0.0002165069,"about_ca_topic_score_gemma":0.00028661024,"teacher_disagreement_score":0.00090625655,"about_ca_system_score_codex":0.00016180633,"about_ca_system_score_gemma":0.0002007456,"threshold_uncertainty_score":0.0030317307},"labels":[],"label_agreement":null},{"id":"W2975041764","doi":"10.1111/ejh.13332","title":"Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; CD34; Hematopoietic stem cell transplantation; Cumulative incidence; Stem cell; Transplantation; Internal medicine; Urology; Gastroenterology; Surgery; Biology","score_opus":0.019091064159130776,"score_gpt":0.2748290739479072,"score_spread":0.2557380097887764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975041764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865377,0.0005437132,0.00022755156,0.00003049892,0.000012196166,0.000011979609,0.000039870192,0.00000524547,0.00047523613],"genre_scores_gemma":[0.9995689,0.000096531796,0.00012693634,0.000025362486,0.000013446401,0.0000052749797,0.00007080842,0.0000018988804,0.000090822396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996842,0.00014185412,0.00002841588,0.000037923033,0.0000641506,0.000043544827],"domain_scores_gemma":[0.99937564,0.00030158643,0.00013984843,0.000041451633,0.000038496484,0.000102971346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048183248,0.0001529956,0.00022150105,0.0001078184,0.00006158086,0.00021885574,0.00012158408,0.00011099059,0.0012003925],"category_scores_gemma":[0.001005154,0.000040758037,0.00017145395,0.000085027896,0.00012248149,0.00010230259,0.0001283487,0.00021398505,0.00013893083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03567897,0.0018779609,0.4476468,0.0003404554,0.00072859833,0.0005524068,0.00019061987,0.008746833,0.22857925,0.00042900234,0.0013504456,0.2738787],"study_design_scores_gemma":[0.00052490964,0.023854125,0.9022269,0.0000938802,0.00076048507,0.001256229,0.00009065461,0.0050418796,0.062097315,0.00024373809,0.0037908154,0.000019031075],"about_ca_topic_score_codex":0.00017729777,"about_ca_topic_score_gemma":0.0002418117,"teacher_disagreement_score":0.0012003925,"about_ca_system_score_codex":0.00011550303,"about_ca_system_score_gemma":0.00011851687,"threshold_uncertainty_score":0.004015684},"labels":[],"label_agreement":null},{"id":"W2983490569","doi":"10.1111/ejh.13353","title":"Allogeneic stem cell transplant in myelodysplastic syndrome‐factors impacting survival","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Cumulative incidence; Myelodysplastic syndromes; Incidence (geometry); Oncology; Survival analysis; Transplantation; Ferritin; Bone marrow; Surgery","score_opus":0.022544785628342813,"score_gpt":0.2615934662579578,"score_spread":0.239048680629615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983490569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931455,0.0004221788,0.000044895954,0.000015939167,0.0000022199001,0.0000019464899,0.000046954272,0.0000012267791,0.00015007093],"genre_scores_gemma":[0.9997484,0.0000890904,0.000018765051,0.000007289902,0.000005159322,0.0000012561397,0.000089176596,3.6975234e-7,0.000040549447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998827,0.000038286977,0.000014759762,0.000015678681,0.000026475127,0.000022074539],"domain_scores_gemma":[0.99956197,0.000100307596,0.0002210585,0.00001454353,0.000026949574,0.000075248885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039172554,0.0000930867,0.00012637199,0.00025543323,0.0001112136,0.00023615068,0.000059530405,0.00011477074,0.00072975917],"category_scores_gemma":[0.0007207765,0.000029200553,0.00015288332,0.00029154375,0.00014102475,0.000120133045,0.00014041302,0.0001642578,0.000085104155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005275739,0.000030833893,0.99036705,0.000014789157,0.00003655987,0.00017739704,0.000030142039,0.0001765678,0.00070616073,0.000032546992,0.000082975756,0.007817348],"study_design_scores_gemma":[0.000018850535,0.00042437614,0.99758244,0.000011555498,0.00004918288,0.0007813653,0.00005469856,0.00030262824,0.00042209466,0.00004915423,0.00030198702,0.0000017850858],"about_ca_topic_score_codex":0.00040326428,"about_ca_topic_score_gemma":0.0006805933,"teacher_disagreement_score":0.00072975917,"about_ca_system_score_codex":0.0001508088,"about_ca_system_score_gemma":0.0002089281,"threshold_uncertainty_score":0.0024413466},"labels":[],"label_agreement":null},{"id":"W2985042324","doi":"10.1111/ejh.13343","title":"Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Daratumumab; Hematopoietic cell; Pure red cell aplasia; Refractory (planetary science); Medicine; Transplantation; Hematopoietic stem cell transplantation; Aplasia; Cell; Oncology; Cancer research; Immunology; Haematopoiesis; Stem cell; Internal medicine; Bortezomib; Multiple myeloma; Bone marrow; Biology","score_opus":0.010680294613957201,"score_gpt":0.24082056424326742,"score_spread":0.23014026962931022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985042324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604696,0.022723764,0.0071005607,0.0021332828,0.000475138,0.00043809472,0.00012672589,0.00034787704,0.0061849174],"genre_scores_gemma":[0.99331,0.0026224514,0.0010817939,0.0011721508,0.00023327282,0.00004933135,0.000127066,0.0000212267,0.0013826672],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998217,0.000042181684,0.00002997803,0.000031949818,0.000027659915,0.000046494377],"domain_scores_gemma":[0.9997124,0.00008745728,0.000055959743,0.00004813131,0.0000211013,0.00007490805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033566568,0.00045901636,0.0008167859,0.00037210344,0.00064188725,0.00032123466,0.00041701592,0.0008922933,0.0005647242],"category_scores_gemma":[0.00078915164,0.00013776835,0.0006587078,0.00018790399,0.00025322108,0.00033889702,0.00033295387,0.0010308571,0.00036138517],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022614615,0.0016774514,0.023913886,0.00077120354,0.0004693236,0.6971837,0.0008865952,0.001600833,0.06100718,0.0014006331,0.0034438425,0.20538385],"study_design_scores_gemma":[0.0012165154,0.012704314,0.039303545,0.00018679208,0.00047449084,0.86862177,0.00018063669,0.0040448727,0.04013839,0.0012820066,0.031775776,0.00007092905],"about_ca_topic_score_codex":0.00025333842,"about_ca_topic_score_gemma":0.00042522865,"teacher_disagreement_score":0.0008922933,"about_ca_system_score_codex":0.00025348822,"about_ca_system_score_gemma":0.00025756794,"threshold_uncertainty_score":0.0018891692},"labels":[],"label_agreement":null},{"id":"W2997945764","doi":"10.1111/ejh.13376","title":"Development of the pyruvate kinase deficiency diary and pyruvate kinase deficiency impact assessment: Disease‐specific assessments","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Biochemical Acid Research Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"Agios Pharmaceuticals","keywords":"Pyruvate kinase; Medicine; Quality of life (healthcare); Disease; Patient-reported outcome; Population; Pyruvate kinase deficiency; Internal medicine; Environmental health","score_opus":0.018135464847422844,"score_gpt":0.2994349143009339,"score_spread":0.28129944945351104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997945764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66392434,0.004755505,0.19271451,0.003511196,0.0008404847,0.04345614,0.04827109,0.001584032,0.040942848],"genre_scores_gemma":[0.6909278,0.002501799,0.24541917,0.0006133256,0.00017734095,0.03553217,0.020116167,0.00011894101,0.0045932964],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953544,0.002132897,0.00094462425,0.0002587027,0.0011531428,0.00015630384],"domain_scores_gemma":[0.9909108,0.0028393788,0.0019777855,0.00053199043,0.00313187,0.0006081803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008194507,0.00051359384,0.00072632765,0.0015243494,0.0002596977,0.0008140827,0.0008226771,0.00033491783,0.0028014171],"category_scores_gemma":[0.017845487,0.00027635545,0.0010126445,0.0011478192,0.00024627277,0.0009034588,0.0013293284,0.0011497402,0.0008212336],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014617271,0.0014934207,0.34711784,0.0021650228,0.0004916693,0.00017694708,0.0010855555,0.004075434,0.004057392,0.0026116257,0.027248245,0.6080151],"study_design_scores_gemma":[0.0007704036,0.0040085292,0.90492016,0.0010247102,0.00036417015,0.0009215965,0.0006590723,0.012153762,0.008200172,0.0034750153,0.063321635,0.00018080122],"about_ca_topic_score_codex":0.0007338305,"about_ca_topic_score_gemma":0.0012744422,"teacher_disagreement_score":0.008194507,"about_ca_system_score_codex":0.00069217745,"about_ca_system_score_gemma":0.0014921905,"threshold_uncertainty_score":0.043337226},"labels":[],"label_agreement":null},{"id":"W3010183597","doi":"10.1111/ejh.13403","title":"Outcomes of therapy‐related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Malignancy; Lymphoblastic Leukemia; Multivariate analysis; Oncology; Leukemia; Acute leukemia; Stem cell","score_opus":0.014139057552876103,"score_gpt":0.2486395751561109,"score_spread":0.23450051760323481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010183597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985373,0.00053997757,0.000088869594,0.000064494205,0.00000758565,0.00000857017,0.00025430636,0.000005053084,0.0004937798],"genre_scores_gemma":[0.9992899,0.00014662351,0.000029312874,0.000017956165,0.00001857098,0.000004458119,0.00044526253,0.0000013179822,0.00004659812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968386,0.000076885015,0.000046417394,0.000043096272,0.000075161726,0.00007449251],"domain_scores_gemma":[0.99851495,0.00020410067,0.0008886803,0.000040246265,0.00008344319,0.00026854794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046626254,0.00019393225,0.0002674647,0.0004981307,0.0002651317,0.0005214121,0.00016192101,0.00024056007,0.0011134078],"category_scores_gemma":[0.0019023002,0.00006672906,0.00018427783,0.000659934,0.0002331165,0.00038771852,0.00036842274,0.00028815857,0.00017640572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002598661,0.000021316284,0.9946143,0.000012537592,0.00003001523,0.0006066445,0.0000558983,0.00010552713,0.00019729584,0.000033142627,0.00013604958,0.0039274944],"study_design_scores_gemma":[0.000037401584,0.00050632854,0.9903846,0.000024392746,0.000068279034,0.0073615056,0.0001753416,0.00031157632,0.00023147675,0.00015856512,0.0007344963,0.0000060117786],"about_ca_topic_score_codex":0.0005703782,"about_ca_topic_score_gemma":0.000675668,"teacher_disagreement_score":0.0011134078,"about_ca_system_score_codex":0.00027955827,"about_ca_system_score_gemma":0.00025787164,"threshold_uncertainty_score":0.0037247539},"labels":[],"label_agreement":null},{"id":"W3010273422","doi":"10.1111/ejh.13405","title":"c‐MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide‐dexamethasone in myeloma","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; SAIT Polytechnic","funders":"Agence Nationale de la Recherche","keywords":"Lenalidomide; Medicine; Internal medicine; Oncology; Multiple myeloma; Hazard ratio; Dexamethasone; Placebo; Ixazomib; Autologous stem-cell transplantation; Confidence interval; Pathology; Carfilzomib","score_opus":0.04591443661562897,"score_gpt":0.2880934337399425,"score_spread":0.24217899712431354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010273422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979266,0.0014784693,0.00011752516,0.000084038795,0.000005866604,0.0000136666695,0.000057268833,0.0000064427068,0.00031018996],"genre_scores_gemma":[0.99953926,0.0001529278,0.00007660027,0.000023898854,0.000009376928,0.000005248585,0.00009064682,0.0000011106587,0.00010095299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997954,0.00007563717,0.000014403196,0.000036231773,0.000045457607,0.000032941964],"domain_scores_gemma":[0.9991104,0.0002566325,0.00042774226,0.000026797501,0.000019949872,0.0001584173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064078765,0.0001715058,0.00030560757,0.00013772947,0.00010627593,0.00032930117,0.00013506706,0.00021439146,0.0010515959],"category_scores_gemma":[0.0010449647,0.0000925371,0.0003838527,0.00013133851,0.00017726464,0.00018054561,0.00020669427,0.00069199904,0.00006090579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15280212,0.0013812735,0.64656353,0.00035170565,0.0018689673,0.0002161578,0.00010202882,0.0035806638,0.07881453,0.00021540093,0.00066632516,0.1134372],"study_design_scores_gemma":[0.001672873,0.007285121,0.98302966,0.000026097518,0.00051399134,0.00038512275,0.000038040893,0.0016933334,0.0045440905,0.000167046,0.0006341624,0.000010414054],"about_ca_topic_score_codex":0.0003779019,"about_ca_topic_score_gemma":0.0005715289,"teacher_disagreement_score":0.0010515959,"about_ca_system_score_codex":0.00031457498,"about_ca_system_score_gemma":0.00021750439,"threshold_uncertainty_score":0.0035179853},"labels":[],"label_agreement":null},{"id":"W3023296941","doi":"10.1111/ejh.13437","title":"Causes of hypereosinophilia in 100 consecutive patients","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Hypereosinophilia; Eosinophilia; Medicine; Granulomatosis with polyangiitis; Hypereosinophilic syndrome; Context (archaeology); Eosinophilic; Vasculitis; Dermatology; Pathology; Immunology; Internal medicine; Gastroenterology; Disease","score_opus":0.02915228858587913,"score_gpt":0.2550555463843551,"score_spread":0.225903257798476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023296941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99877053,0.0003566655,0.00008598541,0.000036668636,0.000006853096,0.00002417559,0.00007998488,0.00000900893,0.0006301206],"genre_scores_gemma":[0.9994759,0.00012386614,0.0000996185,0.000052759257,0.000019188119,0.000013129148,0.00012039226,0.0000031802278,0.00009201053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950206,0.000071870825,0.00007040614,0.00012073001,0.00011373205,0.00012108514],"domain_scores_gemma":[0.99888283,0.00031540848,0.0004229765,0.000055824647,0.000085935964,0.00023702554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032556214,0.0004123236,0.00039120123,0.000981271,0.000630293,0.0006300191,0.00036221364,0.0006726303,0.0025347832],"category_scores_gemma":[0.0020786498,0.00048447258,0.00024809878,0.0008305949,0.0005541124,0.000562874,0.0005610109,0.00048453608,0.00032317295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064570166,0.00004681269,0.98341584,0.000018576671,0.000016165986,0.013468081,0.00022296609,0.000048785318,0.00040621354,0.000021473332,0.00019051414,0.0020799572],"study_design_scores_gemma":[0.000043729728,0.0002934144,0.9103063,0.000027630065,0.000035027413,0.087014094,0.0005719901,0.00039096296,0.00051716215,0.000043637952,0.0007434674,0.00001266863],"about_ca_topic_score_codex":0.0014440846,"about_ca_topic_score_gemma":0.0024282883,"teacher_disagreement_score":0.0025347832,"about_ca_system_score_codex":0.0005056867,"about_ca_system_score_gemma":0.00038852193,"threshold_uncertainty_score":0.008479655},"labels":[],"label_agreement":null},{"id":"W3037528322","doi":"10.1111/ejh.13478","title":"Sickle cell trait and the potential risk of severe coronavirus disease 2019—A mini‐review","year":2020,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pandemic; Disease; Medicine; Sickle cell trait; Epidemiology; Asymptomatic; Pneumonia; Public health; Coronavirus; Coronavirus disease 2019 (COVID-19); Intensive care medicine; Environmental health; Infectious disease (medical specialty); Internal medicine; Pathology","score_opus":0.019641937636184863,"score_gpt":0.28339515384703906,"score_spread":0.2637532162108542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037528322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059366084,0.9989661,0.00003483714,0.00033751148,0.00021657262,0.000002829047,0.000016295917,0.0000037310956,0.0003626333],"genre_scores_gemma":[0.0003667262,0.9990119,0.000068853915,0.00018570799,0.00016623738,0.00000393269,0.000027118102,7.7500664e-7,0.0001687675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974936,0.000052762723,0.000053495874,0.00003434243,0.000089706205,0.000020304824],"domain_scores_gemma":[0.99903893,0.00056976906,0.00013295076,0.000015243889,0.00019093491,0.00005228439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007220439,0.0006069396,0.0011501954,0.0023785231,0.0002500122,0.0009967269,0.00079839694,0.0010343706,0.0046065934],"category_scores_gemma":[0.0020662653,0.0002252945,0.0007883418,0.0018419245,0.0002735354,0.0011169257,0.00056754256,0.0013372202,0.0011348969],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009437129,0.000052630177,0.0003181479,0.045883838,0.00022985549,0.00015520811,0.000079501566,0.00027739245,0.0005280428,0.002529122,0.04708369,0.9027682],"study_design_scores_gemma":[0.00001858288,0.00011345299,0.0014204425,0.024914647,0.0004972489,0.0014577241,0.00010192541,0.00010100644,0.00017553083,0.0018441732,0.9693319,0.000023365305],"about_ca_topic_score_codex":0.0011744816,"about_ca_topic_score_gemma":0.0019720956,"teacher_disagreement_score":0.0046065934,"about_ca_system_score_codex":0.00056210364,"about_ca_system_score_gemma":0.0018478384,"threshold_uncertainty_score":0.015410602},"labels":[],"label_agreement":null},{"id":"W3038486853","doi":"10.1111/ejh.13482","title":"Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Angina; Hematopoietic stem cell transplantation; Cohort; Retrospective cohort study; Stroke (engine); Anthracycline; Cardiomyopathy; Coronary artery disease; Transplantation; Cardiology; Surgery; Heart failure; Myocardial infarction","score_opus":0.05202972940087471,"score_gpt":0.2888122664873757,"score_spread":0.23678253708650096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038486853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989973,0.00027609142,0.000039966646,0.000020058142,0.0000036789393,0.0000063124226,0.00030623347,0.0000029436283,0.0003475397],"genre_scores_gemma":[0.9995499,0.00006849531,0.000020971731,0.000009436,0.000006177496,0.00000460275,0.00028399454,8.363625e-7,0.000055540815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996966,0.00005068728,0.000048348433,0.00006397568,0.000076816665,0.00006355924],"domain_scores_gemma":[0.9983498,0.0001917291,0.0009830492,0.00005917203,0.00009575468,0.0003205137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039526288,0.00015193348,0.00022011095,0.00058327074,0.0002712976,0.00047314115,0.0002128914,0.0002898078,0.0019198131],"category_scores_gemma":[0.0016452507,0.00014011517,0.0002702487,0.0006612155,0.00023533567,0.00036380088,0.00032501045,0.00041997764,0.00022013085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004485828,0.000010898171,0.99934953,0.0000037378638,0.000012620019,0.000089547604,0.000016095046,0.000018606375,0.00006962657,0.000004321434,0.00003372876,0.00034640578],"study_design_scores_gemma":[0.0000021913704,0.00006045328,0.99919313,0.0000044271164,0.000006429651,0.000570172,0.00004251801,0.000033643948,0.000032599444,0.000007627918,0.000044995464,0.0000017707916],"about_ca_topic_score_codex":0.001243034,"about_ca_topic_score_gemma":0.0017095852,"teacher_disagreement_score":0.0019198131,"about_ca_system_score_codex":0.00021858483,"about_ca_system_score_gemma":0.00023118065,"threshold_uncertainty_score":0.0064224005},"labels":[],"label_agreement":null},{"id":"W3041190648","doi":"10.1111/ejh.13485","title":"Beneficial effects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International Paroxysmal Nocturnal Hemoglobinuria Registry","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alexion Pharmaceuticals","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Hemoglobinuria; Bone marrow failure; Bone marrow; Internal medicine; Surgery; Pediatrics; Anemia; Immunology; Antibody","score_opus":0.016380195855437634,"score_gpt":0.23577955306504847,"score_spread":0.21939935720961085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041190648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391586,0.0031247055,0.00012948214,0.00020730158,0.00002082546,0.000024653276,0.0008915025,0.000015908869,0.0016698042],"genre_scores_gemma":[0.99751127,0.00091102143,0.00018436505,0.00008814538,0.000039111477,0.000015336665,0.001061879,0.0000054121847,0.00018350677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986981,0.0006242041,0.00014035829,0.00015174944,0.00029522256,0.00009024394],"domain_scores_gemma":[0.99678206,0.0009297344,0.001591651,0.0002449922,0.00023232301,0.00021919739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024741043,0.00019149923,0.00052753044,0.00027269407,0.000109258566,0.00044685067,0.00021085852,0.00020229428,0.00082087645],"category_scores_gemma":[0.0046947324,0.00008703763,0.0004953709,0.00029466226,0.00011120491,0.00030347583,0.00022701154,0.00031557225,0.00012752804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016749002,0.000662949,0.902326,0.00015232174,0.0017798928,0.00018377908,0.00008526184,0.00058844115,0.0022418797,0.00006626509,0.0017044371,0.073459685],"study_design_scores_gemma":[0.00060304103,0.0027252843,0.9926973,0.000031767653,0.0011716926,0.00042439738,0.00006035137,0.00032664466,0.00069673825,0.000024814468,0.0012280967,0.000009767807],"about_ca_topic_score_codex":0.00065720035,"about_ca_topic_score_gemma":0.0013508648,"teacher_disagreement_score":0.0024741043,"about_ca_system_score_codex":0.0001476694,"about_ca_system_score_gemma":0.00027914118,"threshold_uncertainty_score":0.013084471},"labels":[],"label_agreement":null},{"id":"W3044606577","doi":"10.1111/ejh.13496","title":"Maintenance therapy in transplant ineligible adults with newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis","year":2020,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Ottawa Hospital; University of Ottawa; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Meta-analysis; Confidence interval; Hazard ratio; Adverse effect; Randomized controlled trial; Internal medicine; Multiple myeloma; Maintenance therapy; MEDLINE; Relative risk; Surgery; Chemotherapy","score_opus":0.056808534067040915,"score_gpt":0.3254934137450504,"score_spread":0.2686848796780095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044606577","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021868893,0.99700004,0.00018696974,0.00010610953,0.000066952,0.00015930219,0.00014893086,0.000009791694,0.00013504505],"genre_scores_gemma":[0.0796058,0.91708773,0.001323273,0.0005956513,0.00014029813,0.0007252543,0.00033526833,0.000011601671,0.00017506737],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945761,0.0027305752,0.0015379384,0.00047013763,0.00051668996,0.00016850531],"domain_scores_gemma":[0.98548746,0.011118672,0.0023212074,0.00027769507,0.0006495426,0.00014552978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009222602,0.001873209,0.0145541355,0.0036054887,0.0004430537,0.0023769645,0.0016688862,0.0020853113,0.0029368054],"category_scores_gemma":[0.025441935,0.0011231118,0.020358423,0.0042318264,0.0005161554,0.0013562404,0.0009163517,0.0015985348,0.00020021075],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023886512,0.000035292433,0.0017980706,0.68251693,0.29024994,0.00012095782,0.00008075521,0.000410414,0.00022061348,0.00015641988,0.00068682915,0.021335127],"study_design_scores_gemma":[0.0011984755,0.0004704207,0.003528571,0.081043325,0.9098526,0.00015467063,0.000053222568,0.0002115208,0.00018116971,0.00025659075,0.0030228104,0.000026565122],"about_ca_topic_score_codex":0.0048636654,"about_ca_topic_score_gemma":0.010073702,"teacher_disagreement_score":0.0145541355,"about_ca_system_score_codex":0.002317006,"about_ca_system_score_gemma":0.0029241224,"threshold_uncertainty_score":0.04877436},"labels":[],"label_agreement":null},{"id":"W3047580662","doi":"10.1111/ejh.13504","title":"Single UM171‐expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Aplastic anemia; Fludarabine; Cord blood; Cyclophosphamide; Transplantation; Stem cell; Haematopoiesis; Anemia; CD34; Hematopoietic stem cell transplantation; Progenitor cell; Surgery; Immunology; Internal medicine; Gastroenterology; Bone marrow; Chemotherapy","score_opus":0.026500904094581043,"score_gpt":0.24085192664927413,"score_spread":0.21435102255469307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047580662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363744,0.0026858633,0.0015933706,0.00010291832,0.000031032745,0.000018919209,0.000040931758,0.000085156455,0.0018044858],"genre_scores_gemma":[0.99874794,0.00040518123,0.00033035822,0.000036837766,0.000015061071,0.000003830403,0.000058060985,0.000005976272,0.00039681286],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99998295,0.000002959781,0.0000014912322,0.0000027325168,0.0000030768017,0.000006735842],"domain_scores_gemma":[0.9999399,0.000017545195,0.000011856354,0.0000057359716,0.0000026832015,0.000022310096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006758599,0.00018114965,0.00018274556,0.00012846343,0.000107901404,0.00012447745,0.000096228774,0.00015616481,0.0012185809],"category_scores_gemma":[0.000119618984,0.000041898675,0.00010893742,0.00007011586,0.00011535764,0.00007474872,0.0001267664,0.00027503542,0.00016655604],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004086136,0.0009600909,0.022190377,0.0006741896,0.00012829345,0.038055748,0.00025509213,0.0018285678,0.6978742,0.0010354272,0.0026000096,0.23031197],"study_design_scores_gemma":[0.00092202344,0.020757612,0.19285817,0.00032189317,0.0003797023,0.2789156,0.00029193747,0.009676303,0.45605257,0.0014929498,0.038288195,0.00004305778],"about_ca_topic_score_codex":0.00011501418,"about_ca_topic_score_gemma":0.00020062448,"teacher_disagreement_score":0.0012185809,"about_ca_system_score_codex":0.000086526044,"about_ca_system_score_gemma":0.00008007074,"threshold_uncertainty_score":0.0040766},"labels":[],"label_agreement":null},{"id":"W3091916167","doi":"10.1111/ejh.13531","title":"Prolactin, a potential biomarker for chronic GVHD activity","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Prolactin; Medicine; Biomarker; Internal medicine; Cohort; Hormone; Gastroenterology; Odds ratio; Endocrinology; Biology","score_opus":0.03621521186632647,"score_gpt":0.2819842436058146,"score_spread":0.2457690317394881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091916167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97828317,0.017799435,0.0007040699,0.0003428999,0.00006019823,0.000024423067,0.00082868023,0.000044641853,0.0019124338],"genre_scores_gemma":[0.9978446,0.0012683464,0.0003647837,0.00005281217,0.000036493137,0.0000071365066,0.00023288537,0.000002237568,0.00019084236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996476,0.00011887023,0.000045446468,0.000051986604,0.000085051215,0.000051022285],"domain_scores_gemma":[0.9987638,0.00022428783,0.0007033915,0.00003259793,0.000119749835,0.00015612382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007166502,0.00034300034,0.0003160965,0.00097308203,0.00021786451,0.00075606705,0.00019526466,0.00027139258,0.0013525537],"category_scores_gemma":[0.0015207828,0.000118881,0.0002918978,0.0008254156,0.00025779667,0.00028674852,0.00029992443,0.00047475583,0.0002531426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029850323,0.000022865996,0.9872777,0.000060765844,0.000056613855,0.00018481132,0.000025962141,0.00007142439,0.0015002053,0.00002273154,0.00019599932,0.010282445],"study_design_scores_gemma":[0.000015905342,0.0004742426,0.99183613,0.000086055916,0.00012727315,0.0033849112,0.00020563806,0.000581879,0.0015793493,0.0000984261,0.0015976034,0.000012481092],"about_ca_topic_score_codex":0.0010087856,"about_ca_topic_score_gemma":0.000839882,"teacher_disagreement_score":0.0013525537,"about_ca_system_score_codex":0.00034429735,"about_ca_system_score_gemma":0.00027718928,"threshold_uncertainty_score":0.004524708},"labels":[],"label_agreement":null},{"id":"W3092252175","doi":"10.1111/ejh.13533","title":"Association of anticoagulation dose and survival in hospitalized COVID‐19 patients: A retrospective propensity score‐weighted analysis","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Propensity score matching; Medicine; Coronavirus disease 2019 (COVID-19); Retrospective cohort study; 2019-20 coronavirus outbreak; Internal medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Survival analysis; Virology; Disease","score_opus":0.06118369551701191,"score_gpt":0.35904077255986705,"score_spread":0.29785707704285513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092252175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853134,0.00032364784,0.00035996467,0.000034526187,0.000010323006,0.000014972118,0.00053279125,0.0000037328914,0.00018865523],"genre_scores_gemma":[0.9992435,0.00006792019,0.000098065844,0.000015607511,0.000009717967,0.000010443003,0.00051738264,0.0000022630372,0.00003505226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989108,0.0002780943,0.0002115222,0.0003282046,0.00014708332,0.00012439102],"domain_scores_gemma":[0.9966317,0.0006052649,0.001846666,0.0004624517,0.00020206218,0.0002518588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016828914,0.00031410242,0.00047630243,0.0009429685,0.00032975638,0.0006488666,0.00039095944,0.00036394468,0.0013293213],"category_scores_gemma":[0.0036672244,0.00029796525,0.0010343854,0.0013456957,0.00027926525,0.0004827064,0.00049918325,0.00059208745,0.00014591528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027545585,0.000011354294,0.99861276,0.00000897684,0.00023220318,0.00003104137,0.0000143045245,0.000103869985,0.00007868067,0.000026299413,0.000095451986,0.00050965167],"study_design_scores_gemma":[0.000042911593,0.00023186221,0.9963336,0.000012846668,0.00027048404,0.0003579909,0.000088021334,0.0020956888,0.00009862689,0.00010252563,0.00035492243,0.00001056716],"about_ca_topic_score_codex":0.0015024967,"about_ca_topic_score_gemma":0.0015147438,"teacher_disagreement_score":0.0016828914,"about_ca_system_score_codex":0.00033486646,"about_ca_system_score_gemma":0.00033557927,"threshold_uncertainty_score":0.008900106},"labels":[],"label_agreement":null},{"id":"W3094933225","doi":"10.1111/ejh.13543","title":"Prevalence and risk factors for Pulmonary Hypertension associated with chronic Myeloproliferative Neoplasms","year":2020,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Essential thrombocythemia; Polycythemia vera; Myelofibrosis; Pulmonary hypertension; Internal medicine; Myeloproliferative neoplasm; Bone marrow","score_opus":0.044727797251144424,"score_gpt":0.2880866734117881,"score_spread":0.2433588761606437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094933225","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026291631,0.97122926,0.0003770284,0.00036152723,0.00012599133,0.00006204092,0.0010809192,0.000012203983,0.0004593998],"genre_scores_gemma":[0.61462736,0.38024202,0.0016282863,0.000702518,0.00053295365,0.00032039906,0.0016369736,0.000021131682,0.00028835653],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.99531555,0.001664391,0.0014168379,0.00082330295,0.0005965056,0.00018353816],"domain_scores_gemma":[0.979045,0.015294433,0.0040875194,0.00046131064,0.000906574,0.00020523155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006770399,0.0009990028,0.0041943933,0.0035645443,0.00032475646,0.0017544951,0.0009768482,0.0014657709,0.0021440815],"category_scores_gemma":[0.018336453,0.0006859632,0.013784555,0.0059226295,0.00041810703,0.00091651274,0.0008044235,0.00092556217,0.00013258374],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033857317,0.00006925313,0.21290696,0.2467145,0.4983372,0.00028121163,0.00018172697,0.0008352802,0.00058254367,0.0002970606,0.0015419386,0.034866523],"study_design_scores_gemma":[0.00086736155,0.00048257227,0.19249362,0.03968394,0.75819623,0.0008845577,0.00018911775,0.00084918994,0.00040263074,0.00058068,0.005300758,0.00006939799],"about_ca_topic_score_codex":0.0048624543,"about_ca_topic_score_gemma":0.006341388,"teacher_disagreement_score":0.006770399,"about_ca_system_score_codex":0.00085850456,"about_ca_system_score_gemma":0.0010905707,"threshold_uncertainty_score":0.03580576},"labels":[],"label_agreement":null},{"id":"W3095174995","doi":"10.1111/ejh.13542","title":"Comorbidity profile of adult survivors at 20 years following allogeneic hematopoietic cell transplantation","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Comorbidity; Transplantation; Depression (economics); Internal medicine; Cohort; Dyslipidemia; Quality of life (healthcare); Hematopoietic stem cell transplantation; Anxiety; Surgery; Pediatrics; Psychiatry; Disease","score_opus":0.022806511894719276,"score_gpt":0.2497925551750155,"score_spread":0.22698604328029623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095174995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995307,0.00018267486,0.000018757171,0.000018773888,0.0000022295383,0.0000023220173,0.00010404818,8.321774e-7,0.0001396578],"genre_scores_gemma":[0.99956423,0.00012446978,0.000021102316,0.000014523659,0.0000064271826,0.0000022519528,0.00022404626,3.891454e-7,0.00004259254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982506,0.000033473236,0.0000290079,0.000023169236,0.000047403642,0.00004188966],"domain_scores_gemma":[0.9992285,0.00008276581,0.0004061414,0.000016475393,0.00006662951,0.00019950411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002850425,0.00011969989,0.00022871593,0.00071554846,0.00028758714,0.00029311536,0.0001222698,0.00021595601,0.000884158],"category_scores_gemma":[0.0012937321,0.000081842256,0.00019229496,0.00066973525,0.00014720154,0.0002856113,0.00028779695,0.00022241316,0.000094471805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023648296,0.0000065731224,0.9992243,0.000002269631,0.000009255719,0.000100584024,0.000026359348,0.000013923981,0.000069768255,0.0000039516344,0.000024337225,0.00049514096],"study_design_scores_gemma":[0.0000011235801,0.00005537139,0.99919397,0.000004193716,0.0000075717753,0.0005075818,0.000103034254,0.000041684107,0.00001657164,0.000005304171,0.000062245934,0.0000013706184],"about_ca_topic_score_codex":0.002421113,"about_ca_topic_score_gemma":0.0036431388,"teacher_disagreement_score":0.002421113,"about_ca_system_score_codex":0.00013647471,"about_ca_system_score_gemma":0.0001776074,"threshold_uncertainty_score":0.0048140883},"labels":[],"label_agreement":null},{"id":"W3106232974","doi":"10.1111/ejh.13552","title":"The impact of COVID‐19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single‐center experience","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Amyloidosis; Pandemic; Outbreak; AL amyloidosis; Coronavirus disease 2019 (COVID-19); Disease; Intensive care medicine; Internal medicine; Pediatrics; Immunology; Antibody; Infectious disease (medical specialty); Pathology","score_opus":0.02132332063777698,"score_gpt":0.29642383992898896,"score_spread":0.275100519291212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106232974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969946,0.000908506,0.0005495233,0.00021052938,0.000035743105,0.00006504715,0.000060568655,0.000013779972,0.0011616091],"genre_scores_gemma":[0.99762964,0.0006956713,0.00074598455,0.00020426151,0.00012070189,0.000049547907,0.0001254615,0.000010424119,0.00041824655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940276,0.00026759508,0.000057022713,0.000079502,0.000059691167,0.00013341382],"domain_scores_gemma":[0.9983335,0.00028867295,0.000244457,0.00007729235,0.000107291184,0.0009487219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009178647,0.0006607157,0.00037755098,0.00032925815,0.00096233084,0.0008181561,0.00051299034,0.0005640271,0.0018827448],"category_scores_gemma":[0.0019351486,0.00023521521,0.0005219444,0.0004817154,0.00041939496,0.0004572307,0.00080452935,0.0007822903,0.00045351047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008015059,0.023089672,0.62635666,0.0006000469,0.00059142214,0.06655367,0.008066521,0.003354086,0.010497529,0.00044702788,0.0064133857,0.24601488],"study_design_scores_gemma":[0.0039198683,0.08009746,0.72992444,0.000422989,0.00049251306,0.15005884,0.007078968,0.0044922805,0.007735502,0.00050724274,0.015031299,0.00023851701],"about_ca_topic_score_codex":0.0011124277,"about_ca_topic_score_gemma":0.0015886999,"teacher_disagreement_score":0.0018827448,"about_ca_system_score_codex":0.00083045405,"about_ca_system_score_gemma":0.00069924555,"threshold_uncertainty_score":0.006298363},"labels":[],"label_agreement":null},{"id":"W3111386845","doi":"10.1111/ejh.13564","title":"One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Hemoglobinuria; Adverse effect; Internal medicine; Anemia; Immunology; Antibody","score_opus":0.02286949683580114,"score_gpt":0.2583178488033262,"score_spread":0.23544835196752506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111386845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891583,0.005947666,0.00047641923,0.00043828183,0.0002822007,0.0012179558,0.0012308493,0.000060475766,0.0011878373],"genre_scores_gemma":[0.9923199,0.0017263907,0.00059628225,0.00078543957,0.00021764272,0.0015383177,0.0016160853,0.00001695675,0.001183035],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986494,0.0007359432,0.000112999696,0.00022858001,0.00010072403,0.0001723955],"domain_scores_gemma":[0.997974,0.00060061266,0.00060448394,0.0001986753,0.00013978034,0.0004825221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036300041,0.0015021175,0.002808383,0.0003183505,0.00053518795,0.0012728579,0.0008180022,0.001664593,0.0043830774],"category_scores_gemma":[0.0030304645,0.00065074774,0.004222431,0.00030284375,0.00065581605,0.0010186485,0.00047782695,0.003701572,0.00061792316],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.976863,0.00343147,0.0018280832,0.00048721716,0.0037854407,0.00005925481,0.000057446414,0.00039640593,0.0020689426,0.000060156086,0.00094160595,0.010020973],"study_design_scores_gemma":[0.89132535,0.087176904,0.015274568,0.00008133902,0.0039075008,0.00010764566,0.00004057446,0.0006253587,0.00059509045,0.00015460818,0.00067716907,0.00003383608],"about_ca_topic_score_codex":0.0010557858,"about_ca_topic_score_gemma":0.002182734,"teacher_disagreement_score":0.0043830774,"about_ca_system_score_codex":0.00073786196,"about_ca_system_score_gemma":0.000777363,"threshold_uncertainty_score":0.019197464},"labels":[],"label_agreement":null},{"id":"W3113677185","doi":"10.1111/ejh.13572","title":"Comorbidities and complications in adults with pyruvate kinase deficiency","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"Agios Pharmaceuticals","keywords":"Medicine; Pyruvate kinase deficiency; Pyruvate kinase; Splenectomy; Internal medicine; Population; Cohort; Gastroenterology; Iron deficiency; Hemolytic anemia; Anemia; Glycolysis","score_opus":0.028732588243687605,"score_gpt":0.24465824352526333,"score_spread":0.21592565528157573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113677185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732167,0.0013977579,0.000074677264,0.00010580671,0.000011931123,0.000007378842,0.00038783607,0.00000420063,0.0006888767],"genre_scores_gemma":[0.99910945,0.00035837633,0.000081276674,0.00003372156,0.000015441918,0.000005497098,0.00030364373,6.2678413e-7,0.00009188097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998097,0.00003309724,0.00003892911,0.000036310154,0.00004923979,0.000032766722],"domain_scores_gemma":[0.99945265,0.000055299748,0.0003374909,0.000012730579,0.000033621283,0.00010819796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019480236,0.00015867237,0.00019748362,0.00043438261,0.0003218637,0.00028412734,0.00010454697,0.0002167872,0.0013171097],"category_scores_gemma":[0.0012397965,0.00010296694,0.00018696288,0.00068544527,0.00011104141,0.00020109233,0.00028866917,0.00033175998,0.00011141316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007028762,0.000015686355,0.9977672,0.000011586089,0.000016309268,0.00021599524,0.000026042311,0.000021882797,0.000098120916,0.000010970001,0.00009559171,0.0016502604],"study_design_scores_gemma":[0.0000074373,0.00007576481,0.99776745,0.000017664523,0.000014096983,0.0017145504,0.00006783306,0.00008188138,0.000039265466,0.00002423243,0.00018769754,0.0000021678318],"about_ca_topic_score_codex":0.0017290432,"about_ca_topic_score_gemma":0.0023983035,"teacher_disagreement_score":0.0017290432,"about_ca_system_score_codex":0.00015273571,"about_ca_system_score_gemma":0.00019855094,"threshold_uncertainty_score":0.0044062138},"labels":[],"label_agreement":null},{"id":"W3120212210","doi":"10.1111/ejh.13576","title":"Refined hepatic grading system in chronic graft‐versus‐host disease improves prognostic risk stratification of long‐term outcomes","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Cutoff; Grading (engineering); Risk stratification; Bilirubin; Predictive value; Surgery","score_opus":0.02874996879369944,"score_gpt":0.2880799857745002,"score_spread":0.25933001698080077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120212210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991071,0.000820314,0.0056081545,0.00013616947,0.00003534102,0.00009096033,0.0005292553,0.000056269957,0.0016526285],"genre_scores_gemma":[0.9974605,0.00009474544,0.0018412032,0.00001705204,0.000017910957,0.000015827603,0.00038052181,0.0000035591615,0.00016857244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993161,0.0003019613,0.00008161096,0.00008685635,0.00014981777,0.000063658226],"domain_scores_gemma":[0.99825996,0.00035343654,0.00069342874,0.0001868967,0.00033735976,0.00016892522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001955463,0.00044670483,0.0003400401,0.0012943544,0.00015695108,0.0005643855,0.0002869211,0.00023451317,0.001139643],"category_scores_gemma":[0.003517216,0.00007952416,0.00037914774,0.0006535044,0.00024954567,0.00037605793,0.0006433296,0.00037453987,0.00029470582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061601703,0.000053066567,0.959044,0.000052973734,0.000115603136,0.000057377492,0.000038155693,0.0012729929,0.0028728228,0.000099665725,0.00040242053,0.035374794],"study_design_scores_gemma":[0.0000650805,0.00071830506,0.9869391,0.000040679406,0.00012495664,0.00034582196,0.000081708284,0.008380192,0.0018994549,0.00037423644,0.0010142471,0.000016318141],"about_ca_topic_score_codex":0.0014298313,"about_ca_topic_score_gemma":0.0020942867,"teacher_disagreement_score":0.001955463,"about_ca_system_score_codex":0.00031027725,"about_ca_system_score_gemma":0.00039046927,"threshold_uncertainty_score":0.010341585},"labels":[],"label_agreement":null},{"id":"W3126448789","doi":"10.1111/ejh.13593","title":"Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Ruxolitinib; Medicine; Hemophagocytic lymphohistiocytosis; Cytokine storm; Cytokine release syndrome; Tocilizumab; Internal medicine; Immunology; Macrophage activation syndrome; Oncology; Immunotherapy; Immune system; Chimeric antigen receptor; Bone marrow; Myelofibrosis","score_opus":0.028086633971856026,"score_gpt":0.30637414547763986,"score_spread":0.27828751150578385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126448789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97654486,0.0069070593,0.0037127933,0.0019486827,0.00042371376,0.0002681591,0.00023509275,0.00023425686,0.009725382],"genre_scores_gemma":[0.99638915,0.0010534027,0.00070440775,0.00040758197,0.0004833163,0.000030881823,0.00007756718,0.000018290924,0.0008354844],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992144,0.00010270192,0.0001247907,0.00017656542,0.0001165229,0.00026495423],"domain_scores_gemma":[0.9985876,0.00035294952,0.00033963806,0.00016205458,0.000078751356,0.00047904093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038408002,0.0022590088,0.0012106167,0.0021721139,0.002322802,0.0016462229,0.0012556507,0.00402868,0.0027560885],"category_scores_gemma":[0.0022146148,0.00093099667,0.0014140711,0.0010315296,0.0017135433,0.0013080885,0.0014616618,0.0025988878,0.0010728969],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003007378,0.00007155916,0.0053743776,0.000030285553,0.000017480708,0.99215347,0.00012302963,0.00006637502,0.00037615228,0.000086973494,0.00024578194,0.0014244838],"study_design_scores_gemma":[0.000018367546,0.000072421346,0.0036217682,0.000012725448,0.00002090791,0.99513775,0.00008692941,0.00019007002,0.00036727876,0.000052593972,0.00041107368,0.000008075205],"about_ca_topic_score_codex":0.0014623781,"about_ca_topic_score_gemma":0.0017072002,"teacher_disagreement_score":0.00402868,"about_ca_system_score_codex":0.001184017,"about_ca_system_score_gemma":0.0009194293,"threshold_uncertainty_score":0.009220064},"labels":[],"label_agreement":null},{"id":"W3127156187","doi":"10.1111/ejh.13596","title":"The impact of lenalidomide maintenance on second‐line chemotherapy in transplant eligible patients with multiple myeloma","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; University of Saskatchewan; Dalhousie University; University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital; Institute of Cancer Research; Saint John Regional Hospital; BC Cancer Agency; CancerCare Manitoba; Occupational Cancer Research Centre; Ottawa Hospital; Canadian Institutes of Health Research; McGill University; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Internal medicine; Oncology; Cohort; Maintenance therapy; Thalidomide; Chemotherapy; Surgery","score_opus":0.01508152340516909,"score_gpt":0.2850994780564227,"score_spread":0.2700179546512536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127156187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975744,0.0017760523,0.000038225666,0.00015654403,0.00000823498,0.0000091902375,0.0000709471,0.0000032892913,0.0003631942],"genre_scores_gemma":[0.99934715,0.0002836238,0.000040657214,0.00009433191,0.000015040817,0.0000045431657,0.00014522839,0.0000010032285,0.000068485075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997173,0.00008965594,0.000026680575,0.000045245295,0.000054888955,0.00006617255],"domain_scores_gemma":[0.9992931,0.00013888079,0.00038156848,0.00001633547,0.000024644902,0.00014544092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045255478,0.00010560666,0.00022737308,0.00017791454,0.00020600407,0.0004839976,0.00022342041,0.00022489596,0.0010255787],"category_scores_gemma":[0.0016171148,0.00004996506,0.00027579218,0.00029883353,0.0001246768,0.00024563633,0.00023453463,0.0003058349,0.000084918516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041120662,0.00031566076,0.93988097,0.00010316174,0.00020515967,0.00028583684,0.00008586078,0.00038507022,0.0013932216,0.000041726333,0.00053001416,0.05266132],"study_design_scores_gemma":[0.00016219087,0.002033438,0.9948003,0.000036662463,0.00013466642,0.00077412295,0.00013222595,0.00045489921,0.0004865826,0.00003473735,0.0009452881,0.0000048966285],"about_ca_topic_score_codex":0.0027320397,"about_ca_topic_score_gemma":0.006894537,"teacher_disagreement_score":0.0027320397,"about_ca_system_score_codex":0.0006522761,"about_ca_system_score_gemma":0.00069980754,"threshold_uncertainty_score":0.005432248},"labels":[],"label_agreement":null},{"id":"W3165184255","doi":"10.1111/ejh.13673","title":"Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Pancytopenia; Cumulative incidence; Internal medicine; Bone marrow; Cohort; Transplantation; Gastroenterology; Incidence (geometry); Myeloid leukemia; Oncology; Hematopoietic stem cell transplantation","score_opus":0.024707375714897697,"score_gpt":0.24442332911963768,"score_spread":0.21971595340473998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165184255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996917,0.00010144287,0.000040980685,0.000011409722,9.4854454e-7,0.0000022965717,0.00003893666,0.0000023465288,0.000109930625],"genre_scores_gemma":[0.9998153,0.000018120196,0.000020434456,0.0000050339177,0.0000024845142,0.000001368745,0.00009679456,8.2897617e-7,0.000039628907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979025,0.000039512775,0.00002694442,0.00004436829,0.00004912504,0.000049838105],"domain_scores_gemma":[0.9986779,0.00031517303,0.0006339648,0.000083280385,0.000067319575,0.00022239768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046559545,0.00011401274,0.00019761303,0.00025425796,0.00015134166,0.00028177255,0.00022713646,0.00021474046,0.002288599],"category_scores_gemma":[0.0018033672,0.00007329851,0.00018282537,0.00024955353,0.00017107738,0.00017963945,0.00019804724,0.0003831904,0.0002396174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046915075,0.000029855864,0.9952982,0.0000080107675,0.000022341334,0.00012425942,0.000028668053,0.00008189432,0.00083297264,0.000011071794,0.000048529113,0.0030450237],"study_design_scores_gemma":[0.000009303431,0.00032450358,0.99813986,0.000003629318,0.000030215762,0.00073640543,0.00003404583,0.00020772606,0.0003572114,0.000022492513,0.00013278729,0.0000018474426],"about_ca_topic_score_codex":0.0006225428,"about_ca_topic_score_gemma":0.0010038294,"teacher_disagreement_score":0.002288599,"about_ca_system_score_codex":0.00020877061,"about_ca_system_score_gemma":0.00024571738,"threshold_uncertainty_score":0.007656157},"labels":[],"label_agreement":null},{"id":"W3165778820","doi":"10.1111/ejh.13671","title":"A descriptive cost‐analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high‐dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Victoria Hospital; Hôtel-Dieu de Québec; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University of Toronto; Université Laval; University of Alberta; Queen's University","funders":"","keywords":"Medicine; Clinical trial; Regimen; Multiple myeloma; Carfilzomib; Internal medicine; Dexamethasone; Lenalidomide","score_opus":0.12795554083561045,"score_gpt":0.42214811278364356,"score_spread":0.2941925719480331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165778820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9407356,0.0021728456,0.0024515686,0.00047119538,0.000028633844,0.001080191,0.049630336,0.000068255875,0.0033614687],"genre_scores_gemma":[0.9669325,0.0006609132,0.0017986783,0.00021872851,0.000021858932,0.0006526818,0.02834161,0.000024728983,0.0013482589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997523,0.0010624303,0.00024203319,0.00028026797,0.0005676285,0.0003246688],"domain_scores_gemma":[0.984937,0.009485428,0.0030250058,0.0004970926,0.0015323977,0.0005230441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043266555,0.00063477457,0.0012611463,0.0030558216,0.0003149546,0.0013321743,0.0010372585,0.0006686625,0.0041496907],"category_scores_gemma":[0.01337057,0.0005100056,0.00313628,0.00390418,0.00038215236,0.0007071526,0.0005599035,0.000831369,0.000287338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07068477,0.0036482164,0.55794805,0.003591173,0.018865691,0.001358354,0.00030959042,0.256333,0.0016494688,0.0064522587,0.024259668,0.054899693],"study_design_scores_gemma":[0.004952684,0.009423053,0.6648803,0.0004806799,0.006992521,0.0013787606,0.00086625054,0.29773724,0.0012693745,0.0024451786,0.009278754,0.0002952355],"about_ca_topic_score_codex":0.08924833,"about_ca_topic_score_gemma":0.076210774,"teacher_disagreement_score":0.08924833,"about_ca_system_score_codex":0.007795758,"about_ca_system_score_gemma":0.003999598,"threshold_uncertainty_score":0.17745769},"labels":[],"label_agreement":null},{"id":"W3170905114","doi":"10.1111/ejh.13678","title":"Retrospective study of treatment patterns and outcomes post‐lenalidomide for multiple myeloma in Canada","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; University of Alberta; Dalhousie University; Queen Elizabeth II Health Sciences Centre; University of Saskatchewan; Université de Montréal; Hôpital Maisonneuve-Rosemont; University of Calgary; Vancouver General Hospital; Princess Margaret Cancer Centre; Occupational Cancer Research Centre; CancerCare Manitoba; Ottawa Hospital; Institute of Cancer Research; McGill University; Canadian Institutes of Health Research","funders":"Celgene","keywords":"Lenalidomide; Daratumumab; Medicine; Salvage therapy; Bortezomib; Pomalidomide; Multiple myeloma; Carfilzomib; Internal medicine; Oncology; Autologous stem-cell transplantation; Ixazomib; Combination therapy; Dexamethasone; Maintenance therapy; Surgery; Chemotherapy","score_opus":0.02875396049537949,"score_gpt":0.2991474922586249,"score_spread":0.27039353176324543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170905114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913345,0.00060015323,0.0000828881,0.00013036437,0.0000067168603,0.00006674884,0.0060358397,0.0000137224415,0.0017290324],"genre_scores_gemma":[0.99583155,0.00043332955,0.000117043455,0.000103108505,0.000005656924,0.000027123418,0.002900191,0.00000928127,0.00057277124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876535,0.0000650305,0.00012927545,0.00024445084,0.00041961332,0.00037628497],"domain_scores_gemma":[0.9966634,0.0001394633,0.00090818945,0.000112588525,0.0015830663,0.0005933222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042246722,0.00036590468,0.0005108733,0.0019363352,0.0023791625,0.0009436439,0.0011962195,0.00044716324,0.0015979634],"category_scores_gemma":[0.0018967665,0.000456481,0.0005759271,0.0061715944,0.0006107803,0.0003186557,0.000783429,0.00055008073,0.0003098625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008383816,0.000021313412,0.9962441,0.000024749115,0.000036619123,0.00016418143,0.00023521089,0.00006256437,0.0001809787,0.000037647023,0.00049426395,0.0024145183],"study_design_scores_gemma":[0.0000075466805,0.000037722322,0.99797875,0.000015191697,0.000022639642,0.00020451819,0.00044209664,0.00012224013,0.00010349493,0.000009110599,0.0010473548,0.0000092735945],"about_ca_topic_score_codex":0.97629356,"about_ca_topic_score_gemma":0.9807372,"teacher_disagreement_score":0.02486549,"about_ca_system_score_codex":0.02486549,"about_ca_system_score_gemma":0.02683681,"threshold_uncertainty_score":0.18041265},"labels":[],"label_agreement":null},{"id":"W3182316807","doi":"10.1111/ejh.13689","title":"Effect of pre‐transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cumulative incidence; Myelofibrosis; Incidence (geometry); Internal medicine; CD34; Gastroenterology; Transplantation; Calcineurin; Tacrolimus; Surgery; Stem cell; Bone marrow","score_opus":0.009999089130386468,"score_gpt":0.2669885512672627,"score_spread":0.25698946213687623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182316807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994261,0.00032628214,0.000023599603,0.000023192038,0.0000031862016,0.0000017390215,0.00005680964,0.0000010628642,0.00013801287],"genre_scores_gemma":[0.99978095,0.00004650969,0.00001511751,0.0000119577935,0.0000058867276,0.000001495512,0.000093287264,4.0364023e-7,0.00004433049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998311,0.000055383083,0.000022484237,0.00002211723,0.00003220261,0.00003664007],"domain_scores_gemma":[0.99902534,0.00028986397,0.00040377377,0.000025489806,0.0000442749,0.00021124569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005048022,0.000093658695,0.00017387175,0.00020111573,0.0001527628,0.00026296012,0.00010059661,0.0001814245,0.0010792547],"category_scores_gemma":[0.0011284681,0.000044005716,0.00025141586,0.00016094848,0.0001159377,0.0001702611,0.00012755784,0.00030010578,0.0001214843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018209737,0.0001299894,0.9906481,0.000012709494,0.000053734995,0.00015821903,0.000028697006,0.00012617199,0.0005707492,0.0000151179065,0.000121307974,0.006314176],"study_design_scores_gemma":[0.000029142408,0.0010685937,0.997445,0.000008465393,0.000048531812,0.00048043425,0.000034855555,0.00026377445,0.00039507612,0.000025646248,0.0001978498,0.0000026197542],"about_ca_topic_score_codex":0.0003831144,"about_ca_topic_score_gemma":0.00090471614,"teacher_disagreement_score":0.0010792547,"about_ca_system_score_codex":0.00017554108,"about_ca_system_score_gemma":0.00013720176,"threshold_uncertainty_score":0.0036104918},"labels":[],"label_agreement":null},{"id":"W3196712864","doi":"10.1111/ejh.13705","title":"T cell–mediated autoimmunity in immune thrombocytopenia","year":2021,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"Health Canada; Government of Canada; Australian Government; Ministry of Health, Ontario; Canadian Blood Services; McMaster University","keywords":"Immune thrombocytopenia; Immunology; Autoimmunity; Autoantibody; Platelet; CD8; Medicine; Immune system; Cytotoxic T cell; T cell; Autoimmune thrombocytopenia; Biology; Antibody","score_opus":0.04948419544022473,"score_gpt":0.32872458900027757,"score_spread":0.2792403935600528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196712864","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008323333,0.9992041,0.00004302037,0.000096957796,0.0001352325,0.0000026860384,0.000009263621,0.0000038018513,0.0004216986],"genre_scores_gemma":[0.0005027029,0.9989642,0.0000568766,0.00010405418,0.000109842666,0.0000036355661,0.000014596829,5.4607574e-7,0.0002435623],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998659,0.00002517192,0.000025188632,0.000020820664,0.000050972485,0.000011946306],"domain_scores_gemma":[0.99977916,0.00010828669,0.000038756563,0.00000525744,0.000053453616,0.000015017787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034846953,0.0006520343,0.0010708934,0.0021197987,0.00017476483,0.00069603464,0.0004849122,0.0007849277,0.003048471],"category_scores_gemma":[0.0004956106,0.00020515648,0.00040940626,0.0018256016,0.00024196855,0.00062001235,0.00045163473,0.0010302077,0.0014246473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010612087,0.00007540124,0.00022256759,0.04435367,0.0001810342,0.00029329065,0.00006277555,0.00027703156,0.0020292422,0.0020815548,0.029759534,0.9205578],"study_design_scores_gemma":[0.000042386127,0.00017726983,0.0018256528,0.014688824,0.00038937954,0.0032060829,0.00006751602,0.000106872074,0.00064181484,0.0019054034,0.97692454,0.000024155634],"about_ca_topic_score_codex":0.0006781804,"about_ca_topic_score_gemma":0.001019012,"teacher_disagreement_score":0.003048471,"about_ca_system_score_codex":0.00035320132,"about_ca_system_score_gemma":0.0007175294,"threshold_uncertainty_score":0.010198176},"labels":[],"label_agreement":null},{"id":"W3197669971","doi":"10.1111/ejh.13706","title":"Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Fleurimont; Centre Hospitalier Universitaire de Sherbrooke; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"Bristol-Myers Squibb","keywords":"Medicine; Lenalidomide; Pomalidomide; Internal medicine; Hazard ratio; Bortezomib; Multiple myeloma; Dexamethasone; Clinical endpoint; Creatinine; Renal function; Gastroenterology; Progression-free survival; Surgery; Randomized controlled trial; Chemotherapy; Confidence interval","score_opus":0.03265644451244482,"score_gpt":0.3192080389079468,"score_spread":0.286551594395502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197669971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699926,0.0025126254,0.00010268506,0.000042499978,0.0000071099344,0.000054808523,0.00013487338,0.000004072893,0.0001419988],"genre_scores_gemma":[0.99911207,0.0002759936,0.00012633715,0.000058563604,0.000021428143,0.00003721024,0.00029386484,0.0000018178102,0.0000726173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912196,0.00043168914,0.00007989536,0.00015201698,0.0001376687,0.0000767832],"domain_scores_gemma":[0.9987149,0.00043343977,0.00047238093,0.00009907083,0.00006091888,0.0002191889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024237,0.00035718238,0.0011540393,0.00041580363,0.0001947368,0.00051189057,0.00035715615,0.00031557167,0.0009341603],"category_scores_gemma":[0.001461181,0.00020362141,0.0016208607,0.0004944967,0.000231074,0.00032523207,0.000398036,0.00053784234,0.00011847801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31565645,0.0018877522,0.58979243,0.00053825666,0.009526475,0.0000896035,0.00013030297,0.0015162462,0.0052331723,0.000089389956,0.00060067576,0.07493938],"study_design_scores_gemma":[0.025713606,0.045918826,0.9166441,0.00007609746,0.0052948,0.0004595908,0.00010557149,0.0023147627,0.0017061245,0.00021866037,0.0015161011,0.00003182286],"about_ca_topic_score_codex":0.000488858,"about_ca_topic_score_gemma":0.00090717623,"teacher_disagreement_score":0.0024237,"about_ca_system_score_codex":0.0005742977,"about_ca_system_score_gemma":0.0004863961,"threshold_uncertainty_score":0.012817919},"labels":[],"label_agreement":null},{"id":"W3201679150","doi":"10.1111/ejh.13714","title":"Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Cryopreservation; Medicine; Cyclophosphamide; Hematopoietic stem cell transplantation; Stem cell; Transplantation; Anti-thymocyte globulin; Cohort; Surgery; Incidence (geometry); Haematopoiesis; Internal medicine; Oncology; Chemotherapy; Biology","score_opus":0.03222355219946579,"score_gpt":0.27444041956172,"score_spread":0.2422168673622542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201679150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942446,0.00026825911,0.00006246672,0.00002193784,0.000003471729,0.0000024826572,0.000034807483,0.0000011923854,0.00018099617],"genre_scores_gemma":[0.99982184,0.000062177925,0.00002207025,0.000017003216,0.000004256317,0.0000011064494,0.000037300546,6.473057e-7,0.000033647302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996984,0.00006187126,0.00003146446,0.000049458828,0.000074588,0.00008420375],"domain_scores_gemma":[0.99908555,0.00019962135,0.000482751,0.000057539764,0.00006487497,0.00010966989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005212215,0.00010654422,0.00021125215,0.0003745406,0.00025037362,0.00046186158,0.00015198636,0.00014745539,0.0008714342],"category_scores_gemma":[0.0010146933,0.00006421046,0.00020995995,0.00048492855,0.000332441,0.00019617497,0.0002299908,0.00031624117,0.00008936664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030576452,0.000020621643,0.9948236,0.0000094813395,0.00003757811,0.0002748965,0.000049625156,0.00009136415,0.001372379,0.000032601165,0.00004848715,0.0029337427],"study_design_scores_gemma":[0.000005079575,0.0002843314,0.99616987,0.000013252895,0.000055333418,0.0015310223,0.00017833932,0.00023564915,0.0011250746,0.000060150927,0.00033883675,0.0000030565227],"about_ca_topic_score_codex":0.0019047653,"about_ca_topic_score_gemma":0.0028050654,"teacher_disagreement_score":0.0019047653,"about_ca_system_score_codex":0.00037759417,"about_ca_system_score_gemma":0.00037670502,"threshold_uncertainty_score":0.0037873983},"labels":[],"label_agreement":null},{"id":"W3205545929","doi":"10.1111/ejh.13717","title":"Use of midostaurin in mixed phenotype acute leukemia with <i>FLT3</i> mutation: A case series","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Midostaurin; Medicine; Discontinuation; Myeloid leukemia; Internal medicine; Oncology; Induction chemotherapy; Leukemia; Chemotherapy; Immunology","score_opus":0.03234183208156242,"score_gpt":0.27892429858555096,"score_spread":0.24658246650398855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205545929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883682,0.0040904586,0.0027503385,0.00062796404,0.00009147013,0.00010153656,0.00006808149,0.0001059717,0.0037960464],"genre_scores_gemma":[0.99726933,0.0009975792,0.0006797228,0.00030606202,0.0001322932,0.000018999808,0.000052656233,0.00001545596,0.00052780245],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99959487,0.000049737304,0.0000751569,0.00008682161,0.00007360287,0.00011973409],"domain_scores_gemma":[0.9991492,0.00020840323,0.00023409318,0.00011083561,0.00004242089,0.0002551044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021019751,0.00093485875,0.0006758145,0.00088664383,0.0012352355,0.0008344221,0.00059605576,0.0023885395,0.0013022994],"category_scores_gemma":[0.0011966468,0.0005033135,0.0008900656,0.0005348633,0.00095175224,0.0008716601,0.0007104612,0.0013988614,0.000607631],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018538455,0.00023031207,0.036428057,0.000069032496,0.0000523798,0.9473333,0.00036568023,0.00015335655,0.004923796,0.00015899679,0.00030569002,0.009793982],"study_design_scores_gemma":[0.000022043663,0.00023625967,0.008307585,0.0000108171525,0.000043779313,0.98743886,0.000087748085,0.00021821065,0.0025369911,0.0000682499,0.0010169225,0.00001250127],"about_ca_topic_score_codex":0.00063498516,"about_ca_topic_score_gemma":0.0007684265,"teacher_disagreement_score":0.0023885395,"about_ca_system_score_codex":0.00047871345,"about_ca_system_score_gemma":0.00043035747,"threshold_uncertainty_score":0.0043566227},"labels":[],"label_agreement":null},{"id":"W3211611146","doi":"10.1111/ejh.13726","title":"Kinetics of response to first‐ and second‐line therapies in multiple myeloma: Assessment by both M‐spikes and light chains","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Oncology; Medicine; Cohort; Multiple myeloma; Bortezomib; Internal medicine; Immunoglobulin light chain; Dexamethasone; Cyclophosphamide; Clearance; Melphalan; Complete response; Kinetics; Immunology; Chemotherapy; Urology; Antibody","score_opus":0.023104294104956746,"score_gpt":0.3006644771747745,"score_spread":0.2775601830698178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211611146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705553,0.0016063139,0.00067868916,0.000049074744,0.0000043400532,0.000008995947,0.00014812847,0.00001991378,0.0004289609],"genre_scores_gemma":[0.99930525,0.00019061679,0.00021080127,0.000015860656,0.000009007942,0.0000043512277,0.00013941566,0.0000054687803,0.00011918567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957377,0.00012012832,0.00006441889,0.00008643776,0.00010308216,0.00005216905],"domain_scores_gemma":[0.99726224,0.0009491307,0.001184178,0.00014799762,0.0002868262,0.00016956576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014262818,0.00014922017,0.00032956782,0.0010084357,0.00012286424,0.00048113603,0.00025246292,0.00029355637,0.00071290444],"category_scores_gemma":[0.0031300355,0.00010626307,0.00029232167,0.0005512037,0.00015677727,0.0005473345,0.00024628238,0.0002923144,0.00026740352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009784452,0.000039107865,0.96902645,0.000051077048,0.00008770391,0.00016567946,0.00009460228,0.0009274018,0.007342298,0.00005593498,0.00014630212,0.021085061],"study_design_scores_gemma":[0.0000146979555,0.00060275523,0.98757124,0.000012843697,0.00006659306,0.0019215059,0.000120289835,0.0024061399,0.006379437,0.00008561522,0.00081104826,0.000007778804],"about_ca_topic_score_codex":0.0006564129,"about_ca_topic_score_gemma":0.00050491723,"teacher_disagreement_score":0.0014262818,"about_ca_system_score_codex":0.00033215084,"about_ca_system_score_gemma":0.00021248987,"threshold_uncertainty_score":0.007542968},"labels":[],"label_agreement":null},{"id":"W4200189388","doi":"10.1111/ejh.13735","title":"Anti‐thymocyte Globulin and Post‐Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen‐A and ‐B mismatched donors","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cyclophosphamide; Internal medicine; Incidence (geometry); Immunology; Single Center; Gastroenterology; Transplantation; Anti-thymocyte globulin; Chemotherapy","score_opus":0.017022438706966903,"score_gpt":0.2681771097958236,"score_spread":0.2511546710888567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200189388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990501,0.000595714,0.000085089436,0.000011259909,0.00000645891,0.000004719553,0.000013284115,0.0000035641674,0.00022982145],"genre_scores_gemma":[0.99970204,0.00010826686,0.000053935884,0.000015869133,0.0000067886813,0.0000034894786,0.000032589334,7.300448e-7,0.00007622438],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998543,0.00005537349,0.000013751935,0.000014606756,0.00002359371,0.000038307735],"domain_scores_gemma":[0.9997471,0.00005773276,0.00008569976,0.000027489186,0.000006880153,0.00007512227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034542737,0.00011379573,0.00022863875,0.00012211717,0.00006289292,0.0001660657,0.00012598181,0.00010231731,0.0005407015],"category_scores_gemma":[0.00030897753,0.000052175692,0.0001518127,0.00009849215,0.00017099128,0.00010078865,0.00010486818,0.00020454475,0.000078626756],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03710822,0.005106494,0.32740414,0.00043767763,0.00077342824,0.0015743657,0.00016571378,0.0023802794,0.43363434,0.0009032867,0.0009459753,0.18956603],"study_design_scores_gemma":[0.00134539,0.054746523,0.85876137,0.000058503814,0.00035913577,0.004611471,0.00010089694,0.0015137465,0.07392541,0.00025086736,0.0043089124,0.000017683384],"about_ca_topic_score_codex":0.00014770348,"about_ca_topic_score_gemma":0.00061915227,"teacher_disagreement_score":0.0005407015,"about_ca_system_score_codex":0.000092941154,"about_ca_system_score_gemma":0.0001677199,"threshold_uncertainty_score":0.0018268228},"labels":[],"label_agreement":null},{"id":"W4200239384","doi":"10.1111/ejh.13733","title":"Poor outcome after hematopoietic stem cell transplantation of patients with unclassified inherited bone marrow failure syndromes","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Janeway Children's Health and Rehabilitation Centre; McMaster University; London Health Sciences Centre; McMaster Children's Hospital; University of Alberta; Centre hospitalier universitaire de Québec; Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke; Queen's University; Centre Hospitalier Universitaire Sainte-Justine; Health Sciences Centre; CancerCare Manitoba; Izaak Walton Killam Health Centre; Alberta Children's Hospital; Children's Hospital of Eastern Ontario; Princess Margaret Cancer Centre; University of Saskatchewan; Hospital for Sick Children; BC Children's Hospital; Montreal Children's Hospital; University of Toronto","funders":"","keywords":"Medicine; Cord blood; Hematopoietic stem cell transplantation; Transplantation; Stem cell; Bone marrow; Haematopoiesis; Internal medicine; Bone marrow failure; Surgery; Oncology; Biology","score_opus":0.01897387518674901,"score_gpt":0.2488259980760348,"score_spread":0.2298521228892858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200239384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995258,0.0002469211,0.000026248428,0.000019114885,0.0000030546944,0.0000020982518,0.000030984476,0.0000014250479,0.00014442253],"genre_scores_gemma":[0.9997763,0.000054835793,0.00001359009,0.0000145697795,0.000004773756,0.0000012094499,0.00010413103,3.801622e-7,0.000030163239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998528,0.00003627105,0.000011593897,0.000014578928,0.000028790535,0.000055902838],"domain_scores_gemma":[0.99946254,0.000094925104,0.00020231867,0.000021572014,0.000033034354,0.0001856191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002511281,0.0001855517,0.00019633515,0.00034609454,0.00027790136,0.00027469525,0.00013767,0.00018301357,0.00061221665],"category_scores_gemma":[0.0010175267,0.000047662463,0.00014393833,0.0003388237,0.00028427932,0.00015527925,0.00029246855,0.00021766644,0.00007741162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045881074,0.00002285389,0.9933634,0.000008960635,0.000032797558,0.0005349237,0.000061926985,0.000101842634,0.00048577596,0.00002989999,0.00011831056,0.0047804345],"study_design_scores_gemma":[0.000019394109,0.0002988707,0.9973647,0.000009307508,0.0000232417,0.0015599688,0.00011275266,0.00021555794,0.00014393241,0.000077626464,0.0001712382,0.0000035052797],"about_ca_topic_score_codex":0.0040997756,"about_ca_topic_score_gemma":0.005763473,"teacher_disagreement_score":0.0040997756,"about_ca_system_score_codex":0.00037798783,"about_ca_system_score_gemma":0.0003798373,"threshold_uncertainty_score":0.008151829},"labels":[],"label_agreement":null},{"id":"W4200300045","doi":"10.1111/ejh.13731","title":"Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Perioperative; Hemostasis; Von Willebrand disease; Thrombosis; Surgery; Prospective cohort study; Von Willebrand factor; Internal medicine","score_opus":0.038627378290777406,"score_gpt":0.3312029643355121,"score_spread":0.2925755860447347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200300045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96806,0.0030411733,0.001520781,0.00090490637,0.00006327692,0.0003250607,0.020730034,0.00008241745,0.0052723256],"genre_scores_gemma":[0.9728822,0.0015540969,0.004240236,0.00038627762,0.00008914497,0.00027974855,0.02021936,0.000017285001,0.00033162083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99581087,0.0011717264,0.001167194,0.0005045609,0.0010349742,0.00031070525],"domain_scores_gemma":[0.9792797,0.0038265735,0.011222164,0.0010740029,0.00288517,0.001712311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032748217,0.00022567331,0.0003111968,0.0040458157,0.00038490034,0.001179042,0.00065298355,0.0003221701,0.0014470925],"category_scores_gemma":[0.010893389,0.00024648182,0.00031959853,0.0045654248,0.00025423372,0.000998608,0.001060003,0.0004937224,0.0003470155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055738266,0.00004250875,0.98984015,0.000047096622,0.000037157533,0.0000509768,0.00007543854,0.00010028459,0.00009034203,0.00006587093,0.0009943492,0.008600079],"study_design_scores_gemma":[0.000020751813,0.00013583704,0.9930871,0.00016110508,0.000049110804,0.0006578323,0.00062930177,0.0010963,0.00033055295,0.00005425034,0.00376367,0.000014177227],"about_ca_topic_score_codex":0.006904911,"about_ca_topic_score_gemma":0.009400202,"teacher_disagreement_score":0.006904911,"about_ca_system_score_codex":0.0011764847,"about_ca_system_score_gemma":0.0025014873,"threshold_uncertainty_score":0.017319143},"labels":[],"label_agreement":null},{"id":"W4210777755","doi":"10.1111/ejh.13750","title":"Allogeneic hematopoietic stem cell transplantation in patients with therapy‐related hematologic malignancies developing after multiple myeloma","year":2022,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Hematopoietic stem cell transplantation; Transplantation; Oncology; Monosomy; Population; Cohort; Gastroenterology; Karyotype; Chromosome; Biology","score_opus":0.017251799663774423,"score_gpt":0.23133553108340002,"score_spread":0.2140837314196256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210777755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998466,0.0008345307,0.0000901588,0.00005953748,0.000011343308,0.000011898141,0.00009170025,0.000004308946,0.0004304882],"genre_scores_gemma":[0.999458,0.00024495393,0.00006235526,0.000032586417,0.000024811701,0.0000044267867,0.00012169962,8.0674613e-7,0.000050419832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998148,0.000054122578,0.000020236825,0.000026249809,0.00003946336,0.00004518227],"domain_scores_gemma":[0.99934536,0.0001691734,0.00030440878,0.000020567146,0.000028423729,0.00013206486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035226915,0.00017348291,0.00027994768,0.0005130121,0.0003248475,0.00039501727,0.00016953517,0.0002852801,0.0012496606],"category_scores_gemma":[0.001027991,0.00009522903,0.00020151846,0.00066561444,0.00023152301,0.00026214283,0.00020076225,0.000378368,0.0001409559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025817213,0.000030274668,0.99324787,0.00001577387,0.000026134856,0.0017811678,0.00004415899,0.000058834394,0.00044431735,0.000019939735,0.00012378485,0.0039495495],"study_design_scores_gemma":[0.00007358659,0.0008727692,0.97164524,0.00003402611,0.000090935966,0.024432886,0.00028896937,0.0005729249,0.00067855313,0.00012478238,0.0011783789,0.0000069298926],"about_ca_topic_score_codex":0.0005637513,"about_ca_topic_score_gemma":0.0008487712,"teacher_disagreement_score":0.0012496606,"about_ca_system_score_codex":0.00017618819,"about_ca_system_score_gemma":0.00032840733,"threshold_uncertainty_score":0.0041805506},"labels":[],"label_agreement":null},{"id":"W4210818981","doi":"10.1111/ejh.13752","title":"Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real‐world outcomes from a population‐based cohort","year":2022,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Incidence (geometry); Population; Residence; Demography; Socioeconomic status; Cohort; Rural area; Pediatrics; Gerontology; Internal medicine; Environmental health; Pathology","score_opus":0.014123140668207213,"score_gpt":0.2765303402350199,"score_spread":0.2624071995668127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210818981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963574,0.00024063454,0.000081948565,0.000116699666,0.00001045187,0.00002199969,0.0027680204,0.0000034036095,0.0003993879],"genre_scores_gemma":[0.99727577,0.00022094234,0.000060378086,0.00005676033,0.000016773585,0.000028890208,0.0022216265,0.0000020776504,0.00011683297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994506,0.00011903114,0.000101478,0.00012563012,0.000102850296,0.00010035115],"domain_scores_gemma":[0.998703,0.0000726143,0.0007605665,0.0000998898,0.00016037402,0.00020353106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081027416,0.00026284507,0.00032225857,0.0008319007,0.0004582668,0.0007924213,0.0003423476,0.0004279583,0.0014575238],"category_scores_gemma":[0.0024352577,0.0002496268,0.0005471303,0.0013311438,0.0002362448,0.00087811693,0.00094369694,0.0006841642,0.0003299979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041277017,0.000022091637,0.99901986,0.000009167951,0.00005872127,0.00003032604,0.000070060065,0.000025899788,0.000039026883,0.0000121147805,0.0001929812,0.00047863027],"study_design_scores_gemma":[0.00000679564,0.00004115395,0.9992562,0.00001043323,0.000021571776,0.000110220055,0.00021049482,0.00009780017,0.0000146114035,0.000013794394,0.0002134071,0.00000348382],"about_ca_topic_score_codex":0.01155754,"about_ca_topic_score_gemma":0.011462668,"teacher_disagreement_score":0.01155754,"about_ca_system_score_codex":0.00037894232,"about_ca_system_score_gemma":0.0003341967,"threshold_uncertainty_score":0.02298057},"labels":[],"label_agreement":null},{"id":"W4220983498","doi":"10.1111/ejh.13762","title":"Systematic review of hematuria and acute renal failure with tranexamic acid","year":2022,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Pediatric Urology and Nephrology Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Mount Sinai Hospital; Foothills Medical Centre; University of Toronto; University of Calgary; St. Michael's Hospital","funders":"","keywords":"Medicine; Tranexamic acid; Randomized controlled trial; Urinary system; Surgery; Placebo; Renal function; Internal medicine; Urology; Pathology","score_opus":0.020828849043925263,"score_gpt":0.2812728447252225,"score_spread":0.2604439956812973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220983498","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076988025,0.9982975,0.000085031825,0.00013023156,0.000084188934,0.0002351508,0.0002162923,0.0000070663373,0.00017467859],"genre_scores_gemma":[0.009960939,0.98848814,0.0004792399,0.0003231701,0.0000712638,0.0004134331,0.00014340873,0.0000039280185,0.00011641637],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9947784,0.0018520314,0.0019964043,0.00033630678,0.0008820983,0.00015478855],"domain_scores_gemma":[0.98493505,0.0096316505,0.0037998199,0.00020661438,0.0012378138,0.00018911407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047297585,0.0013695576,0.008550287,0.0083200345,0.00055464986,0.0020379587,0.0016259188,0.0013181336,0.004837428],"category_scores_gemma":[0.020024428,0.00084812444,0.0057555297,0.008670721,0.00073505566,0.0016838154,0.0011832566,0.0008908012,0.00026827506],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012776213,0.000009018963,0.0003404616,0.9719568,0.0061531714,0.000076804405,0.00008301036,0.000052775114,0.00010266485,0.000119965116,0.0010164975,0.019961217],"study_design_scores_gemma":[0.00039030032,0.0003186731,0.004498966,0.8797443,0.09097647,0.0006016316,0.00020653661,0.00010039053,0.00019902668,0.0002913097,0.022634003,0.000038493516],"about_ca_topic_score_codex":0.007332403,"about_ca_topic_score_gemma":0.02058717,"teacher_disagreement_score":0.008550287,"about_ca_system_score_codex":0.002813991,"about_ca_system_score_gemma":0.009144642,"threshold_uncertainty_score":0.025013685},"labels":[],"label_agreement":null},{"id":"W4221007142","doi":"10.1111/ejh.13769","title":"Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first‐line systemic treatment or best supportive care: A multicenter international study","year":2022,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"AbbVie","keywords":"Medicine; Myeloid leukemia; Intensive care medicine; Chemotherapy; Health care; Internal medicine","score_opus":0.041475496076281045,"score_gpt":0.33796020609165556,"score_spread":0.2964847100153745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221007142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99844235,0.000298208,0.00004369819,0.00004749314,0.000002601557,0.000009710806,0.0009184424,0.000002915985,0.00023446538],"genre_scores_gemma":[0.9987319,0.00015043354,0.00006955051,0.00002990443,0.0000069135567,0.000013208723,0.0009648354,0.0000014874829,0.00003182909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991767,0.0002595436,0.00017015799,0.00018077606,0.00011127799,0.000101500606],"domain_scores_gemma":[0.9965237,0.00044986603,0.002320174,0.0001301947,0.00028109,0.00029498799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008909213,0.00017701565,0.00037112762,0.0014568056,0.00031540325,0.0007535675,0.0003627097,0.0003289648,0.00089273084],"category_scores_gemma":[0.0026555578,0.00019193887,0.0004406191,0.0026013027,0.00026437268,0.0007511074,0.0004175036,0.00042904113,0.00014441015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002925131,0.000012179569,0.99934274,0.00000616159,0.000024677429,0.000019046356,0.000045559693,0.000023699211,0.000026946465,0.00000572356,0.00004943619,0.00041462286],"study_design_scores_gemma":[0.000004300097,0.00006324227,0.9992065,0.0000087269555,0.0000154679,0.00012624059,0.00024115492,0.00012745682,0.000030523748,0.0000045101774,0.00016853881,0.0000032893636],"about_ca_topic_score_codex":0.0086675,"about_ca_topic_score_gemma":0.008477115,"teacher_disagreement_score":0.0086675,"about_ca_system_score_codex":0.0005961537,"about_ca_system_score_gemma":0.00046736613,"threshold_uncertainty_score":0.017234087},"labels":[],"label_agreement":null},{"id":"W4223439915","doi":"10.1111/ejh.13774","title":"Important questions for the malignant hematologist to consider when designing or evaluating a study with patient‐reported outcome measures (<scp>PROMs</scp>)","year":2022,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Hospital","funders":"","keywords":"Patient-reported outcome; Hematologist; Medicine; Quality of life (healthcare); Cancer; MEDLINE; Health care; Medical physics; Physical therapy; Pathology; Nursing; Disease","score_opus":0.301061035879106,"score_gpt":0.42186651440669853,"score_spread":0.12080547852759255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223439915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010675221,0.82329005,0.0050103255,0.15995006,0.0070145247,0.0012575552,0.0006106347,0.000054912114,0.0017444104],"genre_scores_gemma":[0.03013069,0.71940535,0.095519,0.12782753,0.012259946,0.011653237,0.0008732554,0.00011783396,0.0022131943],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8308823,0.123163596,0.031506695,0.0031640437,0.010453057,0.0008302905],"domain_scores_gemma":[0.26283985,0.68878174,0.025409412,0.0054423446,0.016124656,0.0014019795],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21322636,0.0010752794,0.0069235833,0.0034999629,0.0017060767,0.006161544,0.0031325372,0.009033669,0.01030369],"category_scores_gemma":[0.52306235,0.0010557324,0.004677396,0.007086715,0.0044209757,0.014139878,0.0022556945,0.006537524,0.0016444088],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008728481,0.00015582844,0.0050198315,0.34722364,0.005070578,0.0007542759,0.0034953968,0.00050223235,0.00068549975,0.02305992,0.108785965,0.5043739],"study_design_scores_gemma":[0.0011541442,0.0003750962,0.00795303,0.52771616,0.0070902705,0.0016185021,0.0045303963,0.0006948611,0.00045527972,0.0643999,0.38377586,0.00023647299],"about_ca_topic_score_codex":0.0027634744,"about_ca_topic_score_gemma":0.008484241,"teacher_disagreement_score":0.7867736,"about_ca_system_score_codex":0.002950675,"about_ca_system_score_gemma":0.018612113,"threshold_uncertainty_score":0.97023195},"labels":[],"label_agreement":null},{"id":"W4224030651","doi":"10.1111/ejh.13779","title":"Validation of the <scp>HScore</scp> and the <scp>HLH</scp>‐2004 diagnostic criteria for the diagnosis of hemophagocytic lymphohistiocytosis in a multicenter cohort","year":2022,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Hemophagocytic lymphohistiocytosis; Context (archaeology); Etiology; Cutoff; Internal medicine; Immunology; Disease","score_opus":0.022165643548159423,"score_gpt":0.28573249269383,"score_spread":0.2635668491456706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224030651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976615,0.00013161231,0.00050640537,0.00007333458,0.000012700447,0.00012842639,0.00062427076,0.000016426104,0.0008453027],"genre_scores_gemma":[0.99655294,0.00003655942,0.00115905,0.00007293495,0.000013716466,0.00007793684,0.0018305575,0.0000064299556,0.0002498986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976507,0.0006784528,0.00021064139,0.0003631551,0.0008393207,0.00025780572],"domain_scores_gemma":[0.993437,0.0010140083,0.0018735233,0.00057495706,0.0024773707,0.0006231873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057844683,0.000687923,0.00039101273,0.0011006681,0.000652011,0.00086630497,0.000943894,0.0007322758,0.000724994],"category_scores_gemma":[0.010480898,0.00023979979,0.00056838465,0.00062663143,0.00078392046,0.0003374331,0.00081981684,0.00057097763,0.00046686165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023210376,0.00005176629,0.9965862,0.000011223027,0.00004912941,0.000054230066,0.00006717622,0.00022607934,0.00066703645,0.000029505982,0.00024154267,0.0017840066],"study_design_scores_gemma":[0.00003973299,0.00016035256,0.9974196,0.00001509156,0.000029187837,0.00024703488,0.00009194628,0.0010261679,0.000555956,0.0000188762,0.00039115627,0.000004979118],"about_ca_topic_score_codex":0.080252185,"about_ca_topic_score_gemma":0.119399,"teacher_disagreement_score":0.080252185,"about_ca_system_score_codex":0.0026613974,"about_ca_system_score_gemma":0.0030648836,"threshold_uncertainty_score":0.1595701},"labels":[],"label_agreement":null},{"id":"W4229451231","doi":"10.1111/ejh.13786","title":"Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review","year":2022,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Tumor lysis syndrome; Hematology; Malignancy; Adverse effect; Incidence (geometry); Internal medicine; Hematologic malignancy; Oncology; Tyrosine kinase; Chemotherapy","score_opus":0.04386186007752226,"score_gpt":0.3017999458061116,"score_spread":0.25793808572858934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229451231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020635665,0.99928707,0.00002462314,0.00015834789,0.00008503076,0.000017249595,0.00004189975,0.0000022108939,0.00017722862],"genre_scores_gemma":[0.0018400204,0.9975795,0.000104239974,0.0002100755,0.00011519742,0.000028089113,0.000044534798,7.681849e-7,0.00007755239],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9987828,0.00025314098,0.0005063424,0.0001046344,0.000296089,0.00005690067],"domain_scores_gemma":[0.99311686,0.0042490005,0.0016197271,0.00006549081,0.00084591645,0.00010312391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018767606,0.00082287355,0.0024790873,0.009772611,0.00042270508,0.0014037425,0.00086250337,0.0013217172,0.0035102253],"category_scores_gemma":[0.006427515,0.00037163388,0.0024243963,0.009311425,0.00042511395,0.0016202042,0.0007258955,0.00077762234,0.00038248493],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024667173,0.000052593874,0.001618928,0.7239574,0.0019097058,0.00046056052,0.00023980837,0.0001958351,0.00060565467,0.0008455749,0.012874066,0.25699323],"study_design_scores_gemma":[0.00014986673,0.00037540664,0.008611109,0.7363721,0.021189036,0.0043763407,0.0004401313,0.00016441471,0.00049418793,0.0011997607,0.22657086,0.00005678131],"about_ca_topic_score_codex":0.0020177152,"about_ca_topic_score_gemma":0.0040769977,"teacher_disagreement_score":0.009772611,"about_ca_system_score_codex":0.0013082107,"about_ca_system_score_gemma":0.00487632,"threshold_uncertainty_score":0.01174289},"labels":[],"label_agreement":null},{"id":"W4240708520","doi":"10.1111/ejh.12579","title":"Foreword","year":2015,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Stichting Haemophilia; Novo Nordisk Fonden","keywords":"Haemophilia; Medicine; Psychosocial; Life expectancy; Presentation (obstetrics); Quality of life (healthcare); Haemophilia A; Health care; Session (web analytics); Family medicine; Pediatrics; Nursing; Psychiatry; Surgery; Population","score_opus":0.0945526178501564,"score_gpt":0.34220438884995585,"score_spread":0.24765177099979946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240708520","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00086966046,0.009233171,0.0026884172,0.06598996,0.14606439,0.0003888202,0.002869323,0.0013244196,0.7705718],"genre_scores_gemma":[0.0041700737,0.00552352,0.0013302774,0.029532528,0.019520756,0.0002447491,0.002410645,0.00089881895,0.9363686],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99834466,0.00029216037,0.00012717406,0.00028296773,0.0007592198,0.00019381099],"domain_scores_gemma":[0.99692744,0.00054037274,0.00014021463,0.00024914613,0.0014134549,0.00072944514],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013187208,0.001028663,0.00089845405,0.00121173,0.0022531096,0.0058903736,0.0019102778,0.0042291107,0.62072176],"category_scores_gemma":[0.009033238,0.0003515976,0.00076688087,0.00106735,0.0009268691,0.0045824,0.0032535829,0.004860717,0.5761231],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002281526,0.00001889881,0.000050585968,0.00013661782,0.0000023241134,0.00008526095,0.000078090685,0.00001558478,0.00010667401,0.0038917405,0.95025814,0.045333266],"study_design_scores_gemma":[0.0000032636844,0.0000099739955,0.00006316072,0.000088302746,9.628388e-7,0.00011329791,0.00007060899,0.000007326949,0.00003589589,0.00087766146,0.99872714,0.000002290648],"about_ca_topic_score_codex":0.0013116465,"about_ca_topic_score_gemma":0.0017200911,"teacher_disagreement_score":0.37927824,"about_ca_system_score_codex":0.0015660132,"about_ca_system_score_gemma":0.0029452299,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4250808196","doi":"10.1111/ejh.12951","title":"Issue Information","year":2018,"lang":"en","type":"paratext","venue":"European Journal Of Haematology","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health","keywords":"Citation; Computer science; Information retrieval; Library science; World Wide Web; Internet privacy","score_opus":0.017971164148900334,"score_gpt":0.3059243906027594,"score_spread":0.28795322645385907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250808196","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025536527,0.0014674062,0.00041290757,0.0023622902,0.017515268,0.00026867667,0.006245428,0.0013348346,0.9701379],"genre_scores_gemma":[0.0008640057,0.000859466,0.00026082862,0.0012430574,0.0028978458,0.00006547136,0.003504515,0.0004430126,0.98986185],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877816,0.00012336673,0.00008185333,0.00019987689,0.0006719802,0.00014476624],"domain_scores_gemma":[0.9971277,0.00032790884,0.00018332672,0.00029869427,0.0010551696,0.0010072802],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010795,0.0016154227,0.001400743,0.0032221244,0.0018832164,0.008631866,0.0017651477,0.002244826,0.9219986],"category_scores_gemma":[0.0048014037,0.00063318154,0.000996217,0.002820461,0.00063371885,0.0051402594,0.0026787415,0.0022489373,0.87205875],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017426997,0.000022430826,0.000047982252,0.00010906571,0.0000016849741,0.000022331127,0.000009361534,0.000017113787,0.00007324811,0.0009932502,0.96698785,0.031698335],"study_design_scores_gemma":[0.0000072570942,0.000008909692,0.00020131594,0.00006514589,8.576301e-7,0.000038209044,0.000021004225,0.00002102511,0.000028857658,0.0003655866,0.9992387,0.0000031733541],"about_ca_topic_score_codex":0.0017605853,"about_ca_topic_score_gemma":0.00297253,"teacher_disagreement_score":0.07800138,"about_ca_system_score_codex":0.001004467,"about_ca_system_score_gemma":0.0016091197,"threshold_uncertainty_score":0.1112594},"labels":[],"label_agreement":null},{"id":"W4283746005","doi":"10.1111/ejh.13824","title":"Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals","year":2022,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Irish Research eLibrary","keywords":"Medicine; Internal medicine; CD38; Stage (stratigraphy); Cohort; Gastroenterology; Biology","score_opus":0.017552632825233675,"score_gpt":0.27480311968981974,"score_spread":0.25725048686458607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283746005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99954647,0.00013786372,0.000053860775,0.000009003847,0.00000291931,0.0000016890015,0.000058251997,0.0000020015332,0.00018777399],"genre_scores_gemma":[0.9997296,0.000044134005,0.000028921246,0.000004332512,0.000005528804,0.000001693211,0.000113454786,6.6975105e-7,0.000071640665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998111,0.000043869117,0.000025401654,0.000034735443,0.00003718709,0.000047723493],"domain_scores_gemma":[0.9988888,0.00035776146,0.00045826996,0.000057832796,0.000064673804,0.00017260003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037037654,0.00017958875,0.00026530743,0.00050666224,0.00025880983,0.0005904008,0.00021195224,0.00027913612,0.0012355902],"category_scores_gemma":[0.0013942609,0.00014444155,0.00021006969,0.00038650862,0.00019709648,0.0003438414,0.0002861237,0.00027679213,0.00020841956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023953982,0.000015824306,0.996802,0.000005330966,0.000010000205,0.00012799187,0.000031655207,0.00003510588,0.0007364114,0.000006421462,0.000026291536,0.0019635682],"study_design_scores_gemma":[0.000009649863,0.000121533136,0.9981346,0.0000029025587,0.00001909154,0.0010462909,0.0000733334,0.00017501073,0.00023287066,0.000014369702,0.00016685727,0.0000034289396],"about_ca_topic_score_codex":0.0010952401,"about_ca_topic_score_gemma":0.0019632024,"teacher_disagreement_score":0.0012355902,"about_ca_system_score_codex":0.00020098347,"about_ca_system_score_gemma":0.00015547451,"threshold_uncertainty_score":0.0041335225},"labels":[],"label_agreement":null},{"id":"W4293312760","doi":"10.1111/ejh.13850","title":"Patient age and donor <scp>HLA</scp> matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups","year":2022,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University Health Network; University of Toronto; Hamilton Health Sciences; Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Confidence interval; Hematopoietic stem cell transplantation; Cohort; Human leukocyte antigen; Transplantation; Multivariate analysis; Oncology; Propensity score matching; Myeloid; Framingham Risk Score; Recursive partitioning; Scoring system; Immunology; Disease; Antigen","score_opus":0.01038637672080116,"score_gpt":0.2225755609359384,"score_spread":0.21218918421513722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293312760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986167,0.00044595325,0.00039290998,0.000043344528,0.000009379965,0.0000038571375,0.00011365601,0.0000047029334,0.00036952904],"genre_scores_gemma":[0.99946207,0.00010385566,0.00018768563,0.000015438533,0.000019733532,0.0000022097843,0.00015489655,0.0000017374444,0.000052437492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995628,0.00018255325,0.00005702907,0.00006642856,0.00008472699,0.000046460576],"domain_scores_gemma":[0.9961492,0.0017811473,0.0013949528,0.00023657014,0.0001855623,0.00025255297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015346666,0.0002555226,0.0002066444,0.00050082017,0.00011907887,0.00040451717,0.00018230993,0.00024992807,0.0016031761],"category_scores_gemma":[0.004674278,0.000063233,0.0002561798,0.00054886495,0.00023704894,0.00034368428,0.00023462612,0.00031380187,0.00037044717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021344624,0.000009091241,0.9946595,0.000007110851,0.000034233042,0.000019947975,0.000013827062,0.000115307914,0.00026705675,0.000016652904,0.00006888476,0.0045749284],"study_design_scores_gemma":[0.00001315614,0.00022465023,0.99665713,0.000011508481,0.00008520632,0.000421484,0.000039101324,0.0014619441,0.0005527283,0.00018153405,0.00034659405,0.000004978824],"about_ca_topic_score_codex":0.00031918898,"about_ca_topic_score_gemma":0.00043438177,"teacher_disagreement_score":0.0016031761,"about_ca_system_score_codex":0.00011251946,"about_ca_system_score_gemma":0.0001535009,"threshold_uncertainty_score":0.008116186},"labels":[],"label_agreement":null},{"id":"W4297909302","doi":"10.1111/ejh.13867","title":"The association of age and adverse events of <scp>PEG</scp>‐asparaginase in a pediatric tertiary care hospital; a retrospective review","year":2022,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Asparaginase; Pediatrics; Adverse effect; Retrospective cohort study; Population; Pancreatitis; Incidence (geometry); Internal medicine","score_opus":0.015411260933298978,"score_gpt":0.30008074341351026,"score_spread":0.2846694824802113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297909302","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95900756,0.038483996,0.00017800277,0.00014054922,0.000017742628,0.000063545944,0.001275384,0.000007265633,0.00082600245],"genre_scores_gemma":[0.9843523,0.014650762,0.000213028,0.00009395145,0.000035366553,0.00004451444,0.0005343394,0.0000023682637,0.00007345101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893004,0.00021549144,0.00031386816,0.00016448002,0.00029779252,0.00007820766],"domain_scores_gemma":[0.9944944,0.0010665087,0.0036548623,0.0001125699,0.0004697154,0.00020193771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091174454,0.00016024667,0.00040273412,0.0015512103,0.00030398462,0.0005122596,0.00033117633,0.00022456513,0.000703572],"category_scores_gemma":[0.002961995,0.00020083712,0.00043842362,0.002752445,0.00026210884,0.00037727936,0.0002984836,0.00026935534,0.00008789941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049118502,0.000009009957,0.9949531,0.00040652245,0.00009887176,0.00048696235,0.00008937023,0.000018940646,0.00007840174,0.000015900356,0.00020817046,0.003585607],"study_design_scores_gemma":[0.0000066418384,0.00010796762,0.9934255,0.00024277199,0.00020864901,0.003846112,0.00046412236,0.00007277841,0.0001440393,0.000010565374,0.0014651521,0.0000057539005],"about_ca_topic_score_codex":0.006614077,"about_ca_topic_score_gemma":0.008060181,"teacher_disagreement_score":0.006614077,"about_ca_system_score_codex":0.0006979576,"about_ca_system_score_gemma":0.0012885027,"threshold_uncertainty_score":0.013151169},"labels":[],"label_agreement":null},{"id":"W4319060525","doi":"10.1111/ejh.13940","title":"Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Internal medicine; Medicine; NPM1; Myeloid leukemia; Cytogenetics; Hematopoietic stem cell transplantation; Transplantation; Oncology; Leukemia; Myeloid; Chemotherapy; Gastroenterology; Karyotype; Biology; Chromosome; Gene; Genetics","score_opus":0.009969441528545939,"score_gpt":0.2745431104625056,"score_spread":0.26457366893395967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319060525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938715,0.00025952846,0.000033927572,0.000018016666,0.000002131139,0.0000021354704,0.00009138307,0.0000013702652,0.00020429103],"genre_scores_gemma":[0.9997421,0.000051656774,0.00001808869,0.00001071705,0.0000052018668,0.0000012622755,0.00014961901,4.9171507e-7,0.000020906424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975187,0.00004609103,0.000041460036,0.000047871268,0.000056854282,0.000055838802],"domain_scores_gemma":[0.99882406,0.00020648855,0.0005882536,0.000041379237,0.000091131216,0.00024882416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036223006,0.00014202432,0.00023495138,0.0004959244,0.00017970831,0.00034715596,0.00016642697,0.00018867815,0.00081013096],"category_scores_gemma":[0.0014400169,0.000067545276,0.00018323271,0.0005389081,0.00021337974,0.0002388765,0.0002700092,0.00021952619,0.00010545169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017432478,0.000011906428,0.99759513,0.0000056004073,0.000017164808,0.00024639597,0.000017907569,0.000055029992,0.00026265508,0.000013801046,0.00004907565,0.00155093],"study_design_scores_gemma":[0.0000074007635,0.00013676309,0.9973175,0.000007975666,0.000028088081,0.0018595372,0.00007946546,0.00021707035,0.00015965014,0.000034820536,0.00014937221,0.0000025399859],"about_ca_topic_score_codex":0.0008600303,"about_ca_topic_score_gemma":0.0011695191,"teacher_disagreement_score":0.0008600303,"about_ca_system_score_codex":0.00026250823,"about_ca_system_score_gemma":0.00019716265,"threshold_uncertainty_score":0.002710104},"labels":[],"label_agreement":null},{"id":"W4320857106","doi":"10.1111/ejh.13944","title":"<scp>VEXAS</scp> syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation","year":2023,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Bone marrow; Bone marrow aspirate; Myeloid cells; Myeloid; Pathology; Medicine; Biopsy; Cancer research","score_opus":0.05765889196432333,"score_gpt":0.3295710321045395,"score_spread":0.27191214014021614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320857106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20219572,0.788177,0.0020709892,0.00096056826,0.00025692218,0.000060133872,0.0004919087,0.00017674598,0.005610126],"genre_scores_gemma":[0.557342,0.43582374,0.0030458884,0.0012630203,0.00036602144,0.00004101989,0.0010147521,0.000041600346,0.0010618893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992078,0.00012644594,0.00024315492,0.00011274212,0.0002516297,0.000058324073],"domain_scores_gemma":[0.9980476,0.0006339367,0.0005928699,0.000064606276,0.00048570466,0.0001753891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009283738,0.00054291985,0.00040377548,0.0049715964,0.00040293593,0.0006532522,0.0007698412,0.0005105449,0.00080572267],"category_scores_gemma":[0.0022853785,0.00028910048,0.00026929012,0.0032654994,0.00063927035,0.0007767066,0.00046691348,0.00035295996,0.00051428995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049102644,0.00009129368,0.24963193,0.0097191725,0.0004987418,0.24105206,0.0013716134,0.0006481336,0.034201235,0.0005559086,0.017669048,0.44406983],"study_design_scores_gemma":[0.00002014592,0.00015127695,0.18654963,0.0026947171,0.00031033976,0.7482579,0.0010135963,0.0002500511,0.0052292235,0.00023988816,0.055242464,0.000040776416],"about_ca_topic_score_codex":0.002306874,"about_ca_topic_score_gemma":0.003126263,"teacher_disagreement_score":0.0049715964,"about_ca_system_score_codex":0.00041464152,"about_ca_system_score_gemma":0.000617185,"threshold_uncertainty_score":0.004909754},"labels":[],"label_agreement":null},{"id":"W4360946230","doi":"10.1111/ejh.13969","title":"Fatigue and health‐related quality of life in paroxysmal nocturnal haemoglobinuria: A post hoc analysis of the pegcetacoplan <scp>PEGASUS</scp> trial data","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University Health Network","funders":"Swedish Orphan Biovitrum","keywords":"Medicine; Minimal clinically important difference; Quality of life (healthcare); Internal medicine; Physical therapy; Post-hoc analysis; Randomized controlled trial","score_opus":0.14049709640977695,"score_gpt":0.34853498259522875,"score_spread":0.2080378861854518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360946230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98961824,0.0032560944,0.0006193002,0.000323978,0.00016204701,0.0008561605,0.0038589295,0.00005045358,0.0012547115],"genre_scores_gemma":[0.9922901,0.0004739466,0.0005629224,0.00020247693,0.00017702879,0.0016348249,0.003019409,0.000046452064,0.0015929204],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9928767,0.004979646,0.00036416965,0.00070408976,0.00043254715,0.0006427082],"domain_scores_gemma":[0.99012345,0.006210213,0.0015479184,0.0009962064,0.00047941922,0.0006428261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010892716,0.0013738143,0.0037247986,0.00046613437,0.00035061853,0.0013453369,0.0009921456,0.0010594578,0.0061694128],"category_scores_gemma":[0.008922981,0.0004364567,0.007934765,0.000590324,0.00063000625,0.0012657619,0.00067347963,0.0023248773,0.0004853161],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9044993,0.0020126652,0.033692557,0.0015394767,0.03492274,0.00024817133,0.00014965511,0.002080448,0.0024709478,0.00015571111,0.0035015177,0.014726884],"study_design_scores_gemma":[0.30638438,0.15214223,0.4607457,0.0003247436,0.05742794,0.00064954883,0.00027813425,0.010706444,0.0036953252,0.00080872665,0.006647581,0.00018920226],"about_ca_topic_score_codex":0.0009906003,"about_ca_topic_score_gemma":0.002014043,"teacher_disagreement_score":0.010892716,"about_ca_system_score_codex":0.0006581048,"about_ca_system_score_gemma":0.0012280698,"threshold_uncertainty_score":0.057606876},"labels":[],"label_agreement":null},{"id":"W4375955180","doi":"10.1111/ejh.13982","title":"<scp>PD‐L1</scp> expression predicts efficacy in the phase <scp>II SPiReL</scp> trial with <scp>MVP‐S</scp>, pembrolizumab, and low‐dose <scp>CPA</scp> in R/R <scp>DLBCL</scp>","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Health Sciences Centre; Sunnybrook Hospital; Baker Hughes (Canada); McGill University Health Centre; Sunnybrook Health Science Centre","funders":"Merck","keywords":"Medicine; Pembrolizumab; Internal medicine; Population; Oncology; Discontinuation; Gastroenterology; Immunotherapy; Cancer","score_opus":0.034535795403372906,"score_gpt":0.31449901093513066,"score_spread":0.27996321553175774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375955180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987079,0.00035308936,0.00007670696,0.0001197437,0.000008546372,0.000066691144,0.00026732715,0.000013213533,0.00038672803],"genre_scores_gemma":[0.99853826,0.00008355455,0.0001599041,0.00007187551,0.000023855551,0.000059188846,0.000845229,0.0000035991018,0.0002146621],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99958366,0.00023887372,0.000021833897,0.000056856214,0.000042394266,0.000056340796],"domain_scores_gemma":[0.99905807,0.0002868214,0.00024581217,0.000048169764,0.00004760594,0.00031349194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002023996,0.00052375696,0.00053448573,0.00024083292,0.00021449797,0.00095251016,0.00033489932,0.00043774775,0.002016984],"category_scores_gemma":[0.0012813275,0.00021840233,0.0005555493,0.00017844731,0.00037352456,0.00043496682,0.0002929296,0.0011200871,0.00036686996],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3460158,0.0067664315,0.54100156,0.00048076728,0.0019753205,0.00026747352,0.00019559468,0.005552483,0.023113392,0.00020139574,0.005250867,0.069178924],"study_design_scores_gemma":[0.054471843,0.09079499,0.8186034,0.000089994675,0.0020037438,0.0011322831,0.00014454064,0.018710721,0.009933057,0.00034731245,0.0037101253,0.000058077007],"about_ca_topic_score_codex":0.00033710833,"about_ca_topic_score_gemma":0.00071050174,"teacher_disagreement_score":0.002023996,"about_ca_system_score_codex":0.00051128084,"about_ca_system_score_gemma":0.0006021524,"threshold_uncertainty_score":0.0107040405},"labels":[],"label_agreement":null},{"id":"W4376133026","doi":"10.1111/ejh.13979","title":"Impact of secondary‐type mutations in <scp><i>NPM1</i></scp> mutated <scp>AML</scp>","year":2023,"lang":"en","type":"letter","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Computer science; Computational biology; Genetics; Biology","score_opus":0.033359794818361786,"score_gpt":0.3206159618144294,"score_spread":0.28725616699606765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376133026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.742132,0.0041127075,0.000582353,0.1277783,0.0032578486,0.000091991475,0.0035547416,0.000075018914,0.11841506],"genre_scores_gemma":[0.973081,0.0011584646,0.00039174524,0.014393689,0.0013884231,0.000028113196,0.0005840955,0.000036680616,0.008937841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992816,0.00026753815,0.000050991446,0.000078963465,0.00015946358,0.00016139299],"domain_scores_gemma":[0.9960283,0.0028310695,0.00021167313,0.00017518553,0.00026861206,0.0004851997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008063245,0.00015924592,0.0004091743,0.00039397125,0.0005577955,0.0006964736,0.00029825175,0.0015770646,0.010029162],"category_scores_gemma":[0.005495755,0.00007740949,0.00035920803,0.00049696804,0.00040144907,0.00031180205,0.00022256888,0.0012855516,0.0016274669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01166522,0.0008057573,0.30342022,0.00036129897,0.00026518235,0.20110008,0.0010524201,0.0027346138,0.01745625,0.0143934535,0.26575273,0.18099281],"study_design_scores_gemma":[0.00070681144,0.0024785695,0.4535276,0.0004807736,0.00036090962,0.28065348,0.0019144191,0.00552814,0.009813358,0.022669787,0.22177196,0.00009420503],"about_ca_topic_score_codex":0.003155044,"about_ca_topic_score_gemma":0.0038952278,"teacher_disagreement_score":0.010029162,"about_ca_system_score_codex":0.0011539629,"about_ca_system_score_gemma":0.0006085464,"threshold_uncertainty_score":0.033550918},"labels":[],"label_agreement":null},{"id":"W4384126603","doi":"10.1111/ejh.14040","title":"Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A—Final efficacy and safety results from the <scp>NuProtect</scp> study","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Institute for Clinical Evaluative Sciences; BC Children's Hospital; SickKids Foundation; McMaster University Medical Centre; Hospital for Sick Children; University of British Columbia","funders":"Octapharma","keywords":"Medicine; Adverse effect; Haemophilia; Incidence (geometry); Prophylactic treatment; Clinical endpoint; Internal medicine; Surgery; Clinical trial","score_opus":0.033717184442331065,"score_gpt":0.28183055437352506,"score_spread":0.24811336993119398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384126603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938558,0.0054255766,0.00009158228,0.00006399988,0.000013264342,0.00007375129,0.00011330979,0.0000054139155,0.00035726957],"genre_scores_gemma":[0.99676174,0.002316107,0.00016123954,0.00012963623,0.00004320254,0.000056756722,0.00031531617,0.0000017168362,0.00021421482],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995585,0.00027485797,0.0000347322,0.00004184524,0.000062942345,0.00002719885],"domain_scores_gemma":[0.9993299,0.00017665184,0.00026608567,0.000045477063,0.00003536782,0.00014644225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012055403,0.0003388835,0.00067686744,0.00015528132,0.00016555109,0.0003850471,0.00023030571,0.00039693943,0.00072426995],"category_scores_gemma":[0.0007354183,0.00018095975,0.0007080899,0.00019796212,0.000298866,0.00025157555,0.00013293479,0.0006193527,0.00012979002],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4528597,0.013559383,0.22641352,0.0015332394,0.008126972,0.000861584,0.0005828193,0.0019761815,0.03249961,0.0003386671,0.003018605,0.25822976],"study_design_scores_gemma":[0.12192592,0.47914976,0.3819009,0.00025310178,0.002594991,0.0017338697,0.00014890984,0.0013447911,0.0048534404,0.00012812123,0.005918842,0.000047381676],"about_ca_topic_score_codex":0.0005736984,"about_ca_topic_score_gemma":0.0008650074,"teacher_disagreement_score":0.0012055403,"about_ca_system_score_codex":0.00032276005,"about_ca_system_score_gemma":0.0003229743,"threshold_uncertainty_score":0.006375551},"labels":[],"label_agreement":null},{"id":"W4384626056","doi":"10.1111/ejh.14041","title":"Influence of conditioning regimen intensity on outcomes post‐allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Univariate analysis; Transplantation; Myeloid leukemia; Hematopoietic stem cell transplantation; Regimen; Oncology; Myeloid; Cohort; Propensity score matching; Gastroenterology; Surgery; Multivariate analysis","score_opus":0.02923434032722486,"score_gpt":0.29421925522568576,"score_spread":0.2649849148984609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384626056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978667,0.0014509965,0.00012276052,0.000041123854,0.000005896203,0.000008414438,0.000078373196,0.0000033497272,0.00042239917],"genre_scores_gemma":[0.99940956,0.00024866912,0.00004621374,0.00003064912,0.000018062025,0.0000064863552,0.00017802454,0.0000014282044,0.000060855822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995153,0.00017607285,0.00006840912,0.00006291023,0.000113074704,0.00006426693],"domain_scores_gemma":[0.9983551,0.0006400925,0.00065464847,0.00009288384,0.00007900981,0.00017819201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010991106,0.00014718203,0.00025491163,0.0002725935,0.00011453656,0.00030023055,0.0001860962,0.00019187793,0.0013288846],"category_scores_gemma":[0.0024585766,0.000039462528,0.00036373935,0.00035340086,0.00020248495,0.00016062146,0.00020182303,0.00021721901,0.000163528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005422218,0.00017330283,0.9408504,0.000089625304,0.00056588947,0.00016527512,0.000051375144,0.0005921508,0.0025902404,0.000058489295,0.00026514436,0.049175918],"study_design_scores_gemma":[0.000085071595,0.00152026,0.99557966,0.000029168577,0.0002926553,0.0006564928,0.000025076637,0.0003086193,0.00091596233,0.00007907569,0.0005040313,0.0000040117257],"about_ca_topic_score_codex":0.00019810637,"about_ca_topic_score_gemma":0.0003785139,"teacher_disagreement_score":0.0013288846,"about_ca_system_score_codex":0.00022688885,"about_ca_system_score_gemma":0.00019312403,"threshold_uncertainty_score":0.0058127046},"labels":[],"label_agreement":null},{"id":"W4384924021","doi":"10.1111/ejh.14056","title":"How can artificial intelligence help rehabilitation programs for people with hemophilia in the coming decades?","year":2023,"lang":"en","type":"letter","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"","keywords":"Coming out; Rehabilitation; Medicine; Pediatrics; Gerontology; Physical therapy; Sociology; Gender studies","score_opus":0.06936221222919448,"score_gpt":0.3225731496766002,"score_spread":0.25321093744740575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384924021","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015250845,0.001004054,0.00004258099,0.9941241,0.0029912249,0.0000038130293,0.000020259278,0.000007179199,0.001654153],"genre_scores_gemma":[0.005174856,0.0051052375,0.00041375085,0.96587956,0.015018814,0.000046343797,0.00005422186,0.0000183214,0.008288934],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767095,0.001073127,0.0003105621,0.00014810941,0.0004981889,0.00029904715],"domain_scores_gemma":[0.9850525,0.009076736,0.0006519998,0.00032280455,0.002520427,0.0023755026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036654999,0.00040139665,0.00091703644,0.00063588266,0.0032096317,0.0035040912,0.0011702926,0.033883255,0.014348483],"category_scores_gemma":[0.03621685,0.00029089735,0.00090290635,0.000554718,0.0019653563,0.005316001,0.0016262176,0.023191722,0.010525208],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045863795,0.000062466606,0.0009096491,0.000080052974,0.000014361881,0.0012070797,0.00022400853,0.00005103275,0.00007175355,0.003183093,0.96708506,0.027065638],"study_design_scores_gemma":[0.00013508934,0.00009412686,0.0012395047,0.0010611609,0.00003161448,0.002931154,0.0014210042,0.00032444808,0.00011381696,0.024291351,0.96830875,0.000048010603],"about_ca_topic_score_codex":0.006119297,"about_ca_topic_score_gemma":0.011410215,"teacher_disagreement_score":0.033883255,"about_ca_system_score_codex":0.0025729195,"about_ca_system_score_gemma":0.005095347,"threshold_uncertainty_score":0.048000455},"labels":[],"label_agreement":null},{"id":"W4385264516","doi":"10.1111/ejh.14062","title":"Prognostic implication of pre‐transplant FEV<sub>1</sub> on long‐term outcomes following allogeneic hematopoietic stem cell transplantation","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Oncology; Multivariate analysis; Incidence (geometry); Retrospective cohort study; Cohort; Cutoff","score_opus":0.02744930365224022,"score_gpt":0.27834510158051234,"score_spread":0.2508957979282721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385264516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993,0.00023251506,0.000051711348,0.00003623555,0.0000038676544,0.0000028576176,0.00017481133,0.0000020456037,0.00019597796],"genre_scores_gemma":[0.9997042,0.000023056076,0.000018662106,0.000010610029,0.000007636144,0.0000014221969,0.00020072152,6.588177e-7,0.000033056524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996649,0.000078709956,0.000039225313,0.000058473033,0.00007603627,0.00008271443],"domain_scores_gemma":[0.9974909,0.0005744207,0.0011751626,0.0001247652,0.00019389729,0.0004408209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000658489,0.00015680851,0.00024476944,0.00047838775,0.00023917209,0.0005847338,0.00031327966,0.00036159813,0.0012617848],"category_scores_gemma":[0.002054862,0.000092843096,0.00022509742,0.000426345,0.00035663578,0.00032656587,0.00037976017,0.00048834056,0.00021065497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011208614,0.0000099482295,0.9987802,0.0000034639436,0.000010832088,0.000037729544,0.000008739644,0.000039913593,0.00013272125,0.0000055291716,0.000047048055,0.00081183045],"study_design_scores_gemma":[0.000001863749,0.00005146342,0.99946445,0.0000026356165,0.00000968453,0.00013694658,0.000023811097,0.00014893238,0.00009731827,0.000012674253,0.00004888432,0.0000013249187],"about_ca_topic_score_codex":0.0019146667,"about_ca_topic_score_gemma":0.002458724,"teacher_disagreement_score":0.0019146667,"about_ca_system_score_codex":0.00030978187,"about_ca_system_score_gemma":0.00025089143,"threshold_uncertainty_score":0.004221022},"labels":[],"label_agreement":null},{"id":"W4385791443","doi":"10.1111/ejh.14082","title":"Outcome of carfilzomib/pomalidomide‐based regimens after daratumumab‐based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; University of British Columbia; Memorial University of Newfoundland; University of Saskatchewan; Queen Elizabeth II Health Sciences Centre; University of Ottawa; Dalhousie University; Saskatchewan Cancer Agency; Ottawa Hospital; CancerCare Manitoba; McGill University; London Health Sciences Centre; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of Calgary; BC Cancer Agency; McGill University Health Centre; Jewish General Hospital; Alberta Cancer Foundation; Canadian Institutes of Health Research; Juravinski Cancer Centre; Université de Montréal; Western University; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Pomalidomide; Daratumumab; Carfilzomib; Medicine; Multiple myeloma; Oncology; Internal medicine; Lenalidomide","score_opus":0.10225996986042807,"score_gpt":0.3763843437896896,"score_spread":0.27412437392926153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385791443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95988834,0.0035001023,0.00012481071,0.00024110079,0.000008144037,0.00013496078,0.034801535,0.000012970334,0.001288045],"genre_scores_gemma":[0.9822995,0.0010959653,0.0002251677,0.00009913565,0.000008323863,0.00004547964,0.01608302,0.000005063061,0.00013827418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997761,0.0002472432,0.00029557853,0.00044939914,0.0009342249,0.0003126386],"domain_scores_gemma":[0.99539375,0.000526408,0.0022370408,0.0002595801,0.0011134322,0.00046993914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015130023,0.00031432588,0.0007721029,0.002368259,0.0007916043,0.001184896,0.0012033735,0.0004844917,0.0010795051],"category_scores_gemma":[0.005057536,0.00024401098,0.00096378557,0.006603461,0.00035281145,0.00041020653,0.00051791704,0.00059200905,0.000112599104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080625335,0.000050195962,0.9908546,0.00018960421,0.0005729331,0.000098224285,0.000091953334,0.00031849236,0.00015586411,0.00008017131,0.00164724,0.005134469],"study_design_scores_gemma":[0.00010075492,0.000083514344,0.9969932,0.000053966443,0.0003647245,0.00018176228,0.0001182275,0.00067893806,0.00009019751,0.000022296343,0.0012950687,0.000017325374],"about_ca_topic_score_codex":0.7595212,"about_ca_topic_score_gemma":0.81016713,"teacher_disagreement_score":0.989314,"about_ca_system_score_codex":0.010686007,"about_ca_system_score_gemma":0.011242282,"threshold_uncertainty_score":0.48379004},"labels":[],"label_agreement":null},{"id":"W4386208612","doi":"10.1111/ejh.14094","title":"Outpatient consolidation chemotherapy with intermediate dose cytarabine has similar survival and relapses rates in acute myeloid leukemia as compared to high dose cytarabine: A single center analysis","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Cytarabine; Medicine; Internal medicine; Regimen; Outpatient clinic; Chemotherapy; Oncology; Surgery","score_opus":0.029474219476904533,"score_gpt":0.2961845969885831,"score_spread":0.2667103775116786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386208612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993598,0.00024858964,0.00007203672,0.000012128302,0.0000025630638,0.000017702201,0.00012246372,0.000003318376,0.00016134145],"genre_scores_gemma":[0.9994079,0.00008340129,0.000056997887,0.000014986805,0.000008368664,0.000009424229,0.0003247213,0.0000035396783,0.00009064251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926597,0.00023599861,0.00009349584,0.00018340054,0.00013948587,0.00008162928],"domain_scores_gemma":[0.9978085,0.00038117042,0.0011135046,0.00018366124,0.00018616907,0.00032700872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084520155,0.00019346719,0.00046721514,0.000570497,0.00024540504,0.00062294374,0.00031502338,0.00029352756,0.0023119717],"category_scores_gemma":[0.0017167103,0.00017819721,0.0005642857,0.00068234553,0.00025522753,0.0003123617,0.0003740441,0.00032724373,0.00030233053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051699686,0.00028115226,0.98164326,0.000067547044,0.00038903643,0.00021529161,0.00012864725,0.00012402493,0.0020027112,0.00002694092,0.00029503446,0.009656539],"study_design_scores_gemma":[0.00034375096,0.0033456392,0.99294645,0.000017708382,0.00035751774,0.0011036621,0.00019327622,0.00045108423,0.0006126528,0.000021679822,0.00059605786,0.000010489578],"about_ca_topic_score_codex":0.0012972128,"about_ca_topic_score_gemma":0.0022325846,"teacher_disagreement_score":0.0023119717,"about_ca_system_score_codex":0.000526532,"about_ca_system_score_gemma":0.0004108799,"threshold_uncertainty_score":0.0077342987},"labels":[],"label_agreement":null},{"id":"W4386757545","doi":"10.1111/ejh.14080","title":"Long‐term effectiveness of eculizumab: Data from the International <scp>PNH</scp> Registry","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Alexion Pharmaceuticals; AstraZeneca","keywords":"Eculizumab; Medicine; Paroxysmal nocturnal hemoglobinuria; Internal medicine; Proportional hazards model; Hazard ratio; Renal function; Cohort; Hemoglobinuria; Gastroenterology; Surgery; Anemia; Confidence interval; Immunology; Complement system; Antibody","score_opus":0.0507329098349079,"score_gpt":0.2980045723555129,"score_spread":0.247271662520605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386757545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731049,0.0025187635,0.0007746981,0.00024368751,0.000020517287,0.00007426722,0.021106737,0.00003526759,0.002121145],"genre_scores_gemma":[0.97188145,0.0008739177,0.0005292472,0.000111377754,0.000040476425,0.00013676344,0.026049143,0.000013998125,0.00036371034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99614406,0.0017452143,0.0005802524,0.0004432606,0.0008980056,0.00018922535],"domain_scores_gemma":[0.9883195,0.0028999536,0.0068343063,0.00084400666,0.0006513465,0.00045096074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056244773,0.00020574476,0.0005681913,0.0007994396,0.00014051964,0.0007695818,0.0005223784,0.00026812547,0.0014435304],"category_scores_gemma":[0.009004476,0.00016556561,0.0005279419,0.0016657343,0.00017009073,0.0006358336,0.0004375083,0.00054596283,0.00028233268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025927848,0.00013064573,0.97823775,0.00014498988,0.0008093684,0.00012189581,0.0000552534,0.0008299368,0.00020094271,0.00009672354,0.0029038978,0.013875716],"study_design_scores_gemma":[0.00033031398,0.00042219486,0.99418604,0.000060625865,0.0004554726,0.00030846018,0.000055286353,0.0015928529,0.00026119247,0.00006555869,0.0022494446,0.0000126474915],"about_ca_topic_score_codex":0.002398096,"about_ca_topic_score_gemma":0.0034799282,"teacher_disagreement_score":0.0056244773,"about_ca_system_score_codex":0.00039470353,"about_ca_system_score_gemma":0.0006636117,"threshold_uncertainty_score":0.0297454},"labels":[],"label_agreement":null},{"id":"W4387115637","doi":"10.1111/ejh.14100","title":"Long‐term survivorship care after <scp>CAR‐T</scp> cell therapy","year":2023,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Chimeric antigen receptor; Cytokine release syndrome; Medicine; Tocilizumab; Survivorship curve; Population; CAR T-cell therapy; Immune system; Disease; Immunology; Intensive care medicine; Immunotherapy; Cell therapy; T cell; Bioinformatics; Cell; Internal medicine; Biology","score_opus":0.10031656807501967,"score_gpt":0.36828685148472,"score_spread":0.26797028340970036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387115637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017907686,0.9981304,0.00011445965,0.00027172075,0.0001925229,0.0000071786117,0.000016194972,0.000005937208,0.0010825108],"genre_scores_gemma":[0.0012075448,0.9977774,0.0001545526,0.00023333964,0.00015725094,0.000010385174,0.00003190423,0.0000013068487,0.00042631326],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998306,0.00004238218,0.00002343653,0.000020696045,0.00006044975,0.000022321574],"domain_scores_gemma":[0.9997296,0.00014633662,0.000045979457,0.0000065301733,0.00005104565,0.000020589363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005818878,0.00041453043,0.0008499188,0.0009793806,0.00020381663,0.00069346005,0.00057131785,0.00087400246,0.0026888764],"category_scores_gemma":[0.00089482754,0.00011197733,0.00046625326,0.00088043464,0.00022990903,0.000585895,0.00052466535,0.0011875808,0.0011719419],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064945925,0.00003905087,0.00014205802,0.015411211,0.00008804673,0.00025608414,0.000049268885,0.00020517077,0.0006326947,0.0017879618,0.021470157,0.9598534],"study_design_scores_gemma":[0.000036555783,0.00015256711,0.0012388317,0.011492305,0.0001856369,0.002731033,0.00008241312,0.00006542634,0.00043812086,0.0012580669,0.9823046,0.000014509122],"about_ca_topic_score_codex":0.00074781064,"about_ca_topic_score_gemma":0.0014974403,"teacher_disagreement_score":0.0026888764,"about_ca_system_score_codex":0.00046951236,"about_ca_system_score_gemma":0.0010703722,"threshold_uncertainty_score":0.008995235},"labels":[],"label_agreement":null},{"id":"W4387598782","doi":"10.1111/ejh.14117","title":"Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hematopoietic cell; Cytomegalovirus; Cohort; Internal medicine; Single Center; Univariate analysis; Cumulative incidence; Incidence (geometry); Transplantation; Human cytomegalovirus; Hematopoietic stem cell transplantation; Multivariate analysis; Immunology; Virus; Haematopoiesis; Viral disease; Herpesviridae; Stem cell","score_opus":0.08498975816963134,"score_gpt":0.31477752507409906,"score_spread":0.22978776690446773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387598782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97505194,0.0036313403,0.00030895753,0.00036613867,0.000017075141,0.00013055651,0.016238486,0.000021382408,0.0042340728],"genre_scores_gemma":[0.9908144,0.0018051425,0.00030206444,0.00017192312,0.000017168857,0.000033598353,0.0065139947,0.0000142064955,0.00032760343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813384,0.00021954492,0.00021112945,0.00027294966,0.00083239505,0.0003301431],"domain_scores_gemma":[0.99285465,0.00078880653,0.0026974701,0.00044787643,0.002403093,0.0008080079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015388328,0.00034973488,0.0005807973,0.0015041549,0.0010438965,0.0010068518,0.0010368555,0.00037964614,0.0027241327],"category_scores_gemma":[0.0040853433,0.00027179497,0.0007601822,0.0052373684,0.00041396162,0.00026534157,0.00053389353,0.0005720409,0.00032697152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042256308,0.000049533803,0.99028194,0.00014101047,0.00020619354,0.000090553876,0.00016694861,0.00014854949,0.00016486472,0.00008475638,0.001601195,0.0066418466],"study_design_scores_gemma":[0.00013462166,0.00015682084,0.9950617,0.00015107698,0.00028533046,0.00032180583,0.000330926,0.00031204656,0.00019109453,0.00003184432,0.0030032243,0.000019539602],"about_ca_topic_score_codex":0.871472,"about_ca_topic_score_gemma":0.9134312,"teacher_disagreement_score":0.128528,"about_ca_system_score_codex":0.009072785,"about_ca_system_score_gemma":0.017060392,"threshold_uncertainty_score":0.25856984},"labels":[],"label_agreement":null},{"id":"W4388574779","doi":"10.1111/ejh.14133","title":"Late‐onset <i>Pneumocystis jirovecii</i> pneumonia post‐allogeneic stem cell transplantation after time‐dependent discontinuation of prophylaxis","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Discontinuation; Internal medicine; Pneumonia; Transplantation; Interquartile range; Pneumocystis jirovecii; Immunosuppression; Surgery; Immunology","score_opus":0.00834889908734137,"score_gpt":0.22046299883279363,"score_spread":0.21211409974545226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388574779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996635,0.0013853356,0.0004998614,0.00012519093,0.000025933472,0.000019665707,0.00007306272,0.000032121105,0.0012038284],"genre_scores_gemma":[0.9994605,0.000112514,0.000070997296,0.0000992943,0.00005049469,0.000003990337,0.000090340225,0.000002709138,0.00010915521],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.999635,0.00006203767,0.00004749209,0.000052859927,0.000069331945,0.000133211],"domain_scores_gemma":[0.9976428,0.0004375885,0.0013507885,0.00007725309,0.00012586394,0.00036566786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005190473,0.00029733445,0.00045529357,0.0002481849,0.00035578356,0.0006241487,0.00020165223,0.00031276487,0.0012600289],"category_scores_gemma":[0.0014448274,0.000063884436,0.00036367693,0.0002889071,0.00029730864,0.00022848097,0.000260118,0.0005888032,0.00024179442],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001390156,0.00017443247,0.933272,0.00011335728,0.0000938613,0.030621255,0.00013539016,0.0001558239,0.0069345613,0.00013253036,0.0009288876,0.026047863],"study_design_scores_gemma":[0.00006243119,0.0023024052,0.88579005,0.00006957447,0.00011249988,0.10478898,0.00021492767,0.0006158125,0.00390955,0.00017911699,0.0019367562,0.00001796837],"about_ca_topic_score_codex":0.0003694417,"about_ca_topic_score_gemma":0.0005209625,"teacher_disagreement_score":0.0012600289,"about_ca_system_score_codex":0.00041000516,"about_ca_system_score_gemma":0.00026641565,"threshold_uncertainty_score":0.0042152405},"labels":[],"label_agreement":null},{"id":"W4390005460","doi":"10.1111/ejh.14143","title":"Determinants of durable humoral and T cell immunity in myeloma patients following <scp>COVID</scp>‐19 vaccination","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute for Health and Care Research; Janssen UK; Cancer Research UK; Myeloma UK; European Hematology Association","keywords":"Vaccination; Medicine; Antibody; Immunology; Immune system; Multiple myeloma; Immunity; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease","score_opus":0.028763906509255335,"score_gpt":0.3075254082450133,"score_spread":0.278761501735758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390005460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956363,0.00016791053,0.000029611185,0.000019579247,0.0000023412883,0.0000035928988,0.000108419146,0.0000020180337,0.00010278574],"genre_scores_gemma":[0.9997116,0.000034874407,0.000030145442,0.000013468805,0.0000071500435,0.0000037231557,0.00013877633,8.565349e-7,0.000059420076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960655,0.0000870224,0.000045320132,0.00008880107,0.00007356057,0.00009887108],"domain_scores_gemma":[0.99846435,0.00032595324,0.00080770504,0.000051142233,0.00009068484,0.00026022026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053209363,0.00018391009,0.00033930648,0.00035442165,0.00028049244,0.0004818947,0.00022189465,0.0005066647,0.0015704884],"category_scores_gemma":[0.0020280695,0.00015478433,0.00032877605,0.0005504757,0.0001989047,0.00045613936,0.00034608316,0.00058757263,0.0002647775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034981765,0.000038892504,0.9975349,0.000010014862,0.000021712065,0.000044214703,0.000037287875,0.00003221121,0.00044046508,0.00000504973,0.000052362844,0.0014331338],"study_design_scores_gemma":[0.000011340249,0.00043823203,0.9988319,0.0000052951546,0.000018884011,0.00026204166,0.00007159846,0.00011328149,0.00012172004,0.000010190978,0.000113110815,0.0000024158674],"about_ca_topic_score_codex":0.0010696296,"about_ca_topic_score_gemma":0.0008924297,"teacher_disagreement_score":0.0015704884,"about_ca_system_score_codex":0.0001928333,"about_ca_system_score_gemma":0.0002688089,"threshold_uncertainty_score":0.0052538514},"labels":[],"label_agreement":null},{"id":"W4390769807","doi":"10.1111/ejh.14167","title":"A post hoc analysis of <scp>PROTECT VIII</scp> kids assessing long‐term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia <scp>A</scp>","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Bayer","keywords":"Haemophilia; Medicine; Post-hoc analysis; Certolizumab pegol; Population; Subgroup analysis; Haemophilia A; Post hoc; Clinical trial; Internal medicine; Pediatrics; Tumor necrosis factor alpha","score_opus":0.021213001682114,"score_gpt":0.3042944079689858,"score_spread":0.28308140628687184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390769807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970673,0.00077310833,0.0003952168,0.000050156676,0.00009907722,0.0004656248,0.00071907474,0.000014818609,0.00041565226],"genre_scores_gemma":[0.9966344,0.00017878904,0.00043138216,0.00007672114,0.000088296976,0.0009861308,0.00089421164,0.000010158951,0.0007000381],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99781287,0.00085114484,0.0002290158,0.00056982273,0.00024142036,0.00029573802],"domain_scores_gemma":[0.99565,0.0019860668,0.0009730249,0.00069664867,0.00029075498,0.0004034432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038121701,0.0009300639,0.0026950212,0.00026043513,0.00024113483,0.00072519336,0.00056742196,0.0006668907,0.0037973225],"category_scores_gemma":[0.005288383,0.00026475152,0.004904598,0.00026549012,0.0003603538,0.00058034365,0.0005850033,0.0012267967,0.0002886323],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81714684,0.0031343992,0.123844296,0.0014420106,0.02252575,0.00047141546,0.0003764907,0.0011907648,0.006548021,0.00026444465,0.0017931921,0.021262424],"study_design_scores_gemma":[0.053875163,0.35294947,0.5392742,0.00024460966,0.034879547,0.0005137378,0.00047621375,0.005378117,0.005334936,0.00039868514,0.006579161,0.00009609127],"about_ca_topic_score_codex":0.0005989938,"about_ca_topic_score_gemma":0.000894651,"teacher_disagreement_score":0.0038121701,"about_ca_system_score_codex":0.0005688754,"about_ca_system_score_gemma":0.001063049,"threshold_uncertainty_score":0.020160913},"labels":[],"label_agreement":null},{"id":"W4391932170","doi":"10.1111/ejh.14176","title":"Recombinant factor <scp>IX Fc</scp> for the treatment of hemophilia B","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Swedish Orphan Biovitrum; Sanofi","keywords":"Medicine; Factor IX; Hemostasis; Intensive care medicine; Clinical trial; Bleed; Distribution (mathematics); Pharmacology; Surgery; Internal medicine","score_opus":0.05814494965814852,"score_gpt":0.33350911914275355,"score_spread":0.275364169484605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391932170","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019404314,0.9880633,0.00076606544,0.0011554019,0.00040977282,0.00003423697,0.00021255085,0.000041570194,0.0073766843],"genre_scores_gemma":[0.028323837,0.96122295,0.0017720822,0.0012179005,0.0008049808,0.00005124331,0.0004902715,0.000017233018,0.006099547],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99965036,0.00009432554,0.000045891968,0.00003150901,0.00015447679,0.000023483535],"domain_scores_gemma":[0.9996691,0.00014063953,0.00009348326,0.000011380416,0.00006209056,0.000023378103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051158306,0.00029544768,0.00041506664,0.0011099465,0.00014986155,0.0005117233,0.0002383705,0.00041311246,0.007490206],"category_scores_gemma":[0.0010156188,0.000059054884,0.0005122762,0.0007928643,0.00019714236,0.00032016396,0.00021021195,0.0006516445,0.0019223867],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003357709,0.00006003443,0.000434087,0.011899963,0.00022485113,0.00043573548,0.00004284456,0.0002310904,0.0063676657,0.002956309,0.04615613,0.93085545],"study_design_scores_gemma":[0.00011602647,0.0003661268,0.0024827148,0.0050401213,0.0002832054,0.0034202999,0.000036729783,0.00013381414,0.0037491187,0.0012778563,0.98307896,0.000014986007],"about_ca_topic_score_codex":0.0010605707,"about_ca_topic_score_gemma":0.0012165658,"teacher_disagreement_score":0.007490206,"about_ca_system_score_codex":0.00028794847,"about_ca_system_score_gemma":0.0005975381,"threshold_uncertainty_score":0.025057256},"labels":[],"label_agreement":null},{"id":"W4392106791","doi":"10.1111/ejh.14180","title":"The <scp>EASEMENT</scp> study: <scp>A</scp> multicentre, observational, cross‐sectional study to evaluate patient preferences, treatment satisfaction, quality of life, and healthcare resource use in patients with multiple myeloma receiving injectable‐containing or fully oral therapies","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"Takeda Pharmaceuticals International","keywords":"Medicine; Observational study; Patient satisfaction; Family medicine; Cross-sectional study; Quality of life (healthcare); Internal medicine; Surgery; Nursing","score_opus":0.11404974343214659,"score_gpt":0.3636238877025933,"score_spread":0.24957414427044672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392106791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614906,0.00023622699,0.00007376984,0.00008731244,0.000005181867,0.0003848544,0.0025534627,0.000004590153,0.0005054924],"genre_scores_gemma":[0.99319506,0.00029456508,0.000458242,0.00034345477,0.000047921618,0.0009062826,0.0042283568,0.000005601448,0.00052048074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915075,0.00039519882,0.000087384986,0.00012170886,0.00015450652,0.00009036719],"domain_scores_gemma":[0.99700373,0.0003835962,0.0014253068,0.00016096,0.00036484978,0.0006615346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016309267,0.00047205368,0.00045616954,0.00059483555,0.0007519474,0.0006931376,0.00043077837,0.0005003876,0.0019427432],"category_scores_gemma":[0.0019304198,0.00038534307,0.0005470244,0.0015005155,0.0003849007,0.0005548637,0.00065119,0.00071153406,0.0005375584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031507653,0.0013332085,0.9882875,0.00014258642,0.00023127758,0.00017380201,0.00027518717,0.00006697164,0.0004951201,0.00002522697,0.0015229451,0.0042953854],"study_design_scores_gemma":[0.0010539471,0.0028355804,0.9937496,0.00004225929,0.000120571756,0.00041816253,0.00022224835,0.00018919639,0.00019821373,0.000010850205,0.0011463463,0.00001293163],"about_ca_topic_score_codex":0.012451576,"about_ca_topic_score_gemma":0.017316487,"teacher_disagreement_score":0.012451576,"about_ca_system_score_codex":0.0010545965,"about_ca_system_score_gemma":0.0011822134,"threshold_uncertainty_score":0.02475822},"labels":[],"label_agreement":null},{"id":"W4393315734","doi":"10.1111/ejh.14208","title":"Ocular adverse events following <scp>CAR‐T</scp> cell therapy: A pharmacovigilance study and systematic review","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacovigilance; Adverse effect; Medicine; Pharmacology; Intensive care medicine","score_opus":0.02932337168247901,"score_gpt":0.3358748212748156,"score_spread":0.3065514495923366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393315734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00806723,0.98859507,0.00024846045,0.00033417082,0.000060409468,0.00042023716,0.0017621063,0.0000094933475,0.0005027564],"genre_scores_gemma":[0.09056467,0.9048694,0.00094929023,0.0012184298,0.00013703767,0.0007732375,0.0012575313,0.0000106521,0.00021985648],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.992668,0.0019479638,0.0033400597,0.00058781076,0.0012696021,0.00018661754],"domain_scores_gemma":[0.9652736,0.021105625,0.009891944,0.0005568529,0.0028887661,0.0002831342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006540024,0.0006887439,0.0035958316,0.0080104405,0.00036682692,0.0014680666,0.00076638954,0.0011213943,0.002582638],"category_scores_gemma":[0.025408056,0.00044277462,0.006903302,0.007743463,0.000533745,0.00114512,0.0010039911,0.0006559557,0.00020216279],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007587287,0.00004137125,0.011056649,0.90568125,0.024168408,0.00041575776,0.00029500102,0.00015319769,0.0004576003,0.00024210876,0.0023058718,0.0544242],"study_design_scores_gemma":[0.0007833819,0.00077483844,0.045323685,0.69219744,0.22612391,0.002690591,0.000609355,0.00028135153,0.0006266786,0.0006062776,0.029877296,0.00010516036],"about_ca_topic_score_codex":0.004350847,"about_ca_topic_score_gemma":0.013967816,"teacher_disagreement_score":0.0080104405,"about_ca_system_score_codex":0.0017866241,"about_ca_system_score_gemma":0.0052253925,"threshold_uncertainty_score":0.034587383},"labels":[],"label_agreement":null},{"id":"W4394916661","doi":"10.1111/ejh.14211","title":"Sickle <scp>Cell Health Awareness, Perspectives,</scp> and <scp>Experiences</scp> (<scp>SHAPE</scp>) survey: <scp>Perspectives</scp> of adolescent and adult patients, caregivers, and healthcare professionals on the burden of sickle cell disease","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Pfizer","keywords":"Medicine; Health professionals; Health care","score_opus":0.012048611198366596,"score_gpt":0.26143803542249,"score_spread":0.2493894242241234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394916661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937475,0.00018744529,0.00004337379,0.00024009327,0.000008544994,0.000061160084,0.0043507153,0.000005378113,0.0013558106],"genre_scores_gemma":[0.99420047,0.00036131227,0.00021890448,0.00023532729,0.000019037687,0.00014921768,0.004208392,0.000003160077,0.00060408417],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99926263,0.00023282877,0.00014783387,0.000054283795,0.00016863624,0.00013369224],"domain_scores_gemma":[0.9963863,0.0005543669,0.0015626285,0.0000879967,0.0005753591,0.00083336845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013088383,0.00017970815,0.0002535322,0.0006811948,0.00040940777,0.00046805496,0.00021243053,0.00035448011,0.0018205695],"category_scores_gemma":[0.002803752,0.00017111002,0.00042790486,0.00081205973,0.00022542001,0.0004982402,0.0008178061,0.0005109994,0.00026911535],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008781146,0.000071388844,0.98828286,0.0001011857,0.00005364153,0.00012296608,0.0015668535,0.00010006515,0.00022542353,0.000026163318,0.0027737843,0.0065878853],"study_design_scores_gemma":[0.000011211294,0.00011587456,0.9959906,0.000038132304,0.000013015143,0.00017268931,0.0018621299,0.00008097522,0.00008550135,0.000010089361,0.0016139785,0.000005770364],"about_ca_topic_score_codex":0.008426513,"about_ca_topic_score_gemma":0.016458346,"teacher_disagreement_score":0.008426513,"about_ca_system_score_codex":0.0004849815,"about_ca_system_score_gemma":0.0005023322,"threshold_uncertainty_score":0.016754925},"labels":[],"label_agreement":null},{"id":"W4399326989","doi":"10.1111/ejh.14247","title":"Reviewing the impact of hydroxyurea on <scp>DNA</scp> methylation and its potential clinical implications in sickle cell disease","year":2024,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"DNA methylation; Epigenetics; Fetal hemoglobin; Methylation; Disease; Erythropoiesis; Hydroxycarbamide; Bioinformatics; Medicine; Downregulation and upregulation; Mechanism (biology); Gene; Biology; Cancer research; Immunology; Genetics; Gene expression; Anemia; Fetus; Internal medicine; Pregnancy","score_opus":0.0620446499275406,"score_gpt":0.38920067161508587,"score_spread":0.32715602168754526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399326989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010614022,0.9990409,0.000047956994,0.00017942117,0.00016653037,0.0000033636625,0.000020626832,0.0000030864728,0.00043204206],"genre_scores_gemma":[0.0005064779,0.9987206,0.00010319032,0.00018574452,0.0001423247,0.0000044115513,0.0000376849,9.769918e-7,0.00029860446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998217,0.000040090563,0.000041816198,0.000027424883,0.00005669052,0.000012179285],"domain_scores_gemma":[0.9994991,0.00028562985,0.00007005176,0.000008363985,0.000113182265,0.000023658227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005165942,0.00050690304,0.00091599993,0.0020400663,0.00019664841,0.0005528611,0.00062695413,0.0007045279,0.0028796978],"category_scores_gemma":[0.0012325487,0.00020718835,0.0005548764,0.0021036963,0.0002193841,0.0007520413,0.00038640748,0.00087692245,0.0008227602],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115083705,0.00004473693,0.00025844373,0.07146387,0.00024059,0.00022098907,0.00013607589,0.00035193004,0.0016723349,0.0020884238,0.041909672,0.88149786],"study_design_scores_gemma":[0.00001977507,0.00014406146,0.0018296253,0.015885407,0.00048493908,0.0016167327,0.000089129375,0.00009627308,0.0005230699,0.0011635036,0.9781277,0.000019904792],"about_ca_topic_score_codex":0.0015059764,"about_ca_topic_score_gemma":0.0027779103,"teacher_disagreement_score":0.0028796978,"about_ca_system_score_codex":0.00040774274,"about_ca_system_score_gemma":0.001051675,"threshold_uncertainty_score":0.009633601},"labels":[],"label_agreement":null},{"id":"W4399756908","doi":"10.1111/ejh.14251","title":"Impact of cytomegalovirus (<scp>CMV</scp>) seroconversion pre‐allogeneic hematopoietic cell transplantation on posttransplant outcomes","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Serostatus; Medicine; Seroconversion; Cumulative incidence; Cytomegalovirus; Internal medicine; Transplantation; Human cytomegalovirus; Immunology; Incidence (geometry); Gastroenterology; Serology; Cohort; Betaherpesvirinae; Hematopoietic stem cell transplantation; Antibody; Viral disease; Herpesviridae; Viral load; Virus","score_opus":0.023745147115366776,"score_gpt":0.31713125518623125,"score_spread":0.29338610807086446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399756908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99936515,0.00023655496,0.000022130886,0.000015313573,0.0000026947748,0.0000016758429,0.000038957474,0.0000012748144,0.00031619432],"genre_scores_gemma":[0.999843,0.00005184465,0.000012193049,0.000008663953,0.000005707294,8.250721e-7,0.00004986988,4.337206e-7,0.000027354834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955934,0.00010769454,0.00005827753,0.00005826953,0.00011556108,0.0001007812],"domain_scores_gemma":[0.9977723,0.0005254999,0.0011561699,0.000104061844,0.00011658465,0.00032539075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059784454,0.00012465622,0.0001672885,0.00036108884,0.00021835009,0.000519672,0.00014675684,0.00016795773,0.0012834913],"category_scores_gemma":[0.0019360284,0.000079505124,0.00025093666,0.00034170868,0.00027394827,0.00028436445,0.00027250696,0.00039818158,0.00013775824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008530111,0.000015384005,0.99747473,0.0000042818747,0.000012541541,0.000075016884,0.000017735645,0.00002677798,0.000116223324,0.000007198719,0.000023371053,0.0021413623],"study_design_scores_gemma":[0.0000019951972,0.00013466993,0.9990752,0.0000046904383,0.000013507941,0.00047854814,0.000038812686,0.000064760745,0.00010737344,0.00000970295,0.00006945898,0.0000012425331],"about_ca_topic_score_codex":0.0010711659,"about_ca_topic_score_gemma":0.0020242138,"teacher_disagreement_score":0.0012834913,"about_ca_system_score_codex":0.0002353426,"about_ca_system_score_gemma":0.00027119106,"threshold_uncertainty_score":0.00429374},"labels":[],"label_agreement":null},{"id":"W4399818339","doi":"10.1111/ejh.14253","title":"Childhood autoimmune hemolytic anemia: A scoping review","year":2024,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Observational study; Autoimmune hemolytic anemia; Rituximab; Intensive care medicine; MEDLINE; Randomized controlled trial; Pediatrics; Clinical trial; Anemia; Immunology; Internal medicine; Antibody","score_opus":0.03899514370309518,"score_gpt":0.34511991972104666,"score_spread":0.30612477601795146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399818339","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018736672,0.9989625,0.000064263986,0.00017447435,0.00009291022,0.000087424356,0.00010160629,0.000005776686,0.00032356844],"genre_scores_gemma":[0.0012323546,0.99800664,0.00019720767,0.00020064937,0.000038801507,0.00011733669,0.000090193156,0.0000019368938,0.000114871036],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978582,0.0005757735,0.0008169838,0.00015844345,0.00046172575,0.0001288028],"domain_scores_gemma":[0.9899777,0.0072135716,0.0016623983,0.00013133493,0.0008914906,0.00012350161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003746588,0.0015366055,0.004945775,0.0115897665,0.00072102284,0.0023927449,0.0016884496,0.0019076084,0.0066912915],"category_scores_gemma":[0.015170693,0.00090163527,0.003817396,0.012817563,0.00067360606,0.00179146,0.0016619468,0.0012536603,0.0006595706],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010264738,0.000018972107,0.00031690218,0.8598041,0.0016510258,0.00020323096,0.00023365654,0.00016108646,0.00016411032,0.00064839073,0.007948779,0.128747],"study_design_scores_gemma":[0.000040976258,0.000052131374,0.0010705395,0.9268977,0.00718536,0.00046601405,0.00020069121,0.000050011622,0.00008974979,0.00032757022,0.06360329,0.000015951202],"about_ca_topic_score_codex":0.008801689,"about_ca_topic_score_gemma":0.016793258,"teacher_disagreement_score":0.0115897665,"about_ca_system_score_codex":0.002892828,"about_ca_system_score_gemma":0.009596631,"threshold_uncertainty_score":0.022384524},"labels":[],"label_agreement":null},{"id":"W4399897699","doi":"10.1111/ejh.14258","title":"Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Discontinuation; Adverse effect; Immunosuppression; Cytomegalovirus; Internal medicine; Cohort; Single Center; Transplantation; Hematopoietic stem cell transplantation; Surgery; Immunology; Viral disease; Herpesviridae; Virus","score_opus":0.020473283917950582,"score_gpt":0.2875138084538746,"score_spread":0.26704052453592403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399897699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654275,0.0017845815,0.0007033717,0.000089092806,0.00004017635,0.00008576449,0.00004361335,0.000017658647,0.0006929859],"genre_scores_gemma":[0.99718153,0.0016613937,0.00046788526,0.00016794162,0.00010207188,0.000032861826,0.00011961429,0.000009729261,0.00025701354],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993771,0.00021488403,0.000081603954,0.00009223951,0.0001155117,0.00011860652],"domain_scores_gemma":[0.9991047,0.00021490146,0.00013810447,0.00009539951,0.000057697864,0.00038915523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006828968,0.00080069836,0.00080563483,0.00033896297,0.00071107445,0.00085811736,0.0004252126,0.0006585597,0.00089209265],"category_scores_gemma":[0.0016139307,0.00022420933,0.000772008,0.00035964113,0.00036586737,0.00040452814,0.0004358318,0.0011242566,0.00038103334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015911609,0.03098731,0.38209516,0.000780283,0.0011461173,0.05184281,0.0048518465,0.002552687,0.05294752,0.0006068389,0.0029307238,0.45334712],"study_design_scores_gemma":[0.007745338,0.24107665,0.498109,0.00031000632,0.0010889057,0.1809068,0.0014596418,0.005244945,0.04950553,0.0004904014,0.013838438,0.00022438096],"about_ca_topic_score_codex":0.0006132749,"about_ca_topic_score_gemma":0.00067044894,"teacher_disagreement_score":0.00089209265,"about_ca_system_score_codex":0.0004639587,"about_ca_system_score_gemma":0.0005090437,"threshold_uncertainty_score":0.003611505},"labels":[],"label_agreement":null},{"id":"W4400354929","doi":"10.1111/ejh.14260","title":"Aberrant early hematopoietic progenitor formation marks the onset of hematopoietic defects in Shwachman–Diamond syndrome","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University Health Network; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Haematopoiesis; Induced pluripotent stem cell; Biology; Bone marrow failure; Bone marrow; Stem cell; Embryonic stem cell; Progenitor cell; Diamond–Blackfan anemia; Transcriptome; Cell biology; Cancer research; Immunology; Genetics; Gene; Gene expression; Ribosome; RNA","score_opus":0.008332227450907352,"score_gpt":0.22825750956239999,"score_spread":0.21992528211149262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400354929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510854,0.0010092166,0.002906806,0.000024305658,0.000005962342,0.000014503125,0.00029623657,0.00005230881,0.0005821388],"genre_scores_gemma":[0.9956143,0.0009196942,0.002216127,0.000032791002,0.0000033860708,0.000018163533,0.00038185593,0.000013196984,0.0008005662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994564,0.000006972896,0.0000054072884,0.00001404979,0.000019423871,0.000008584263],"domain_scores_gemma":[0.9999634,0.000008289665,0.0000124760845,0.000003050278,0.0000028769057,0.000009919387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007109197,0.00018946524,0.00012827457,0.0002926853,0.000076911856,0.000107365435,0.00009108155,0.00020788687,0.0007795001],"category_scores_gemma":[0.00008139628,0.00009108025,0.000098694094,0.00012785997,0.00019110304,0.00008981876,0.00019642017,0.0003217551,0.0001085584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013338412,0.000015129002,0.005374235,0.000049677103,0.0000092038035,0.0014049229,0.00006761062,0.00015538515,0.98592097,0.0002758788,0.00006929097,0.0065242928],"study_design_scores_gemma":[0.000028069682,0.00035193117,0.15652473,0.000029284376,0.00005121396,0.009803749,0.00019704008,0.0014238119,0.8244665,0.0005306998,0.0065772887,0.000015647478],"about_ca_topic_score_codex":0.00051599334,"about_ca_topic_score_gemma":0.0009140783,"teacher_disagreement_score":0.0007795001,"about_ca_system_score_codex":0.00008975078,"about_ca_system_score_gemma":0.00011781781,"threshold_uncertainty_score":0.0026077032},"labels":[],"label_agreement":null},{"id":"W4400460542","doi":"10.1111/ejh.14274","title":"Outcomes with low dose anti‐thymocyte globulin based graft versus host disease prophylaxis after mismatched unrelated donor allogeneic hematopoietic cell transplantation","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Anti-thymocyte globulin; Internal medicine; Gastroenterology; Regimen; Graft-versus-host disease; Univariate analysis; Hematopoietic stem cell transplantation; Transplantation; Multivariate analysis; Cumulative incidence; Immunology","score_opus":0.010951650076570426,"score_gpt":0.24401763495142595,"score_spread":0.23306598487485553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400460542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890316,0.0005023307,0.000059590646,0.000032980304,0.000006589849,0.0000060809707,0.000072604475,0.0000022347078,0.00041445706],"genre_scores_gemma":[0.99968266,0.00008303259,0.000020094903,0.000013755003,0.0000066615407,0.0000030980755,0.00015027405,4.3867703e-7,0.000039973133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997074,0.000051781193,0.000046407153,0.000038287424,0.00006469601,0.00009137863],"domain_scores_gemma":[0.9990056,0.0001388317,0.000513606,0.000029673503,0.000060027818,0.00025222456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004383399,0.00012985006,0.00023238108,0.00026922647,0.0002202455,0.00043401445,0.00017626466,0.00012175579,0.00087807584],"category_scores_gemma":[0.0012042474,0.000035433008,0.00027615554,0.00030195806,0.00021289344,0.00029955833,0.00040773535,0.0002961756,0.00008801919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012380601,0.00018423903,0.97815233,0.00006852531,0.0000931309,0.0005353834,0.00009405344,0.00037802802,0.00093474577,0.0000613397,0.0003062414,0.017953916],"study_design_scores_gemma":[0.00004605613,0.0023747017,0.993708,0.000041644413,0.00012549154,0.0017175766,0.00014899946,0.0003194826,0.00082178786,0.000080996935,0.00060817145,0.000007035749],"about_ca_topic_score_codex":0.0009142155,"about_ca_topic_score_gemma":0.002140358,"teacher_disagreement_score":0.0009142155,"about_ca_system_score_codex":0.00072366145,"about_ca_system_score_gemma":0.00041041677,"threshold_uncertainty_score":0.005250573},"labels":[],"label_agreement":null},{"id":"W4400504061","doi":"10.1111/ejh.14267","title":"<scp>CRP</scp> and <scp>sCD25</scp> help distinguish between adult‐onset Still's disease and <scp>HLH</scp>","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; St. Paul's Hospital; BC Children's Hospital; University of British Columbia","funders":"BC Children's Hospital; Clinton Foundation","keywords":"Medicine; Ferritin; Macrophage activation syndrome; D-dimer; C-reactive protein; Internal medicine; Gastroenterology; Hemophagocytic lymphohistiocytosis; Immunology; Leukocytosis; Inflammation; Disease","score_opus":0.020321597052999213,"score_gpt":0.2825908087518603,"score_spread":0.2622692116988611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400504061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902284,0.00027424132,0.000053749613,0.000024774232,0.0000039051997,0.000006705678,0.00008127513,0.0000031622228,0.000529195],"genre_scores_gemma":[0.99960726,0.00007273337,0.0000850413,0.000019080548,0.000008983414,0.0000026243445,0.00013723236,6.9992694e-7,0.000066476314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998062,0.000025152469,0.000036291436,0.000032094256,0.000048438746,0.00005197279],"domain_scores_gemma":[0.99938846,0.00015443646,0.00021106063,0.000016675542,0.000090738395,0.00013855324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029926404,0.00026716042,0.00030122628,0.0006694803,0.00030194683,0.00049622793,0.0001398126,0.00031841337,0.0021121989],"category_scores_gemma":[0.0009236311,0.000083827996,0.00020235409,0.0004456046,0.00028073642,0.00030487566,0.00020831704,0.00030522727,0.0002962216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113623006,0.000015903515,0.9965879,0.000008510876,0.000012467799,0.00039733664,0.000028065822,0.000015741938,0.00058031763,0.0000073059573,0.000058623253,0.0021742776],"study_design_scores_gemma":[0.000015012269,0.00019976731,0.9950675,0.000017922426,0.000018944827,0.0037573348,0.00017489458,0.00013695582,0.0003772082,0.000016970927,0.00021548642,0.0000020726543],"about_ca_topic_score_codex":0.0024144598,"about_ca_topic_score_gemma":0.0041310657,"teacher_disagreement_score":0.0024144598,"about_ca_system_score_codex":0.00022710572,"about_ca_system_score_gemma":0.00024352361,"threshold_uncertainty_score":0.007066071},"labels":[],"label_agreement":null},{"id":"W4400589592","doi":"10.1111/ejh.14271","title":"Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with <i>BCR</i>::<i>ABL1</i> digital <scp>PCR</scp> in chronic myeloid leukemia patients","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Discontinuation; Digital polymerase chain reaction; Imatinib; Myeloid leukemia; Medicine; Internal medicine; breakpoint cluster region; Tyrosine-kinase inhibitor; Cutoff; Oncology; Tyrosine kinase; Clinical endpoint; Gastroenterology; Immunology; Chemistry; Cancer; Polymerase chain reaction; Receptor; Clinical trial","score_opus":0.008593071422898032,"score_gpt":0.21905732001150868,"score_spread":0.21046424858861065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400589592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991947,0.00030607264,0.000092519374,0.00002688962,0.0000024605122,0.0000040198356,0.000171856,0.0000033494669,0.00019805817],"genre_scores_gemma":[0.99967337,0.000039154704,0.000044402765,0.000005956273,0.0000021574208,0.0000017751604,0.000178262,7.8025727e-7,0.000054259617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997217,0.00007835582,0.000025310206,0.00006340959,0.000063741485,0.000047477006],"domain_scores_gemma":[0.9986877,0.00032259247,0.0006742185,0.000050290822,0.00011050404,0.00015472606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006119317,0.00018669228,0.0003029581,0.00037863426,0.00015299866,0.0005378346,0.00029296085,0.00034396554,0.000602039],"category_scores_gemma":[0.001619719,0.000101563855,0.00032411588,0.0004063778,0.00018113153,0.00018091955,0.00022254152,0.00034108947,0.00013233315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006258139,0.000016107784,0.994636,0.000010470795,0.000026399575,0.00004683349,0.000021703834,0.00023880834,0.0005311442,0.000014357211,0.00007506559,0.0037573248],"study_design_scores_gemma":[0.000027994662,0.00025203923,0.9969387,0.000006799804,0.000039844785,0.00021231077,0.000059608432,0.0017804618,0.00037324437,0.000027330523,0.00027667577,0.0000049886344],"about_ca_topic_score_codex":0.009720926,"about_ca_topic_score_gemma":0.0098302085,"teacher_disagreement_score":0.009720926,"about_ca_system_score_codex":0.00060535147,"about_ca_system_score_gemma":0.00040630458,"threshold_uncertainty_score":0.019328654},"labels":[],"label_agreement":null},{"id":"W4401431808","doi":"10.1111/ejh.14283","title":"Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1‐mutated AML","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"NPM1; Malignancy; Myeloid leukemia; Medicine; Internal medicine; Oncology; Myeloid; Biology; Genetics; Karyotype; Gene","score_opus":0.02174067340941448,"score_gpt":0.33769936050605315,"score_spread":0.31595868709663866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401431808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993783,0.00018770929,0.000045213306,0.00003082074,0.0000028711124,0.000002139312,0.000051086292,0.0000017170555,0.00030011882],"genre_scores_gemma":[0.9997955,0.000040966963,0.00002045895,0.000010942024,0.000004784832,0.000001082776,0.000082244995,8.893372e-7,0.000043182135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997347,0.00006296504,0.000031958858,0.00004686278,0.000043796164,0.0000798208],"domain_scores_gemma":[0.9977089,0.00061944325,0.0009354394,0.0001059102,0.00011556098,0.0005146568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052947446,0.000096551776,0.0001891122,0.00030172584,0.00026980232,0.00040794277,0.00016590727,0.00023354165,0.0011897485],"category_scores_gemma":[0.0029304135,0.000068539106,0.0002688863,0.000293935,0.00021428602,0.0003899868,0.00038053497,0.00026877405,0.00015272945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004320167,0.000029459212,0.9914526,0.0000073393862,0.000016407954,0.00019382763,0.000055018474,0.00008514433,0.0006046803,0.00002215299,0.000056855428,0.007044437],"study_design_scores_gemma":[0.000008479753,0.00028343868,0.99816173,0.000006898081,0.000022275648,0.00079188973,0.0000762148,0.0002520307,0.0001733373,0.000040612664,0.00018011976,0.0000029601044],"about_ca_topic_score_codex":0.001043294,"about_ca_topic_score_gemma":0.0022642768,"teacher_disagreement_score":0.0011897485,"about_ca_system_score_codex":0.0003013811,"about_ca_system_score_gemma":0.00029941875,"threshold_uncertainty_score":0.0039801},"labels":[],"label_agreement":null},{"id":"W4401431914","doi":"10.1111/ejh.14287","title":"Recurrent venous thromboembolism and vaginal estradiol in women with prior venous thromboembolism: A nested case–control study","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto","funders":"","keywords":"Venous thromboembolism; Medicine; Nested case-control study; Obstetrics; Case-control study; Internal medicine; Thrombosis","score_opus":0.022732654492614825,"score_gpt":0.30402862000731357,"score_spread":0.28129596551469876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401431914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985827,0.00063000893,0.00034715622,0.000023843604,0.0000080823065,0.000030154364,0.00013855394,0.000003025286,0.00023653934],"genre_scores_gemma":[0.9993044,0.00013500768,0.0002541011,0.00001926449,0.000008661698,0.000020035473,0.00015021247,0.0000015231495,0.00010675618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849033,0.00061520713,0.00012901475,0.00044294656,0.00022959962,0.00009281955],"domain_scores_gemma":[0.9980573,0.0005416671,0.0006763617,0.00037486994,0.00018963417,0.00016013467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013750095,0.00024524645,0.00046489143,0.0004488807,0.0005040077,0.00051182206,0.00043374108,0.00038299413,0.0009759993],"category_scores_gemma":[0.0046392074,0.00042929052,0.00054778805,0.00053533464,0.00036455583,0.00022700094,0.00030802426,0.00031560264,0.00012537026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052991376,0.00016509685,0.99536777,0.00004139819,0.00045843792,0.00032667734,0.00025871405,0.000035405865,0.0010911772,0.00006520127,0.00010140358,0.0015587165],"study_design_scores_gemma":[0.00017817321,0.000844549,0.99379575,0.00003926182,0.00051728357,0.0025661702,0.0002469968,0.0005273535,0.0002796042,0.00008958078,0.000904419,0.000010881632],"about_ca_topic_score_codex":0.006456239,"about_ca_topic_score_gemma":0.0067961514,"teacher_disagreement_score":0.006456239,"about_ca_system_score_codex":0.00026503287,"about_ca_system_score_gemma":0.00033648685,"threshold_uncertainty_score":0.012837291},"labels":[],"label_agreement":null},{"id":"W4402070861","doi":"10.1111/ejh.14295","title":"Idiopathic multicentric Castleman disease with marrow fibrosis and extramedullary hematopoiesis","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"Recordati Rare Diseases; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; Clinton Foundation","keywords":"Extramedullary hematopoiesis; Medicine; Pathology; Haematopoiesis; Bone marrow; Fibrosis; Disease; Stem cell; Biology","score_opus":0.010580768580129973,"score_gpt":0.2420721591799359,"score_spread":0.23149139059980595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402070861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99250364,0.0015165461,0.000724981,0.0000839656,0.00001554307,0.000060567385,0.00010613213,0.000047873596,0.0049407366],"genre_scores_gemma":[0.99919826,0.00015575514,0.00029585673,0.000060223243,0.000032414842,0.0000043657205,0.000045598612,0.0000042397305,0.00020327422],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997546,0.000032622866,0.00002840455,0.000049402588,0.00005035737,0.000084550804],"domain_scores_gemma":[0.9992988,0.00014355838,0.00026088243,0.000071389404,0.00005905479,0.00016623962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032770768,0.0008805483,0.00034110068,0.0011823806,0.0007565741,0.0003552076,0.0003602808,0.00048819743,0.0021244253],"category_scores_gemma":[0.0008244472,0.00025910142,0.00021917858,0.0007465947,0.00050828536,0.0003048309,0.00050564256,0.00045299006,0.00036690998],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031388123,0.00018437755,0.3958277,0.00026924504,0.00007374958,0.56694484,0.00065913727,0.0002678014,0.018701851,0.0006050499,0.00083472487,0.015317622],"study_design_scores_gemma":[0.000039050774,0.00020126045,0.12356163,0.000026873271,0.00003320175,0.8719464,0.000120503464,0.00023235717,0.0021403774,0.00013593337,0.0015527788,0.000009675503],"about_ca_topic_score_codex":0.0009830802,"about_ca_topic_score_gemma":0.0015648194,"teacher_disagreement_score":0.0021244253,"about_ca_system_score_codex":0.00033250725,"about_ca_system_score_gemma":0.00030259698,"threshold_uncertainty_score":0.0071069},"labels":[],"label_agreement":null},{"id":"W4403735421","doi":"10.1111/ejh.14331","title":"Distance to <scp>CAR</scp>‐T Treatment Center Does Not Impede Delivery","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Apheresis; Refractory (planetary science); Internal medicine; Chimeric antigen receptor; Single Center; Referral; Gastroenterology; Surgery; Immunotherapy; Cancer","score_opus":0.02730334715386731,"score_gpt":0.30890125878051883,"score_spread":0.28159791162665154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403735421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98787165,0.002617353,0.002690123,0.0007781408,0.00003932304,0.00007292365,0.00038626252,0.00003075306,0.0055134343],"genre_scores_gemma":[0.99897265,0.0002450319,0.00041245815,0.00007166955,0.000012383382,0.000013569507,0.00009548366,0.0000052888695,0.00017154455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988545,0.0002997545,0.00016630013,0.00015504943,0.0002935309,0.0002308043],"domain_scores_gemma":[0.9957332,0.0013220551,0.0021356714,0.000155344,0.00034319665,0.00031062058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009045997,0.00012564888,0.00024512722,0.00022495193,0.0006132357,0.0010653193,0.00037562117,0.00033079102,0.004105094],"category_scores_gemma":[0.0043813717,0.000099684585,0.00028343307,0.00050473487,0.0007001237,0.0004968143,0.0004974979,0.00036504603,0.00045150684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001092731,0.00006093416,0.94404775,0.0006994659,0.00023507932,0.0022036082,0.0005239197,0.0024387345,0.0051798285,0.00084178,0.0027736293,0.0399026],"study_design_scores_gemma":[0.00016134714,0.0009876692,0.9476233,0.00022478215,0.0004153314,0.012141891,0.0020760067,0.0022378222,0.006366508,0.00062638574,0.027107345,0.000031640546],"about_ca_topic_score_codex":0.032806184,"about_ca_topic_score_gemma":0.05490821,"teacher_disagreement_score":0.032806184,"about_ca_system_score_codex":0.0030799988,"about_ca_system_score_gemma":0.0041996306,"threshold_uncertainty_score":0.06523049},"labels":[],"label_agreement":null},{"id":"W4404020293","doi":"10.1111/ejh.14341","title":"Daratumumab in the Management of Red Cell Aplasia Following Allogeneic Hematopoietic Stem Cell Transplantation","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Daratumumab; Medicine; Pure red cell aplasia; Hematopoietic stem cell transplantation; Aplastic anemia; Oncology; Transplantation; Intensive care medicine; Internal medicine; Anemia; Multiple myeloma; Bone marrow; Bortezomib","score_opus":0.018197237845790984,"score_gpt":0.25904086327607617,"score_spread":0.2408436254302852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404020293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.785429,0.18037386,0.007236052,0.009804986,0.0009505154,0.00022823858,0.000076735436,0.00022624027,0.01567427],"genre_scores_gemma":[0.98196536,0.013344204,0.0018002439,0.0015822374,0.00034962964,0.000021464062,0.00005629795,0.000008903706,0.0008715827],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99984634,0.0000482557,0.000028678955,0.000014712022,0.00003206718,0.000029875167],"domain_scores_gemma":[0.99984205,0.000051708423,0.000047414076,0.00000773191,0.000013659434,0.00003734056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003298831,0.0002734658,0.00046339753,0.00028531736,0.0003532922,0.00037263113,0.00028543957,0.0006643001,0.0003442949],"category_scores_gemma":[0.00061338005,0.00007515591,0.0002924429,0.00020062161,0.00025180902,0.0002271029,0.00025236496,0.0010312585,0.00020245947],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029288363,0.0006769394,0.03688087,0.0014391122,0.0004013239,0.35542,0.00054393755,0.002803706,0.033383176,0.0030822703,0.008484105,0.5539557],"study_design_scores_gemma":[0.0012459754,0.0046942057,0.040535685,0.00060850714,0.00048200134,0.85104924,0.00028579077,0.005919935,0.02081547,0.002639343,0.0716708,0.000052993124],"about_ca_topic_score_codex":0.00025204275,"about_ca_topic_score_gemma":0.0007733901,"teacher_disagreement_score":0.0006643001,"about_ca_system_score_codex":0.0003321746,"about_ca_system_score_gemma":0.00030761285,"threshold_uncertainty_score":0.0024101138},"labels":[],"label_agreement":null},{"id":"W4404050519","doi":"10.1111/ejh.14317","title":"Maternal and Fetal Outcomes of Aplastic Anemia During Pregnancy and Delivery: Systematic Review and Meta‐Analysis","year":2024,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Meta-analysis; Preeclampsia; Aplastic anemia; Abortion; Publication bias; Cohort study; Retrospective cohort study; Prospective cohort study; Pediatrics; Internal medicine","score_opus":0.0446025269717282,"score_gpt":0.3138522281901661,"score_spread":0.26924970121843794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404050519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017580279,0.9972711,0.0002531081,0.0001252417,0.00007180326,0.00017231116,0.00023101052,0.000009683905,0.00010772575],"genre_scores_gemma":[0.061231162,0.93498814,0.0014949224,0.00042035014,0.0001833488,0.0011139339,0.0004052295,0.000012166737,0.00015082897],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98721015,0.006103101,0.0037759647,0.0010215304,0.0015383714,0.00035090538],"domain_scores_gemma":[0.9654256,0.026850404,0.0049849185,0.0007969376,0.0016916482,0.0002505126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017672455,0.002603169,0.01924294,0.008077839,0.00061081146,0.0036053858,0.002219397,0.0023180388,0.003080431],"category_scores_gemma":[0.0471935,0.0012974159,0.031977788,0.008801124,0.0008023473,0.0017599161,0.0015538919,0.001939242,0.00021907328],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011119102,0.000026245847,0.0033369765,0.58025914,0.39984456,0.000110508314,0.0000875334,0.00048602125,0.00013088141,0.00013737855,0.00059335167,0.013875547],"study_design_scores_gemma":[0.00039894905,0.0002231495,0.0043275557,0.06948778,0.92262584,0.00014847252,0.000051267147,0.00018776239,0.0001140169,0.00020950104,0.0021975853,0.000028136774],"about_ca_topic_score_codex":0.0059202295,"about_ca_topic_score_gemma":0.012507007,"teacher_disagreement_score":0.01924294,"about_ca_system_score_codex":0.0029338943,"about_ca_system_score_gemma":0.004725403,"threshold_uncertainty_score":0.09346199},"labels":[],"label_agreement":null},{"id":"W4404473527","doi":"10.1111/ejh.14351","title":"Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; University of Ottawa; Joseph Brant Hospital; Lawson Health Research Institute; University of Toronto; Western University; Canadian Blood Services; SickKids Foundation; Hospital for Sick Children; London Health Sciences Centre; Queen's University; McMaster University; Saskatchewan Health Authority; Impact","funders":"Canadian Institutes of Health Research; Health Canada; Einstein Stiftung Berlin; Canadian Blood Services","keywords":"Immune thrombocytopenia; Medicine; Systematic review; Intensive care medicine; Immune system; Severe bleeding; MEDLINE; Pediatrics; Immunology; Platelet; Surgery","score_opus":0.0303647052277549,"score_gpt":0.33622915115524005,"score_spread":0.30586444592748513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404473527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011988735,0.9976057,0.0001215851,0.00022614945,0.00008223471,0.00030346442,0.00023933777,0.000007727655,0.00021482476],"genre_scores_gemma":[0.02225281,0.97549635,0.0007418116,0.0005825051,0.00009378348,0.000530429,0.00022191023,0.000004805367,0.00007567322],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9929147,0.0028645135,0.0026565182,0.00041547502,0.0009631259,0.0001855849],"domain_scores_gemma":[0.9724917,0.019244704,0.005794861,0.0002987032,0.0018851584,0.00028486643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067387214,0.0012585507,0.0079677375,0.005861878,0.00053157174,0.0021536867,0.0016694457,0.0017352543,0.0033388552],"category_scores_gemma":[0.0363504,0.00089363207,0.008628937,0.0061688046,0.0007005626,0.0017099051,0.000978194,0.0012688695,0.00021996869],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032565015,0.000022950959,0.0008480076,0.953519,0.016192237,0.000068125286,0.00010074739,0.000107787244,0.00008661105,0.00012162867,0.0011243267,0.027483094],"study_design_scores_gemma":[0.00075484114,0.00031927114,0.004074617,0.8677781,0.11557347,0.00029075335,0.00018003942,0.000120566954,0.0001402841,0.00024015318,0.010495849,0.00003214176],"about_ca_topic_score_codex":0.00672815,"about_ca_topic_score_gemma":0.01996896,"teacher_disagreement_score":0.0079677375,"about_ca_system_score_codex":0.0029017793,"about_ca_system_score_gemma":0.007884748,"threshold_uncertainty_score":0.035638213},"labels":[],"label_agreement":null},{"id":"W4405308472","doi":"10.1111/ejh.14362","title":"<scp>BAY</scp> 81‐8973 Demonstrates Long‐Term Safety and Efficacy in Children With Severe Haemophilia A: Results From the <scp>LEOPOLD</scp> Kids Extension Study","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; McMaster University; McMaster Children's Hospital","funders":"Bayer","keywords":"Bay; Extension (predicate logic); Term (time); Medicine; Physics; Computer science; History","score_opus":0.022667379429618363,"score_gpt":0.285579327533637,"score_spread":0.26291194810401863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405308472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980812,0.0012904142,0.000085430904,0.00004136613,0.0000037905447,0.000022544898,0.00014199695,0.0000080629625,0.0003251313],"genre_scores_gemma":[0.99836534,0.0007052107,0.00019082546,0.000054222222,0.00001641742,0.000017644625,0.00040671093,0.00000463246,0.00023901026],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99969995,0.00014262767,0.000026324504,0.000029851968,0.000060421735,0.00004082666],"domain_scores_gemma":[0.9992906,0.00017093243,0.00024609035,0.000057029527,0.00006303564,0.0001723148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000990514,0.00024163678,0.00046946065,0.00008367147,0.00011858629,0.00027396396,0.0001640365,0.00018975722,0.00087846466],"category_scores_gemma":[0.00055665657,0.00008050654,0.0002846593,0.00014326985,0.00029213636,0.00019820234,0.00012755285,0.00056121283,0.00026481866],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14519545,0.012116399,0.32658097,0.0011346716,0.0014412907,0.0024636656,0.0011498552,0.0019126958,0.12888046,0.00038739666,0.007310779,0.37142643],"study_design_scores_gemma":[0.024429305,0.30218154,0.6239535,0.00012443766,0.0007383682,0.0075660003,0.00021719726,0.00090328825,0.025716607,0.000073198906,0.014060719,0.00003587576],"about_ca_topic_score_codex":0.00090713595,"about_ca_topic_score_gemma":0.001162251,"teacher_disagreement_score":0.000990514,"about_ca_system_score_codex":0.00022067095,"about_ca_system_score_gemma":0.00031500147,"threshold_uncertainty_score":0.005238354},"labels":[],"label_agreement":null},{"id":"W4405850856","doi":"10.1111/ejh.14376","title":"Underrepresentation of Small Lymphocytic Lymphoma in Clinical Trials for Chronic Lymphocytic Leukemia","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services","funders":"","keywords":"Chronic lymphocytic leukemia; Chemoimmunotherapy; Medicine; Clinical trial; Follicular lymphoma; Internal medicine; Oncology; Lymphoma; Cancer; Leukemia","score_opus":0.24920460784277412,"score_gpt":0.46771486865956996,"score_spread":0.21851026081679584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405850856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6415206,0.17226891,0.049854223,0.04658952,0.0043095737,0.025494304,0.008008547,0.00033064038,0.051623605],"genre_scores_gemma":[0.95579135,0.005870533,0.010919779,0.012506389,0.0015809232,0.010174805,0.0019893337,0.00009815413,0.0010687927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.2543582,0.62839067,0.07094659,0.012739164,0.030109363,0.0034559588],"domain_scores_gemma":[0.2758468,0.5294363,0.124105476,0.035026483,0.026677066,0.008907845],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.47737807,0.00080228504,0.0031562003,0.0049162176,0.0020210864,0.0075446977,0.0023571656,0.0029225147,0.005107217],"category_scores_gemma":[0.4931281,0.00084267644,0.002689103,0.0053751552,0.0036282819,0.005236742,0.005576254,0.002925996,0.00096149446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05581991,0.0007795378,0.53273016,0.012768427,0.007912827,0.00048990676,0.0046540983,0.0021207652,0.0027068318,0.0116815725,0.017654087,0.35068184],"study_design_scores_gemma":[0.0201801,0.020105029,0.6029773,0.020099735,0.009992008,0.004389868,0.0038710998,0.010481605,0.004559665,0.0365594,0.26645806,0.00032611747],"about_ca_topic_score_codex":0.0006258669,"about_ca_topic_score_gemma":0.0012972079,"teacher_disagreement_score":0.5226219,"about_ca_system_score_codex":0.0028616986,"about_ca_system_score_gemma":0.0048002577,"threshold_uncertainty_score":0.64448595},"labels":[],"label_agreement":null},{"id":"W4406108299","doi":"10.1111/ejh.14380","title":"Impact of Day 11 Methotrexate Dose Adjustments due to Mucositis on the Outcomes Following Allogeneic Stem Cell Transplant in the Setting of Anti Thymocyte Globulin (<scp>ATG</scp>) Based <scp>GVHD</scp> Prophylaxis","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Anti-thymocyte globulin; Mucositis; Methotrexate; Globulin; Stem cell; Immunology; Thymocyte; Medicine; T cell; Internal medicine; Biology; Toxicity; Immune system","score_opus":0.020312369967668192,"score_gpt":0.2887236746398868,"score_spread":0.26841130467221863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406108299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938726,0.00028047807,0.000018482728,0.00004202233,0.0000033655379,0.0000035331975,0.00005264376,9.545671e-7,0.00021126276],"genre_scores_gemma":[0.99983287,0.000056275836,0.000014285402,0.000010268413,0.0000043252307,0.0000015371824,0.00006032935,2.9932542e-7,0.000019783974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992418,0.00020731303,0.00012902569,0.00008109348,0.00017907498,0.000161724],"domain_scores_gemma":[0.9950641,0.00083811523,0.003086028,0.000097222364,0.00023399094,0.00068052113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009893511,0.00012197064,0.00023735042,0.00032287053,0.0003074853,0.0006019134,0.00021508882,0.0001606409,0.00076369103],"category_scores_gemma":[0.0037767102,0.000072197996,0.00037616462,0.00034771988,0.0002869405,0.00026029116,0.00042197958,0.0004336993,0.00008503974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005607455,0.0000324134,0.9953269,0.000018257979,0.00005071274,0.00013670702,0.000056065564,0.00011795845,0.00017972953,0.000012443487,0.00006869041,0.0034392963],"study_design_scores_gemma":[0.000014340241,0.00059738674,0.99818987,0.000016476926,0.000069149435,0.00047342884,0.00012541459,0.00017257158,0.00018415404,0.000013053253,0.00014070018,0.0000034948894],"about_ca_topic_score_codex":0.0037276805,"about_ca_topic_score_gemma":0.009671508,"teacher_disagreement_score":0.0037276805,"about_ca_system_score_codex":0.0012949316,"about_ca_system_score_gemma":0.000898164,"threshold_uncertainty_score":0.009395361},"labels":[],"label_agreement":null},{"id":"W4406926013","doi":"10.1111/ejh.14385","title":"Iron Overload, Oxidative Stress, and Somatic Mutations in <scp>MDS</scp>: What Is the Association?","year":2025,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Myelodysplastic syndromes; Oxidative stress; Bone marrow; International Prognostic Scoring System; Haematopoiesis; Myeloid; Medicine; Somatic cell; Bone marrow failure; Erythropoiesis; Progenitor cell; Bioinformatics; Cancer research; Internal medicine; Oncology; Stem cell; Biology; Genetics; Anemia; Gene","score_opus":0.024635990797010128,"score_gpt":0.33261495520361556,"score_spread":0.30797896440660544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406926013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000080986465,0.99947757,0.000019425855,0.00016607634,0.000059327016,0.0000023823525,0.00001678217,0.0000020886853,0.00017542964],"genre_scores_gemma":[0.0006972396,0.9989165,0.00005966759,0.00011655149,0.000075108626,0.000003842329,0.000022666709,6.209153e-7,0.000107846296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969697,0.000062963736,0.00007655094,0.00005043968,0.000089949244,0.000023138911],"domain_scores_gemma":[0.9990689,0.00054838817,0.00018716378,0.000014885675,0.00014782524,0.000032765245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006687514,0.0006548567,0.0019058571,0.0036300595,0.00025035546,0.0010146531,0.00074412965,0.0010959312,0.003568323],"category_scores_gemma":[0.0017267484,0.00027047994,0.0010553459,0.0034993791,0.00032948298,0.0010984741,0.0004526141,0.0007413766,0.000837862],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016628779,0.000042207364,0.00077758374,0.1538502,0.0006326026,0.0004019568,0.00011913375,0.00017897795,0.0007627388,0.0013314796,0.023752477,0.8179843],"study_design_scores_gemma":[0.00007718755,0.00027047476,0.008886856,0.14366598,0.0042933472,0.0092049595,0.0003255794,0.00020587922,0.0008006287,0.0027397627,0.8294596,0.00006964236],"about_ca_topic_score_codex":0.0019134004,"about_ca_topic_score_gemma":0.002687271,"teacher_disagreement_score":0.0036300595,"about_ca_system_score_codex":0.0005572938,"about_ca_system_score_gemma":0.0017162453,"threshold_uncertainty_score":0.011937201},"labels":[],"label_agreement":null},{"id":"W4407570874","doi":"10.1111/ejh.14392","title":"Sustained Improvement in Health‐Related Quality of Life in Transplant‐Ineligible Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone: <scp>MAIA</scp> Final Analysis of Patient‐Reported Outcomes","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Janssen Research and Development; Johnson and Johnson; Janssen Scientific Affairs; National Cancer Institute; Kite Pharma; Celgene; Amgen","keywords":"Daratumumab; Lenalidomide; Medicine; Dexamethasone; Multiple myeloma; Internal medicine; Oncology; Quality of life (healthcare)","score_opus":0.030771107431434543,"score_gpt":0.3157290462354384,"score_spread":0.2849579388040039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407570874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988728,0.0004842434,0.000109421526,0.000038538812,0.00000985303,0.000052563,0.00028294924,0.0000062325075,0.00014342426],"genre_scores_gemma":[0.99932396,0.000060171973,0.00011073559,0.000030305606,0.0000110340325,0.000056966146,0.00033399195,0.0000015243636,0.000071376846],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.998135,0.0011165405,0.00012931589,0.00021431484,0.00021798628,0.00018679864],"domain_scores_gemma":[0.9973641,0.0011514894,0.0008799192,0.00014255887,0.00013587801,0.00032598333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005617836,0.0004538322,0.0015709881,0.00035375598,0.00021693173,0.0008384227,0.00050046033,0.00032844397,0.0010994242],"category_scores_gemma":[0.0029622824,0.00018366598,0.0028754768,0.0003489346,0.00030367874,0.00043216324,0.00048507977,0.00090371666,0.00008798017],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5191486,0.0033894437,0.4071642,0.0005873045,0.013324901,0.00013048877,0.00020259511,0.0038904294,0.0061715674,0.00010398621,0.0008663618,0.04502022],"study_design_scores_gemma":[0.026325217,0.13447064,0.8208775,0.00007044663,0.0076398025,0.00026031412,0.00016824591,0.0056589055,0.003455945,0.0001511337,0.0008827131,0.0000391181],"about_ca_topic_score_codex":0.00081284397,"about_ca_topic_score_gemma":0.0017429496,"teacher_disagreement_score":0.005617836,"about_ca_system_score_codex":0.0006030112,"about_ca_system_score_gemma":0.0008049265,"threshold_uncertainty_score":0.029710352},"labels":[],"label_agreement":null},{"id":"W4408534942","doi":"10.1111/ejh.14411","title":"Daratumumab for Posttransplant Autoimmune Hemolytic Anemia","year":2025,"lang":"en","type":"letter","venue":"European Journal Of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Autoimmune hemolytic anemia; Medicine; Daratumumab; Immunology; Hemolytic anemia; Anemia; Dermatology; Internal medicine; Antibody; Monoclonal antibody","score_opus":0.0169117475757505,"score_gpt":0.2570097166015386,"score_spread":0.2400979690257881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408534942","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.076073095,0.35294902,0.0067219837,0.41025728,0.14390798,0.00016400166,0.00034400803,0.0006103992,0.008972197],"genre_scores_gemma":[0.47365612,0.07338347,0.003852372,0.21739781,0.217491,0.00012259017,0.00033434466,0.00016200464,0.013600312],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99943906,0.0001681078,0.000097824304,0.000085991036,0.00011556206,0.00009342494],"domain_scores_gemma":[0.9990625,0.0003589584,0.00014880179,0.000033099197,0.00018559294,0.000211207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007825993,0.00047806482,0.001045855,0.0004800389,0.00054879166,0.0007918065,0.00073460507,0.0026781848,0.001093534],"category_scores_gemma":[0.0025913368,0.0002078288,0.00051824516,0.00026946067,0.0004022246,0.0009621658,0.00038575256,0.004113106,0.0006529571],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014785905,0.00029663,0.016768325,0.0020649284,0.0005212328,0.19529577,0.00038606112,0.0005051335,0.008716095,0.0021977255,0.49009258,0.28167692],"study_design_scores_gemma":[0.00037250968,0.0010577914,0.0139418775,0.0007725495,0.0004321728,0.33412316,0.00022140607,0.0021835663,0.0073106657,0.0019970282,0.63749695,0.00009041528],"about_ca_topic_score_codex":0.00026471165,"about_ca_topic_score_gemma":0.00052682945,"teacher_disagreement_score":0.0026781848,"about_ca_system_score_codex":0.00052062917,"about_ca_system_score_gemma":0.00040039918,"threshold_uncertainty_score":0.0041388273},"labels":[],"label_agreement":null},{"id":"W4408580322","doi":"10.1111/ejh.14416","title":"Central Nervous System Manifestations of Graft‐Versus‐Host Disease","year":2025,"lang":"en","type":"letter","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Graft-versus-host disease; Host (biology); Central nervous system; Disease; Medicine; Nervous system; Immunology; Pathology; Neuroscience; Biology; Internal medicine; Genetics","score_opus":0.0221753835575874,"score_gpt":0.2606632549026766,"score_spread":0.2384878713450892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408580322","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03261641,0.010606725,0.0011480252,0.67663413,0.024734318,0.00024731355,0.00149283,0.00022537954,0.25229493],"genre_scores_gemma":[0.3504363,0.019128934,0.0015349736,0.40737724,0.060107343,0.00026266312,0.0013107394,0.0001522589,0.15968958],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99942577,0.00022094743,0.00005509392,0.00005640344,0.00011108706,0.00013083937],"domain_scores_gemma":[0.9990213,0.0005400095,0.000066863286,0.00005635621,0.0001442891,0.00017123416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046679977,0.00061059615,0.0007456647,0.0006469785,0.0012084945,0.0010372907,0.0006666568,0.007916117,0.019144395],"category_scores_gemma":[0.0037113498,0.00025553067,0.00048763675,0.00060547265,0.00082530745,0.0011071907,0.0004495742,0.0042621284,0.008398007],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026255703,0.00011593701,0.0066434257,0.00016462985,0.000036832174,0.34116623,0.0002548009,0.00026943025,0.0014069134,0.0035594518,0.624774,0.021345753],"study_design_scores_gemma":[0.0003210117,0.0002925349,0.023032095,0.0008194018,0.00006951713,0.4354685,0.0006977973,0.0015711271,0.0011275226,0.016791474,0.51972175,0.00008734641],"about_ca_topic_score_codex":0.0035895992,"about_ca_topic_score_gemma":0.003651454,"teacher_disagreement_score":0.019144395,"about_ca_system_score_codex":0.0009762327,"about_ca_system_score_gemma":0.00061671494,"threshold_uncertainty_score":0.06404436},"labels":[],"label_agreement":null},{"id":"W4409741845","doi":"10.1111/ejh.14428","title":"Medical and Nutritional Outcomes Are Similar Among Autologous Transplant Patients on Enteral Nutrition When Compared to Parenteral Nutrition. A Randomized Pilot Study","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Cancer Care Ontario; Western University","funders":"","keywords":"Medicine; Parenteral nutrition; Malnutrition; Randomized controlled trial; Enteral administration; Internal medicine; Body mass index; Hematopoietic stem cell transplantation; Pediatrics; Transplantation","score_opus":0.03019671723004881,"score_gpt":0.31778961146729556,"score_spread":0.28759289423724677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409741845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985701,0.00048084458,0.00013569997,0.00006413376,0.00006416527,0.00025207107,0.00009215616,0.0000047184467,0.00033621673],"genre_scores_gemma":[0.99822897,0.00031092347,0.00029905525,0.00017789702,0.00009929497,0.00029628203,0.0002706933,0.0000023535044,0.000314611],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99836,0.0010582625,0.00012701639,0.00016694922,0.00013431093,0.00015342157],"domain_scores_gemma":[0.9972556,0.0009915753,0.0005687756,0.00028692113,0.00012576037,0.0007713931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024744996,0.0005254168,0.0011949143,0.000376047,0.00033759332,0.0006270237,0.00039814625,0.0010739614,0.0041762628],"category_scores_gemma":[0.002737335,0.0002448628,0.0014847387,0.000413079,0.0010539256,0.00076153333,0.0004199991,0.0009926141,0.00036795333],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91837215,0.022536285,0.028802758,0.00026401773,0.0013107084,0.00012767903,0.00005939869,0.0002636486,0.0027322043,0.00011133538,0.0002893402,0.02513037],"study_design_scores_gemma":[0.2264749,0.7022235,0.06617362,0.00006795701,0.0011350076,0.00027933327,0.00013119259,0.0009824049,0.0012951499,0.00032402299,0.00088109745,0.000031755393],"about_ca_topic_score_codex":0.0003000603,"about_ca_topic_score_gemma":0.0004622527,"teacher_disagreement_score":0.0041762628,"about_ca_system_score_codex":0.00035444513,"about_ca_system_score_gemma":0.00073626783,"threshold_uncertainty_score":0.013970971},"labels":[],"label_agreement":null},{"id":"W4410143391","doi":"10.1111/ejh.14430","title":"Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hematopoietic stem cell transplantation; Gastroenterology; Transplantation; Incidence (geometry); Cyclophosphamide; Myelodysplastic syndromes; Busulfan; Graft-versus-host disease; Anti-thymocyte globulin; Oncology; Chemotherapy; Bone marrow","score_opus":0.017156429193606337,"score_gpt":0.2918642025781279,"score_spread":0.27470777338452157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410143391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988023,0.0006856943,0.000079118516,0.000028156472,0.000005932056,0.0000042950996,0.00008716743,0.0000020771233,0.00030514703],"genre_scores_gemma":[0.9996762,0.000108162625,0.00001238107,0.0000098036435,0.000007997167,0.0000015965228,0.00015065176,5.434403e-7,0.000032710243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959344,0.00012005418,0.000047161993,0.000051702464,0.000095460935,0.00009212883],"domain_scores_gemma":[0.9988772,0.00014549022,0.0005852913,0.000042241423,0.00006116445,0.00028862752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068168837,0.00022376642,0.00029552626,0.00032128827,0.000244702,0.00046002408,0.00014584867,0.00019709743,0.00047586678],"category_scores_gemma":[0.0014185268,0.00007356131,0.00040077706,0.0003382276,0.00027284728,0.000232923,0.00049801415,0.00029723553,0.00010583803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008712798,0.000065624394,0.9893287,0.000024638031,0.00015751395,0.0006307327,0.000073745854,0.00029591436,0.0004592141,0.000050554634,0.000119208285,0.00792289],"study_design_scores_gemma":[0.000035735084,0.0007700482,0.9960951,0.000019397576,0.00017265326,0.0016519661,0.00014148293,0.00037920504,0.0002558509,0.00010369282,0.00036849978,0.000006361715],"about_ca_topic_score_codex":0.0007662705,"about_ca_topic_score_gemma":0.0012957242,"teacher_disagreement_score":0.0007662705,"about_ca_system_score_codex":0.00033613367,"about_ca_system_score_gemma":0.00028716848,"threshold_uncertainty_score":0.0036051273},"labels":[],"label_agreement":null},{"id":"W4410330493","doi":"10.1111/ejh.14434","title":"Genetic Landscape and Risk Stratification of <scp>AML</scp> With Hyperdiploid Karyotype","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"University Health Network","keywords":"Internal medicine; Myeloid leukemia; Karyotype; Oncology; Medicine; Confounding; Cohort; Cytogenetics; Risk stratification; Chromosome; Genetics; Gene; Biology","score_opus":0.010755976729565048,"score_gpt":0.25751127013321506,"score_spread":0.24675529340365002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410330493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999579,0.000100197816,0.00007458578,0.000024297897,0.0000011409224,0.0000024423127,0.000050843297,0.0000024089284,0.00016507464],"genre_scores_gemma":[0.9997472,0.00004303645,0.000052307594,0.000007842268,0.000004152868,0.0000013868244,0.00010446788,0.0000017151079,0.000037861602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997342,0.00007397485,0.000033971894,0.00005318994,0.00005421999,0.000050400016],"domain_scores_gemma":[0.99916613,0.00018205198,0.0003985481,0.00005217568,0.00006445848,0.00013670519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030604695,0.0001681896,0.00018607435,0.0007475768,0.00025897348,0.0004738934,0.00027116627,0.000334082,0.0013349709],"category_scores_gemma":[0.0019073607,0.00013616832,0.00020759708,0.0007818036,0.0003101779,0.00025389556,0.00042224536,0.00028243772,0.00026224932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011592187,0.000008105475,0.99653685,0.0000037453913,0.000019159777,0.00030814248,0.00001903041,0.00008159661,0.0009466836,0.000028090599,0.000046629335,0.0018859936],"study_design_scores_gemma":[0.0000049176883,0.000047246856,0.99721116,0.0000031514594,0.000023864413,0.0016510561,0.00007552366,0.00048557168,0.00023714914,0.00010832388,0.0001491836,0.0000029395176],"about_ca_topic_score_codex":0.0015613872,"about_ca_topic_score_gemma":0.0015551826,"teacher_disagreement_score":0.0015613872,"about_ca_system_score_codex":0.00018788967,"about_ca_system_score_gemma":0.00021187242,"threshold_uncertainty_score":0.004465878},"labels":[],"label_agreement":null},{"id":"W4410873166","doi":"10.1111/ejh.14438","title":"Impact of Conditioning Intensity on Survival in Adult Patients (&lt; 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post‐Transplantation Cyclophosphamide Based <scp>GVHD</scp> Prophylaxis","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cyclophosphamide; Medicine; Myeloid leukemia; Globulin; Myeloid; Transplantation; Internal medicine; Immunology; Conditioning; Gastroenterology; Chemotherapy","score_opus":0.006431586956255188,"score_gpt":0.24237606289306218,"score_spread":0.235944475936807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410873166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995024,0.00025713505,0.000028346734,0.000021952947,0.000003990923,0.0000025818204,0.00003385052,0.0000010495662,0.00014867749],"genre_scores_gemma":[0.9997696,0.00006012617,0.000015765967,0.000019412566,0.000008104441,0.0000015785639,0.000086076914,4.623929e-7,0.000038874205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997514,0.00007995698,0.000023522402,0.000047009846,0.00003747619,0.000060725473],"domain_scores_gemma":[0.9990722,0.00018816539,0.00042814866,0.000049356582,0.000036934234,0.00022519288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057693693,0.00015337246,0.00017735711,0.00028047824,0.00013842055,0.00030171924,0.00012584373,0.0002432157,0.0011600091],"category_scores_gemma":[0.0013058821,0.00007217714,0.00038968967,0.00030101443,0.00021523592,0.00023032483,0.00028052507,0.00024490902,0.00012514082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001915604,0.00007848928,0.99060553,0.000010165393,0.00012439581,0.00007609865,0.00002549805,0.00021526757,0.0005845904,0.000028891396,0.000102922604,0.0062326016],"study_design_scores_gemma":[0.00004626809,0.00086820876,0.99790907,0.000007836453,0.000115569615,0.00022928396,0.00003278625,0.00039561914,0.00015379296,0.00004132521,0.00019706863,0.0000030933045],"about_ca_topic_score_codex":0.00070401136,"about_ca_topic_score_gemma":0.0010401437,"teacher_disagreement_score":0.0011600091,"about_ca_system_score_codex":0.00025060071,"about_ca_system_score_gemma":0.00019823636,"threshold_uncertainty_score":0.0038805604},"labels":[],"label_agreement":null},{"id":"W4410932907","doi":"10.1111/ejh.14443","title":"Efficacy and Safety of Bendamustine‐Rituximab for Nodular Lymphocyte Predominant Hodgkin Lymphoma","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services","funders":"","keywords":"Bendamustine; Medicine; Internal medicine; Tolerability; Neutropenia; Rituximab; Rash; Gastroenterology; Adverse effect; Population; Lymphoma; Surgery; Chemotherapy","score_opus":0.011521212179555798,"score_gpt":0.2727653484747512,"score_spread":0.2612441362951954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410932907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497765,0.0038739012,0.00009523422,0.000088957466,0.0000062076415,0.00003752326,0.000097846685,0.000012385404,0.0008103823],"genre_scores_gemma":[0.999154,0.0004598275,0.00005030471,0.000043924818,0.000014167757,0.000008256024,0.00015715147,0.0000015268627,0.00011092411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997003,0.00009184654,0.000020934918,0.00002509269,0.00011712337,0.00004465447],"domain_scores_gemma":[0.9993864,0.00016387955,0.000198958,0.00003376351,0.00009847689,0.00011848452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012864629,0.00018222666,0.00036967947,0.00019203477,0.00014560937,0.00035172654,0.00025297998,0.0002425254,0.00050797855],"category_scores_gemma":[0.0014298775,0.000089141264,0.00024966302,0.00018005529,0.00028119478,0.00019034253,0.00012202347,0.00043139458,0.00013417735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047108565,0.0026080792,0.6021995,0.0005448274,0.0008598721,0.0013034608,0.0004640418,0.0021571412,0.041934263,0.00011006844,0.0014511857,0.299259],"study_design_scores_gemma":[0.0027246566,0.03268799,0.955696,0.00006646557,0.0003809002,0.002069566,0.00008635359,0.00075462123,0.0030736104,0.00005969548,0.0023860505,0.000014021938],"about_ca_topic_score_codex":0.0034721354,"about_ca_topic_score_gemma":0.007324581,"teacher_disagreement_score":0.0034721354,"about_ca_system_score_codex":0.0010351446,"about_ca_system_score_gemma":0.0007054785,"threshold_uncertainty_score":0.0075104833},"labels":[],"label_agreement":null},{"id":"W4410975252","doi":"10.1111/ejh.14426","title":"Sensitization of Non‐<scp>M3</scp> Acute Myeloid Leukemia Blasts to All‐<i>Trans</i> Retinoic Acid by the <scp>LSD1</scp> Inhibitor Tranylcypromine: <scp>TRANSATRA</scp> Phase I Study","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Deutschen Konsortium für Translationale Krebsforschung","keywords":"Retinoic acid; Tranylcypromine; Myeloid leukemia; Sensitization; Myeloid; Chemistry; Tretinoin; Cancer research; Pharmacology; Medicine; Immunology; Biochemistry; Gene; Enzyme","score_opus":0.006219842120234684,"score_gpt":0.25224893083010763,"score_spread":0.24602908870987295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410975252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791473,0.0004057105,0.0003445906,0.00006322295,0.000022821554,0.00048218225,0.00020513011,0.00003443317,0.00052705995],"genre_scores_gemma":[0.9969433,0.00045357228,0.00059692585,0.00010136862,0.000040163035,0.000500444,0.00050534087,0.000013843026,0.0008449718],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996605,0.000178512,0.000025069492,0.000042935113,0.00003622512,0.000056769284],"domain_scores_gemma":[0.9995803,0.00009041778,0.00006895053,0.00006323686,0.000027508988,0.00016945413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009982716,0.0007567555,0.0011980297,0.00027927483,0.00032152695,0.00044326365,0.0006320435,0.00060980197,0.002503911],"category_scores_gemma":[0.00041948693,0.00036475138,0.00074949034,0.00026760576,0.0005722806,0.00032590682,0.00022615495,0.0018389855,0.0005430326],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2350977,0.07140941,0.0053151855,0.0008049196,0.00068395614,0.00051522563,0.0004552211,0.004283014,0.60867065,0.00050217524,0.0034052206,0.068857335],"study_design_scores_gemma":[0.10882625,0.75823456,0.014884964,0.000037654252,0.00034046455,0.00070659554,0.000089842964,0.0026477478,0.11057012,0.0001972298,0.00343279,0.0000319016],"about_ca_topic_score_codex":0.0006168014,"about_ca_topic_score_gemma":0.0012120451,"teacher_disagreement_score":0.002503911,"about_ca_system_score_codex":0.00043247687,"about_ca_system_score_gemma":0.0008209966,"threshold_uncertainty_score":0.00837636},"labels":[],"label_agreement":null},{"id":"W4413138559","doi":"10.1111/ejh.70020","title":"Renal Involvement in Chronic Graft‐Versus‐Host Disease","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nephrotic syndrome; Membranous nephropathy; Hematopoietic stem cell transplantation; Internal medicine; Kidney disease; Minimal change disease; Immunosuppression; Proteinuria; Gastroenterology; Transplantation; Graft-versus-host disease; Disease; Complication; Kidney; Focal segmental glomerulosclerosis","score_opus":0.025050435843917456,"score_gpt":0.2919700022065511,"score_spread":0.26691956636263364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413138559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943718,0.0032988547,0.00032029444,0.000058522746,0.000008049622,0.000010831443,0.000045350927,0.000008566735,0.0018776878],"genre_scores_gemma":[0.99922097,0.0005048165,0.00009295978,0.00003069628,0.000024817718,0.0000025033808,0.00003254161,0.0000010409581,0.000089737405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997601,0.000059063514,0.000030879568,0.000039371545,0.000046750807,0.00006385667],"domain_scores_gemma":[0.9995005,0.00013481079,0.00018557535,0.000032643886,0.00003796028,0.00010849504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049488666,0.00021561694,0.00028467993,0.00068041263,0.00046616147,0.00033420307,0.00020010045,0.00030357164,0.0009425679],"category_scores_gemma":[0.00085007586,0.00010064411,0.0001697372,0.0005379797,0.00038827056,0.00027932302,0.0003956636,0.00028754683,0.000118313976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121339704,0.000035828492,0.9733412,0.000076246506,0.000020506697,0.0120125795,0.00016354893,0.00009033417,0.0032486531,0.000121436606,0.00014019158,0.010627997],"study_design_scores_gemma":[0.000012392776,0.00031127743,0.8662117,0.000059242677,0.00003361001,0.13044138,0.00023541825,0.00021438305,0.0009892932,0.00018771042,0.0012935806,0.0000100152565],"about_ca_topic_score_codex":0.0007287747,"about_ca_topic_score_gemma":0.0009799845,"teacher_disagreement_score":0.0009425679,"about_ca_system_score_codex":0.00015637939,"about_ca_system_score_gemma":0.0002864081,"threshold_uncertainty_score":0.0031531453},"labels":[],"label_agreement":null},{"id":"W4413270532","doi":"10.1111/ejh.70018","title":"The Clinicopathologic Spectrum of Rosai–Dorfman–Destombes Disease in Adults: An Analysis of 16 Cases","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of British Columbia","funders":"Victoria General Hospital Foundation","keywords":"Rosai–Dorfman disease; Medicine; Dermatology; Disease; Pathology","score_opus":0.014983610140978373,"score_gpt":0.3092551246069061,"score_spread":0.2942715144659277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413270532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988072,0.0005542703,0.00010791844,0.000013765045,0.0000034574625,0.00001876735,0.00006828078,0.000004510216,0.00042184838],"genre_scores_gemma":[0.9991704,0.00040561016,0.00017977433,0.000013944598,0.000007339644,0.000008122045,0.00013796138,0.0000018530876,0.00007492508],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9995159,0.000044919692,0.000104399885,0.000103702696,0.00012467058,0.00010647727],"domain_scores_gemma":[0.9992625,0.00012178401,0.00027323273,0.000050508188,0.00011119089,0.00018074797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041408534,0.00045675915,0.00032568228,0.0018679287,0.0008539643,0.0006017648,0.00025767233,0.00037188586,0.00079646654],"category_scores_gemma":[0.0013476625,0.00026947196,0.00020670787,0.0013256258,0.0006927028,0.00036761918,0.0006342276,0.00020661703,0.0002241166],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004742445,0.000012853682,0.98950094,0.000011931599,0.000010274544,0.006199417,0.0002141929,0.000028895038,0.0007093172,0.000016400209,0.00008229224,0.0031660716],"study_design_scores_gemma":[0.000008091735,0.00013689423,0.936968,0.00004028008,0.00002716337,0.05946746,0.0016321993,0.00024053815,0.00038031794,0.000055026525,0.0010324772,0.000011478191],"about_ca_topic_score_codex":0.008302239,"about_ca_topic_score_gemma":0.015172267,"teacher_disagreement_score":0.008302239,"about_ca_system_score_codex":0.00061505876,"about_ca_system_score_gemma":0.00054391817,"threshold_uncertainty_score":0.016507864},"labels":[],"label_agreement":null},{"id":"W4417361914","doi":"10.1111/ejh.70081","title":"Eltrombopag in Treating Post‐Allogeneic Hematopoietic Stem Cell Transplantation Cytopenias: Efficacy, Response Durability, and Cost Benefit of Early Drug Tapering","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Eltrombopag; Tapering; Cladribine; Context (archaeology); Hematopoietic stem cell transplantation; Cytopenia; Transplantation","score_opus":0.010716933284667876,"score_gpt":0.25623340128535077,"score_spread":0.24551646800068289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417361914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858225,0.0133948,0.00019351984,0.00010426866,0.0000070114006,0.000023139995,0.000043662865,0.0000030298613,0.0004080236],"genre_scores_gemma":[0.99719125,0.0023131233,0.00019874773,0.000056349192,0.000022556052,0.000012168902,0.000054757995,8.242937e-7,0.00015011255],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996507,0.00019788627,0.000039164057,0.000024606788,0.00005707647,0.000030489478],"domain_scores_gemma":[0.9995615,0.00022325348,0.00014350835,0.000020568103,0.000018500608,0.000032777836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082308374,0.00014524399,0.00028966638,0.00028756986,0.0000734584,0.00029288937,0.00012074828,0.00019056426,0.00039484486],"category_scores_gemma":[0.001111915,0.000047034668,0.00020900046,0.00024219613,0.00017471085,0.00016948686,0.00015875636,0.0002746146,0.000058314617],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051065013,0.0022906621,0.291794,0.000736878,0.00064970244,0.001862639,0.00024090194,0.0033132501,0.020410975,0.00051518355,0.00043194613,0.6266888],"study_design_scores_gemma":[0.0036240162,0.10188801,0.84050524,0.00032795963,0.0014989675,0.007992142,0.0002587605,0.004234495,0.027508063,0.00051017123,0.011613243,0.000038886414],"about_ca_topic_score_codex":0.00016868909,"about_ca_topic_score_gemma":0.00033114696,"teacher_disagreement_score":0.00082308374,"about_ca_system_score_codex":0.0001823075,"about_ca_system_score_gemma":0.00013396372,"threshold_uncertainty_score":0.004352927},"labels":[],"label_agreement":null}]}